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Abbreviations 
Bn:    Bent tail 
CI:   confidence interval 
cM:    centiMorgan 
ct:    curly tail 
DAG :    diacylglycerol 
DNA:    deoxyribonucleic acid 
ED:    embryonic day 
EUROCAT:    European Surveillance of Congenital Anomalies 
GLUT:                   glucose transporter  
GPI:   Glycosyl-phosphatidylinositol 
HMIT:          H+myo-inositol transporter 
HPE:   Holoprosencephaly 
IP :                inositol phosphate   
ISYNA1:            myo-inositol 1-phosphate synthase A1 
KST1:   kidney sodium (Na+)/glucose transporter 
MIPMK :  inositol phosphate multikinase 
MLP :   MARCKS like protein 
NIR:   PYK2 N-terminal interacting receptor  
NTDs :   neural tube defects 
OEIS :          Omphalocele-Exstrophy-Imperforate anus-Spinal defects  
PIG:    phosphatidylinositol glycan 
PITP :   phosphatidylinositol transfer protein  
PKC :   protein kinase C 
PLC:   phospholipase C 
PP:   pyrophosphate 
RDGBβ:  retinal degeneration B-beta (=PITP) 
RNA:    ribonucleic acid 
SLC:   solute carrier  
SMIT:   sodium-dependent myo-inositol transporter 
SSCP:    single strand conformation polymorphism 
TDT:   transmission disequilibrium test 
TFAP2A:  transcription factor AP2A 
ZIP:    Zinc (Zn2+)-Iron (Fe2+) permease family 
ZnT:    zinc transporter
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1.1 Neurulation 
Neurulation is commonly described as the developmental process that results in 
the folding of a flat sheet of epithelial cells into an elongated tube. The neural 
tube is formed in humans during the third and fourth week after fertilization. 
Much of the knowledge on mammalian neurulation comes from studies in the 
mouse (Copp et al. 2003) and chicken (Colas and Schoenwolf 2001), but studies 
on human embryos have also been performed (O'Rahilly and Muller 1994). 
Neurulation can be divided into two different events, primary and secondary 
neurulation. Primary neurulation refers to events that occur on the dorsal side of 
the embryo and results in the formation of the brain and spinal cord. Secondary 
neurulation refers to the formation of the caudal neural tube by processes of 
canalization and retrogressive differentiation. 
 
1.1.1 Primary neurulation 
Primary neurulation occurs in four successive stages: formation, elevation and 
convergence of the neural folds, and finally closure of the neural groove (Fig 1; 
events 1-4). The first stage, the formation of the neural folds, is initiated as the 
ectoderm thickens owing to induction by the underlying notochord and chordal 
mesoderm. This process does not require non-neural ectodermal cells (Colas and 
Schoenwolf 2001). During this shaping process the ectodermal cells of the 
forming neural plate increase in height and undergo pseudostratification (Fig 1; 
event 1a). Furthermore, the plate undergoes shaping by convergent extension, 
which is due to elongation of neural plate cells in cranio-caudal direction and 
accompanied by their narrowing in latero-medial direction. The edges of the 
neural plate become elevated relative to its midline, converting the plate into a 
neural groove. The cells of the floorplate decrease in height and become wedge-
shaped. The mechanism of wedging is suggested to involve apical constriction by 
contraction of the apically arranged microfilament bundles. 
The second and third stages of neurulation are elevation and convergence of the 
neural folds, subsequently. During these events the neural plate rotates around the 
hinge points, which consist of wedge-shaped cells. Folding around the median 
hinge point is called elevation (Fig 1; event 2) and that around the lateral hinge 
points is called convergence (Fig 1; event 3). Elevation of the neural folds 
requires the presence of lateral non-neuroepithelial tissues (Schoenwolf et al. 
1988). The last stage of neurulation involves the closure of the neural grooves 
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with formation of the roof plate of the neural tube, the neural crest and the 
overlying surface epithelium (Fig 1; event 4). When the neural folds have 
approached each other, fusion of the folds will occur, and at least an anterior 
neuropore and a posterior neuropore arise. The closure mechanism varies along 
the neural axis, as is discussed by Shum and Copp (1996). 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.  Formation of the neural tube during mammalian embryogenesis (Gilbert 2001). 
Abbreviations: MHP=medial hinge point, DLHP=dorsal lateral hinge point. 
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1.1.2 Fusion of the neural folds in man and mouse 
The manner of fusion of the neural folds differs between man and mouse. This is 
shown in figure 2. This figure shows the regions of fusion of the neural folds 
according to two studies for humans and three studies for the mouse (Nakatsu et 
al. 2000; O’Rahilly and Müller 2002; Copp and Bernfield 1994; MacDonald et 
al. 1989). For the human situation, 2 and 3 fusion initiation sites have been 
described, whereas for  the mouse 3 and 4 sites have been mentioned.  
 
 
 
Fig 2. Comparisons of the areas of fusion of the neural folds according to three schemes 
for the mouse and two schemes for the human situation (O’Rahilly and Müller 2002). For 
each of these schemes the numeral or the letter is placed on the initial sites of fusion. 
Region 4 of the mouse is considered by Copp et al. (2000) to be “a neuropore-type 
closure and not an initiation process.” Somites 1-4 are represented by the four circles. 
The black squares indicate when accessory loci have been found in the study of O’Rahilly 
and Müller (2002). *Macdonald et al. 1989. **Copp and Bernfield 1994. ¶Nakatsu et al. 
2000. ¶¶O’Rahilly and Müller 2002. Abbreviations: Pros.=Prosencephalon, 
Mes.=Mesencephalon, Rhomb.=Rhombencephalon, Mus=Mus musculus, 
Homo=Homos sapiens. 
 
Initial closure of the neural tube starts at somite stage 4-6 in man and 
approximately at the stage with 7 somites in mouse (O’Rahilly and Müller 2002; 
Sakai 1989). The anterior neuropore is closed at the stage with 19-20 somites in 
humans and 12-17 somites in mouse (O’Rahilly and Müller 2002; Sakai 1989). 
Furthermore, the rhombencephalic neuropore is closed at approximately the stage 
with 15-20 somites in mouse. Nakatsu and coworkers had described a 
rhombencephalic neuropore in the human situation, which was not observed by 
Chapter 1 
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O’Rahilly and coworkers (Nakatsu et al. 2000; O’Rahilly and Müller 2002). 
O’Rahilly suggested that this neuropore may exist only briefly. Closure of the 
posterior neuropore in humans is completed at approximately 31 somites, 
whereas in mouse the posterior neuropore is closed when 23-39 somites have 
appeared (O’Rahilly and Müller 2002; Sakai 1989).  
 
1.1.3 Secondary neurulation 
Closure of the posterior neuropore is followed by secondary neurulation, which 
leads to formation of the most caudal portion of the spinal cord (O'Rahilly and 
Muller 1994; Griffith et al. 1992). Like primary neurulation, secondary 
neurulation proceeds in several overlapping stages. Secondary neurulation 
involves canalization of the medullary cord, which is a condensation of 
mesenchymal cells (Schoenwolf and Nichols 1984). The process of canalization 
continues until approximately the seventh week after fertilization in humans, 
whereas formation of the secondary neural tube in mouse occurs in 9.5 to 12 day 
embryos (Schoenwolf 1984). 
 
1.2 Neural tube defects, a general introduction 
When the neural tube is formed incorrectly during early embryogenesis neural 
tube defects (NTDs) arise (Copp and Bernfield 1994; Copp et al. 2000; Juriloff 
and Harris 2000). Several different types of NTDs can be distinghuished in man 
and mouse according to their level of fusion defect along the anterior-posterior 
neural axis. A fusion defect affecting the total neural axis will result in 
craniorachischisis. Lack of fusion on the cephalic part of this axis results in 
anencephaly in man (or its murine homolog exencephaly (Muller and O'Rahilly 
1991)). Children with anencephaly are missing the main part of the brain and 
skull and usually die in the uterus or at birth. The prevalence of anencephaly in 
the northern part of the Netherlands according to EUROCAT is 0.4 per 1,000 
births 
(http://www.rivm.nl/vtv/data/kompas/gezondheidstoestand/ziekte/afwzenuwst/ 
afwzenuwst_omvang.htm). Furthermore, defective fusion at the spinal part of the 
neural axis results in spina bifida, which has a prevalence of 0.7 per 1,000 births 
in the northern part of the Netherlands according to EUROCAT 
(http://www.rivm.nl/vtv/data/kompas/gezondheidstoestand/ 
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ziekte/afwzenuwst/afwzenuwst_omvang.htm). Spina bifida (SB) can be 
subdivided into three different categories: meningocele, myelomeningocele, 
together known as spina bifida aperta (Fig 3) and spina bifida occulta (Copp et al. 
2003). The spina bifida types will be described in more detail in the rest of this 
section. 
 
 
 
 
 
 
 
 
 
 
Fig 3. Category of spinal NTDs (modified from Botto et al. 1999). Meningocele: herniation 
of meninges and cerebrospinal fluid through a bony defect of the spine. Myelomeningocele: 
herniation of the spinal cord, nerves, or both through a bony defect of the spine. 
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1.2.1 Spina bifida 
In the less severe and least common type of spina bifida, meningocele, the 
meninges (membraneous coverings of the spinal cord) herniate through the defect 
of the spine to form a smooth cystic sac filled with cerebrospinal fluid, without 
involvement of the spinal cord (Knowlton et al. 1985). Thus, children with 
meningocele usually have no significant neuronal impairment. The meningocele is 
most commonly situated in the posterior part of the neural axis.  
In the more severe type of spina bifida, myelomeningocele, neural tissue and 
meninges herniate through a defect in the spinal cord to form a sac-like cystic 
midline structure. Most of the myelomeningocele cases involve the lumbosacral 
region of the neural axis, whereas the remainder involves the thoracic region.  
Myelomeningocele is commonly observed with hydrocephalus, whereas this 
phenomenon is observed rarely in patients with meningocele. A malformation of 
the hindbrain, or brainstem, the type 2 Arnold-Chiari malformation is associated 
with myelomeningocele and can cause hydrocephalus (Caviness 1976). The 
cerebellum may be elongated and drops down along the lower brainstem, through 
the case of the skull and into the cervical canal. Children with myelomeningocele 
usually have severe neuronal impairment. 
Spina bifida occulta is the least severe type of NTDs. It is also known as hidden 
split spine. The fusion of one or more vertebral arches does not proceed 
properly. The bony defect is overgrown by skin. There is no defect present in the 
spinal column, meninges or nerve roots of humans with spina bifida occulta. If 
spina bifida occulta is present there may be a small dimple at the bottom of the 
back. Other skin abnormalities like hairy patches or skin colouring can also 
occur. Spina bifida occulta is seen in the general population with a frequency of 
approximately 5-10% (Boone et al., 1985; Fidas et al. 1987). 
 
1.3 Mouse models for human neural tube defects 
The anatomical sites of the human NTDs, anencephaly, spina bifida and 
rachischisis, along the rostro-caudal axis are similar to those of mouse NTDs. 
Now, over 80 mouse models are known for human NTDs (Copp et al. 2003). 
Most of these models are knockout mice that cause specific NTD types, each 
reflecting the failure in closure of the neural folds of particular elevation zones. 
Most of these mutations cause exencephaly, which results from failure of closure 
                                                                                    General introduction 
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of the neural folds of elevation zone 2 or zone 3 according to Copp et al. (2003) 
(Fig 2). In some mouse models exencephaly is present in combination with spina 
bifida, resulting from failure of closure of zone 2 and the caudal part of zone 1 
(Fig 2; Copp et al. 2003), respectively. A few mouse models for NTDs show 
only spina bifida with defective closure of the caudal part of zone 1, and a few 
models show craniorachischisis with defective closure of whole zone 1 (Fig 2; 
Copp et al. 2003). There is just one mouse model that shows encephalocele, but 
no other type of NTD (Bennett 1959). The neural tube closes normally for mice 
showing encephalocele, however the defect results from brain tissue herniating 
through the skull (Fig 2; Copp et al. 2003). Finally, some mouse models for 
NTDs show exencephaly with split face, which result from a closure defect of 
zone 3 (Fig 2; Copp et al. 2003). There is one mouse strain with a genetically 
determined multifactorial risk for exencephaly, the SELH/Bc mouse strain 
(Macdonald et al. 1989). A diverse set of genetic functions can be subscribed to 
the mutated genes of all those models. Some genes are involved in apoptosis, 
cytoskeletal rearrangements, DNA methylation, transcription, signal transduction 
or telomerase activity (Juriloff and Harris 2000). 
 
1.4 Midline closure defects and left-right axis malformations in combination 
with neural tube defects 
In several epidemiologic studies NTDs have been associated with other types of 
embryonic midline closure defects, like omphalocele and cleft lip and palate 
(Calzolari et al. 1997; Calzolari et al. 1995; Czeizel 1981). Formation of the lip 
and palate occurs in humans during the 10th - 12th week of gestation. Cleft lip 
and palate and NTDs have been observed together with the eye disorder, 
anophthalmia, described as anophthalmia-plus syndrome (Christensen et al. 
2000). Combination of clinical features as omphalocele, exstrophy of the cloaca, 
imperforate anus, and spinal NTDs have been observed together in the OEIS 
syndrome (Keppler-Noreuil 2001). In addition, holoprosencephaly, which is 
another midline closure defect, has sometimes been seen to occur together with 
NTDs (Cohen 1989). Holoprosencephaly (HPE) encompasses a range of 
phenotypes that vary in severity and involve the malformation of the brain and 
upper face along the midline. Onset takes place in humans at the 5th and 6th week 
of gestation. At the mild end of the clinical spectrum, patients have a single 
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central incisor; at the severe end, complete fusion of the cerebral hemispheres 
with a single cerebral ventricle (alobar HPE) can be seen. 
NTDs have also been observed together with left-right axis malformations, which 
include organ positioning defects like situs inversus and situs ambiguous (Gebbia 
et al. 1997). For situs inversus a mirror-image pattern is seen for all organs, 
whereas for situs ambiguous only one or a few organs are positioned incorrectly. 
Apart from situs abnormalities, murine NTDs have also been observed with other 
left-right axis malformations: defects in axial rotation (Izraeli et al. 1999). 
Murine axial rotation takes place during the second week of gestation and this 
process is not observed in humans. 
 
1.5 Neural tube defects: a multifactorial trait 
The most common types of birth defects that have a multifactorial predisposition 
are cleft lip with or without cleft palate (Wyszynski and Beaty 1996), and NTDs 
(Hall et al. 1988). Multifactorial diseases are caused by combinations of 
unfavorable genetic and environmental factors. As for the environmental part of 
NTDs many different factors can be of influence. It has been shown that 
geographic location and socioeconomic status, ethnicity, diabetes mellitus, 
hyperthermia, use of anti-epileptica, alcohol intake, maternal age and maternal 
nutrition can be involved in human NTDs (Arruda et al. 1998; Baker et al. 1990; 
Myrianthopoulos and Melnick 1987; Naggan and MacMahon 1967; Milunsky et 
al. 1992; Lindhout and Schmidt 1986; Padmanabhan et al. 1994; Czeizel and 
Dudas 1992; Dolk et al. 1991; Halperin and Wilroy 1978; Smith 1997). One of 
the nutrients of particular attention is folate. It has been shown that 
periconceptional supplementation of folic acid lowers the occurrence and 
recurrence risk of human NTDs (MRC 1991; Czeizel and Dudas 1992; Berry et 
al. 1999; Berrry and Li 2002). Furthermore, genetic factors are involved as is 
shown by the fact that anencephaly affects live-born females more often than live-
born males, whereas the opposite is seen for defects in the lower spines (Cuckle 
et al. 1993; Seller 1995). The involvement of genetic factors is further reflected 
by the increased recurrence risk for close relatives of patients. There is familial 
clustering of NTDs in approximately 3% of cases (Chatkupt et al. 1992; Mariman 
and Hamel 1992). 
A multifactorial threshold model has been proposed to explain the inheritance 
patterns and recurrence risks of NTDs  (Falconer 1981). This model assumes the 
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existence of a continuous variable “liability”, which is determined by a 
cummulative effect of genetic and environmental factors involved in NTDs. An 
individual is affected when the “liability” exceeds a developmental “threshold” 
value. 
 
1.5.1 Folate and neural tube defects 
Folate is a watersoluble “B” vitamin. The term folic acid is used for its synthetic 
form present in multivitamins, folic acid tablets, and fortified foods. Folate is 
involved in DNA/RNA synthesis and methyl-transfer reactions (van der Put et al. 
2001). Studies on the folate status were sometimes conflicting, but overall 
mothers with NTD offspring tended to have slightly less folate in red blood cells 
than controls (Smithells et al. 1976; Yates et al. 1987; Wald 1994). The 
mechanism behind this lower folate status in mothers with NTD children is not 
known, but might result from a defective folic acid metabolism in the mother 
with an effect on embryogenesis (Steegers-Theunissen et al. 1991; Steegers-
Theunissen et al. 1994). Supplementation of folic acid to pregnant women 
reduces both recurrences and occurrences of NTDs (MRC 1991; Czeizel and 
Dudas 1992; Berry et al. 1999; Berry et al. 2002). In addition to human studies 
also in several murine models, like Splotch and Crooked, folic acid 
supplementation reduces the incidence of NTDs as reviewed by Juriloff and 
Harris (2000). One of the enzymes that has been studied for its involvement in 
NTDs is 5,10-methylenetetrahydrofolate reductase (MTHFR), which catalyzes 
the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. It 
was shown by Frosst and coworkers that the genetic variant 677C>T in this gene 
results in a thermolabile enzyme and elevated homocysteine levels (Frosst et al. 
1995). This variant is regarded as a risk factor for human NTDs (van der Put et 
al. 1995). Other genes involved in folate or homocysteine metabolism that have 
been associated with human NTDs are methionine synthase and methionine 
synthase reductase (Zhu et al. 2003; Doolin et al. 2002; Gueant-Rodriguez et al. 
2003; Pietrzyk et al. 2003).  
 
1.5.2 Zinc 
Zinc, a small hydrophilic highly charged trace element is needed for almost all 
cellular processes. In the body zinc is primarily found intracellularly. Thirty to 
40% of intracellular zinc is localized in the nucleus, 50% in the cytosol and 
Chapter 1 
 20
cytosolic organelles and the remainder is incorporated in membranes (Vallee and 
Falchuk 1993). Approximately 90% of all zinc in mammals is present in zinc 
metalloproteins, which serve as a cellular zinc storage. The accumulation of zinc 
in fetal and placental tissues is progressive during pregnancy. Functions of zinc 
can be divided into three categories: 1) catalytic, 2) structural and 3) regulatory. 
The first category includes nearly 300 different enzymes that are dependent on 
zinc to catalyze vital chemical reactions. Zinc-dependent enzymes are present in 
all known classes of enzymes. Zinc ions act via zinc finger domains in proteins. 
There are numerous types of conserved zinc finger domains, which are listed in 
Interpro (http://www.ebi.ac.uk/InterPro) and at the Web-based interface, 
http://cassandra.visac.uq.edu.au/zf. The second category of the functions of zinc 
is the maintenance of the structural integrity of proteins or membranes. Loss of 
zinc from biological membranes increases the susceptibility to oxidative damage 
and impair their cellular function (Bray and Bettger 1990; Bettger 1993; O'Dell 
2000). The third category of zinc-dependent functions is fulfilled by the 
regulatory proteins. This type of protein is involved in a wide range of processes, 
including gene expression regulation, cell signaling, hormone release and nerve 
impulse transmission. 
Dietary intake of zinc by healthy adults varies from 6 to 15 mg per day. Zinc 
absorption is greater from a diet high in animal protein than a diet rich in plant 
proteins. Inositol hexakisphosphates and pentakisphosphates (phytate), which are 
found in whole grain breads and cereals can decrease zinc absorption by the body 
(Davidsson et al. 1996; Lonnerdal et al. 1989). The phosphate groups in inositol 
hexaphosphate can form strong and insoluble complexes with zinc (Irvine et al. 
1988). Because the gastrointestinal tract of higher species lack any significant 
phytase activity, phytate-bound minerals will be excreted in the stool. Amino 
acids, such as histidine and methionine, and organic acids (e.g. citrate), are 
known to have a positive effect on zinc absorption and have been used in zinc 
supplements (Scholmerich et al. 1987).  
 
1.5.2.1 Zinc transport mechanisms 
Since zinc plays an important role in humans, zinc deficiency manifests itself in a 
number of different phenotypes (Fraker et al. 1996; Sazawal et al. 1997; Haeger 
1973; Sandstead et al. 1967; Prasad 1988; Simmer and Thompson 1985; 
Marchesini et al. 1998; Henkin et al. 1975), including NTDs. Causes of zinc 
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deficiency include dietary inadequacy, malabsorption, and problems with zinc 
utilization (e.g. due to chronic infection). In healthy humans in the Netherlands 
the concentrations for zinc are within the range of 15-27 µmol/l in blood plasma 
(Wong et al. 2002). Plasma zinc levels are decreased in cases of zinc deficiency. 
Zinc can not cross biological membranes by passive diffusion, therefore 
specialized mechanisms exist to allow membrane transfer. Two families of zinc 
transporters exist in mammals (Harris 2002). One family comprises the ZnT 
family (ZnT-1 to ZnT-7). The other family comprises the ZIP family of 
transporters (hZIP1, hZIP2, hZIP3, and hZIP4). The ZIP family transporters can 
not only transport Zn2+ into cells, but also Mn2+, Cd2+ and other divalent cations. 
The functions of both transporter families overlap, but their locations in cells, and 
responses to dietary zinc are different. Another transporter of zinc is DCT1, 
which shares no homology with the ZnT and ZIP zinc transporters.  Apart from 
zinc DCT1, can also transport iron, and other cations, and it functions in uptake 
of metal ions in many organs (Rolfs and Hediger 1999). 
 
1.5.2.2 Zinc and neural tube defects 
A relationship between zinc and NTDs has first been established by animal 
studies (Warkany and Petering 1972). Warkany and Petering (1972) showed that 
zinc deficiency is highly teratogenic in rats, leading to NTDs and abnormalities in 
other organ systems. This was also shown by Rogers and coworkers (1995). In 
addition, the relationship between zinc and NTDs has been shown in man as well. 
A higher prevalence of NTDs has been observed in geographical regions with 
zinc deficiency (Sever and Emanuel 1973; Cavdar et al. 1977). Hambidge and 
coworkers (1975) reported that 2 out of 7 pregnancies of women with 
acrodermatitis enteropathica (a severe form of zinc deficiency due to defective 
zinc transport), resulted in a child with congenital malformations including NTD. 
A number of studies have been performed in which zinc levels were determined 
in blood serum, plasma, leucocytes, hair or toenails of mothers with NTD 
offspring and controls immediately after delivery or during the second or third 
trimester of pregnancy. Several research groups showed decreased serum or 
plasma zinc levels in mothers with NTD offspring as compared to controls 
(Soltan and Jenkins 1982; Buamah et al. 1984; Cavdar et al. 1988), while others 
could not show a significant difference (Hambidge et al. 1993; Hinks et al. 1989; 
Zimmerman 1984). Hinks et al. (1989) were the only investigators measuring 
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leucocyte zinc in mothers with an NTD child and they were able to show 
significantly lower values in these mothers as compared to controls. Soltan and 
Jenkins showed that the plasma zinc levels in blood from a number of patients 
with NTDs were significantly lower than those of controls (Soltan and Jenkins 
1982). This has been confirmed by Cavdar et al (1988). Zimmerman et al. (1985) 
showed a higher urinary zinc excretion and excretion of the intracellular zinc 
binding protein metallothionein by children with spina bifida compared with 
controls. 
Toenails and hair have been suggested as a longterm status index for zinc status. 
Srinivas et al. (2001) and Bergmann et al. (1980) showed that hair zinc levels in 
affected children and in their mothers were significantly lower than in controls. 
Milunsky et al. (1992) on the other hand showed an increased zinc concentration 
in toenails of mothers with an increased risk for NTD. 
Velie et al. (1999) investigated the effect of maternal dietary zinc intake on the 
occurrence of NTDs in an American population. The authors showed that the risk 
of NTDs in offspring decreased with increasing maternal preconceptional zinc 
intake. Furthermore, it has been shown that fibroblast cultures of NTD patients 
display a disturbed zinc uptake (Zimmerman and Rowe 1983). 
 
1.5.3 Inositol 
Inositol is a hexahydroxycyclohexane that was first isolated from muscle extracts 
some 150 years ago, and named inosit, from inos the Greek root for muscle 
(Scherer 1850). There are nine possible stereoisomers of inositol, myo-inositol, 
scyllo-inositol, neo-inositol, epi-inositol, muco-inositol, allo-inositol, cis-inositol, 
and the enantiomers, D-chiro-inositol and L-chiro-inositol (Bouveault 1894) (Fig 
4). The inositol isomer that was first identified in muscle as its hexakisphosphate 
ester, phytic acid, appeared to be myo-inositol. This is the most abundant 
naturally isomer. The term inositol is often used in the literature without the 
prefix-name myo, and the terms “inositols” and “cyclitols” are used to refer to all 
inositol isomers in collective. 
Daily about 1g of inositol is consumed by the human body (Holub 1986). The 
human diet provides humans with free inositol and phytate, and to a lesser extent 
inositol lipids. In addition to dietary supplies inositol can also be synthesized in 
several tissues (kidney, liver, testis and brain) by conversion of D-glucose-6-
phosphate to D-inositol-1-phosphate due to enzymatic action of myo-inositol 
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synthase. D-inositol-1-phosphate can then be dephosphorylated to inositol via the 
action of inositol monophosphatase. Inositol is an important osmolyte in cells and 
serves as a molecule for synthesis of inositol lipids, which play an important role 
in signal transduction events (Fisher et al. 1992). 
 
 
 
 
Fig 4. Structures and nomenclature of the inositols (modified from Fisher et al. 2002). 
 
1.5.3.1 Inositol metabolism 
A lot of enzymes that are responsible for inositol metabolism are known 
(Berridge 1987; Shears 1998). Phosphates can be attached to different –OH 
positions at the carbon backbone of myo-inositol, resulting in numerous different 
phosphorylated inositol derivatives (Fisher et al. 2002). Also, more than one 
phosphate can be attached to a single inositol, resulting in a even greater number 
of different inositides. Two main groups of inositol derivatives, also known as 
inositides, can be distinghuished. The first group includes phosphatidylinositides, 
which are hydrophobic and form a part of the structure of the cell membrane. 
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The second group of inositides includes the inositol-phosphates, which are soluble 
in water and are primarily found in the cytoplasm. Inositides play an important 
role in membrane trafficking, actin cytoskeletal organization, anchoring of 
proteins to the membrane and in cell death and survival (Vanhaesebroeck et al. 
2001). 
Phosphatidylinositol is the most abundant phosphoinositide in mammalian cells 
(5-20%), is involved in protein membrane anchoring, and is the precursor for the 
second messengers inositol-(1,4,5) triphosphate and diacylglycerol. 
Phosphatidylinositol is involved in membrane signaling, resulting in activation of 
numerous proteins (Toker 2002). It is unique among phospholipids in that its 
headgroup, the inositol, can be further phosphorylated to phosphatidylinositol 
mono-, di-, or triphosphates. 
Phytate (inositol hexakisphosphate) is one of the most abundant inositol phosphate 
in animal cells and can be metabolized in animal cells to diphosphoinositol 
polyphosphates (Shears et al. 1995). Diphosphoinositol polyphosphates are very 
active metabolically and the concentrations in mammalian cells are low compared 
to other inositol phosphates (Stephens et al 1993). To date, three 
diphosphoinositol polyphosphates have been described in literature, 
diphosphoinositol tetrakisphosphate (PP-IP4), diphosphoinositol pentakisphosphate 
(also known as PP-IP5 and InsP7), and bisdiphospoinositol tetrakisphosphate (also 
known as [PP]2–IP4 and InsP8). One of the diphosphoinositol polyphosphates, PP-
IP4, is synthesized from the precursor inositol-(1,3,4,5,6) pentakisphosphate by 
the enzyme mIPMK (Saiardi et al. 2001). This reaction can also occur through 
diphosphoinositol polyphosphate synthase (also known as IP6 kinase) (Voglmaier 
et al. 1996; Saiardi et al. 2001), however with a lower efficiency than using PP-
IP5 as a precursor. The inositol derivative PP-IP5  is further phosphorylated to 
[PP]2 –IP4 by an IP7  kinase, which has been purified from brain, but which has 
not been cloned yet (Huang et al. 1998). There are two potential enzymatic routes 
for the dephosphorylation. Firstly, the multiple inositol polyphosphate 
phosphatase can carry out the dephosphorylation (Craxton et al. 1997). Secondly, 
diphosphoinositol polyphosphate phosphatases (DIPP) can use PP-IP4, PP-IP5 and  
(PP)2-IP4 as substrates to obtain the products, inositol-(1,3,4,5,6) 
tetrakisphosphate, inositol-(1,2,3,4,5,6) hexakisphosphate, PP-IP5, subsequently. 
Of all isomers only the isomer myo-inositol is a constituent of both 
phosphatidylinositides and inositol phosphates in brain or other animal tissues. 
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However, recent studies showed the presence of another inositol isomer, neo-
inositol, as an inositol phosphate derivative in Entamoeba histolytica (Martin et 
al. 2000). So, may be also neo-inositol is present as an inositol phosphate 
derivative in animal species. 
Not much is known of interconversions between the different inositol isomers. 
Myo-inositol can be converted to scyllo-inositol via the action of an epimerase in 
the brain of rats, but a human homologue has not been found yet (Sun et al. 
2002) 
Inositol degradation occurs via an enzyme called myo-inositol oxygenase that 
cleaves the polyol ring with the resulting production of D-glucuronic acid. Then, 
the catabolite D-glucuronic acid is metabolized in the liver to D-xylulose 5-
phosphate and enters the pentose phosphate pathway, resulting in generation of 
CO2 and H2O. 
 
1.5.3.2 Phosphatidylinositol signaling 
Inositols are involved in membrane signaling through anchoring of hydrolytic 
enzymes, mammalian antigens, and proteins involved in cell-cell interaction (Low 
1989). Inositol forms part of the anchoring structure glycosyl-phosphatidylinositol 
(GPI) in a diverse set of mammalian cells and tissues. GPI anchors are 
synthesized in the lumen of the endoplasmic reticulum, through subsequent 
addition of N-acetyl glucosamine, glycans, and phosphoethanolamine to 
phosphatidylinositol. The first step in GPI synthesis, is catalyzed by a GPI-N-
acetyl transferase. This step is mediated by a number of mammalian genes, PIG-
A, PIG-H, and PIG-C (Kinoshita et al. 1997). 
A second way in which inositol is involved in signaling is as a starting point of 
signal transduction pathways. Phosphatidylinositol can be phosphorylated by a 
sequence of enzymatic conversions. Subsequently, enzymatic action of 
phosphatidylinositol 4-kinase and phospatidylinositol-(4) phosphate 5-kinase I 
results in formation of the phospholipase C (PLC) substrate, phosphatidylinositol-
(4,5) biphosphate. PLC converts the phosphorylated lipid into two intracellular 
products: inositol-(1,4,5) triphosphate, which is a universal calcium-mobilizing 
second messenger, and diacylglycerol (DAG). To date, three PLC subtypes are 
known, β, γ, and δ (Rebecchi and Pentyala 2000). For each of these PLCs 
numerous splice variants have been described in mammals. 
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The PLC product DAG is an activator of protein kinase C (PKC) that leads to 
activation of numerous proteins via phosphorylation. The PKC family is 
composed of at least 10 closely related members of serine/threonine kinases that 
can be divided into three subgroups according to their activators: conventional 
PKCs (α, βI, βII, γ), novel PKCs (δ, ε, η, θ), and atypical PKCs (ζ, λ, µ) 
(Rebecchi and Pentyala 2000). All of these PKC isomers except for the atypical 
PKCs can be activated by DAG. Activated PKC can phosphorylate, and thereby 
activate numerous proteins implicated in regulation of cell growth, 
differentiation, proliferation, neurotransmission, and cytoskeletal ordening. Two 
major cellular substrates are the myristoylated alanine-rich C kinase substrate 
(MARCKS), and its family member MARCKS-related protein, which are both 
involved in a variety of cellular processes in which rearrangement of actin 
cytoskeleton is needed (Aderem 1995). 
The plasma membrane pool of phosphatidylinositols is replenished with 
phosphatidylinositol from intracellular compartments by phosphatidylinositol 
transfer proteins (PITPs) (Allen-Baume et al. 2002). Two types of mammalian 
PITPs are known, PITPI (PITPα, PITPβ) and PITPII (Nir2, Nir3, RdgBβ). 
 
1.5.3.3 Inositol transport mechanisms 
Inositol can be transported across the plasma membrane via specific carrier 
molecules. Different types of transporters are known. The differences between 
these transporters are marked by their substrate specificity and transport 
mechanism. One of the transporters involved in inositol homeostasis is HMIT, 
which is a H+/myo-inositol cotransporter (Uldry et al. 2001). It belongs to the 
SLC2 family of glucose and polyol transporters, which comprises 13 family 
members, GLUT1-12 and HMIT (Uldry and Thorens 2003). Hmit specifically 
transports myo-inositol and is expressed predominantly in the brain. Two other 
members from a different transporter family are also known to be involved in 
inositol homeostasis: the Na+/myo-inositol cotransporters SMIT1 and SMIT2. 
These transporters belong to the Na+/glucose cotransport family SLC5 (Wright 
and Turk 2003). Recently, it was shown that the Smit1 transporter is the primary 
murine transporter for the maintenance of an inositol concentration gradient 
during embryonic and fetal life, with a higher fetal plasma concentration 
compared to maternal plasma (Berry et al. 2003). Apart from myo-inositol, Smit1 
transports the polyols L-fucose, and L-xylose (but not their D-isomers) and D- 
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and L-glucose (Coady et al. 2002). Unlike Smit1, the transporter Smit2 exhibits 
stereospecific cotransport of both D-glucose and D-xylose, and transports D-
chiro-inositol (Hager et al. 1995). Furthermore, the transporter Smit2 has a 
higher affinity for glucose compared to Smit1. Both Smit1 and Smit2 are 
expressed in a wide range of tissues including muscle, spleen, liver, neurons, 
placenta, and embryos. The role of Smit2 during embryonic and fetal life is not 
yet known. At the moment, it is not known which transporter(s) is/are involved 
in intestinal uptake of inositol. 
 
1.5.3.4 Inositol and neural tube defects 
The relation between inositol and neural tube defects was first established by 
Cockroft in 1988. Cockroft showed that omission of inositol from medium used 
to culture rat embryos resulted in cranial NTDs (Cockroft 1988). The relationship 
between inositol and neural tube defects in mammals was confirmed by Seller 
(1994) who suggested that intraperitoneal inositol supplementation to curly tail 
(ct) mice reduces the NTD frequency. In the 1990’s the study performed by 
Seller (1994) was repeated and extended by Greene and Copp (1997), who 
confirmed the findings of Seller both with whole embryo cultures and embryos in 
vivo (Greene and Copp 1997). Intraperitoneal myo-inositol supplementation in 
pregnant curly tail mice reduced the frequency of spina bifida by 70%. In vitro 
studies had shown that glucose-induced NTDs in the cultured rat conceptus could 
be prevented by supplementation of myo-inositol or the DAG cleavage product 
arachidonic acid to the culture medium (Hod et al. 1990). Therefore, Greene and 
Copp investigated whether the protective effect of inositol in curly tail was 
mediated via the arachidonic acid pathway. Unlike in rats inositol action seemed 
not to be mediated by the arachidonic acid pathway (Greene and Copp 1997). 
Arachidonic acid supplementation even had an adverse effect on the NTD 
frequency in curly tail. What appears to be the case in this mouse model is that 
inositol increases the flux through the inositol/lipid cycle, stimulating PKC 
activity and upregulating expression of retinoic acid receptor β, specifically in the 
caudal part of the embryonic hindgut region (Greene and Copp 1997).  
Recently, Cogram and coworkers showed that another stereoisomer of inositol, 
D-chiro-inositol, can exhibit an even more potent effect than myo-inositol on 
cultured embryos and in vivo (Cogram et al. 2002). Interestingly, insulin 
stimulation of rat fibroblasts expressing the human insulin receptor leads to a 
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significant increase in the incorporation of D-chiro-inositol into phospholipids, 
whereas the effect on myo-inositol incorporation is only marginal (Pak et al. 
1993). Moreover, D-chiro-inositol induces a much larger reduction in plasma 
glucose level in rats rendered diabetic by streptozotocin administration compared 
with exogenous myo-inositol (Ortmeyer et al. 1993). These findings suggest an 
inherently greater potency or bioactivity of D-chiro-inositol compared to myo-
inositol, perhaps as a result of incorporation into different phosphatidylinositol 
compounds (Pak and Larner 1992). 
Like in the animal situation, inositol also seems associated with human NTDs. 
Diabetic mothers have a three to four times higher risk of having NTDs in their 
offspring (Platt and Golde 1983). These malformations are considered to 
originate from a deranged maternal metabolism involving a diminished turnover 
of phosphatidylinositol (Baker et al. 1990; Cockroft et al. 1992; Goto and 
Goldman 1994). Recently, the first use of periconceptional inositol in human 
pregnancy was reported in a pregnant female, who previously had two folate-
resistant myelomeningocele pregnancies (Cavalli and Copp 2002). 
Periconceptional inositol (in addition to folate) supplementation to the pregnant 
female resulted in a healthy child. 
 
1.6  Genetic approaches to study human neural tube defects 
Until about a decade ago, association studies were executed on the basis of a 
case-control study. In a case-control study allele frequencies are compared 
between a sample of unrelated affected individuals and a sample of matched 
controls (Weeks and Lathrop 1995). This framework can be affected by 
population stratification, because of the existence of natural selection, genetic 
drift and mutations in the population used for association testing.  
Due to this drawback several new designs for association tests were introduced 
for which such stratification is avoided. One of these tests is the Haplotype 
Relative Risk test, in which for biallelic transmission the two alleles that were not 
transmitted to the affected offspring, are combined to create a “pseudocontrol” 
group (Falk and Rubinstein 1987). The transmission frequencies of the cases and 
pseudocontrols are then compared. This way of association analysis reduces the 
population stratification bias. The Transmission Disequilibrium Test (TDT), was 
introduced by Spielman et al. (1993). The TDT compares the transmission versus 
nontransmission of marker alleles from heterozygous parents to their affected 
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offspring using a chi-square test. Spielman originally used the TDT as a test for 
linkage in the presence of association, but it can also be used as a test for 
association in the presence of linkage. The TDT is not able to distinguish between 
effects caused by the maternal genotype or the genotype of the patient, or between 
codominant, recessive or dominant effects of a risk allele. To include these 
genetic effects in family-based association testing another test was introduced by 
Weinberg et al (1998), the likelihood-based method of analysis of parent-affected 
child triads. This test is a log linear approach that provides an estimate for the 
relative risk conferred by the genotypes containing the risk allele. Weinberg 
improved this modeling approach by including missing parental data in the 
analysis (Weinberg 1999). In order to study gene-environment interactions, 
transmission of alleles in parent-affected child triads can be combined with 
environmental influences (Beaty et al. 2002). 
 
1.7 Objectives of the present study 
NTDs is a multifactorial disease in which a combination of unfavorable genetic 
and environmental factors is involved. Periconceptional intake of the nutrient 
folic acid has a preventive effect on the occurrence and recurrence of human 
NTDs. However, folic acid supplementation can not prevent all NTD cases, still 
about 15-50% of NTD cases occur (MRC 1991; Czeizel and Dudas 1992; Berry 
et al. 1999; Berry and Li 2002). In the 1990’s Greene and coworkers showed that 
in addition to folic acid at least one other nutrient, inositol, was involved in 
NTDs (Greene and Copp 1997). This data was later supported by a case study in 
which supplementation of inositol in a pregnant mother, who had previously had 
a child with spina bifida, resulted in a healthy child (Cavalli and Copp 2002). 
Apart from the nutrient inositol also the trace element zinc is involved in NTDs, 
which was shown by numerous human cohort studies and animal studies (Soltan 
and Jenkins 1982; Buamah et al. 1984; Cavdar et al. 1988; Hinks et al. 1989). In 
addition to environmental factors also genes are involved in NTDs. Most of the 
information about the genetic contribution to NTDs relies on mouse models. 
Until now, very little is known about the role for genes that are related to the 
nutrient inositol and/or the trace element zinc. 
The objectives of this thesis were the investigation of the molecular basis of 
NTDs, with a particular focus on the events underlying zinc and inositol 
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sensitivity of the birth defects. The studies were performed in human material as 
well as mouse models for the disorder. 
 
In chapter 1 we present a review of the literature on the formation of the neural 
tube and defects associated with this process. To date, over 80 mouse models are 
known for human NTDs (Copp et al. 2003). Some of these mouse models have 
been studied extensively, but as yet little is known about the molecular 
mechanism underlying NTDs. One mouse model for human NTDs that had been 
poorly investigated at the start of our study is the Bent tail (Bn) mouse. This 
model was investigated extensively during this study as a model for the role of 
zinc related transcription factors in NTDs. In chapter 2.1 and chapter 2.2 we 
characterized the genetic defect that causes NTDs in Bn. We also analyzed the 
embryonic phenotype of these mice in further detail using scanning electron 
microscopy during the stages of neurulation (chapter 2.3). To gain more insight 
in the nutritional status of Bn, we studied the impact of supplementation of two 
NTD-involved nutrients, inositol and folinic acid (a folate derivative), and the 
NTD-involved trace element zinc on the tail malformation as a marker of NTD 
sensitivity (chapter 2.4). Chapter 3 describes a study in the ct mouse. 
Periconceptional supplementation of inositol reduces the incidence of NTDs in 
the offspring of ct mice and leads to upregulation of Pkc. Using large-scale gene 
expression profiling, we tried to identify the molecular basis of the NTD 
phenotype and inositol sensitivity of this mouse. In chapter 4 we investigated the 
impact of zinc and inositol related candidate genes on human NTDs using 
mutation analysis in a large panel of patients with NTDs and/or association 
testing using spina bifida child-parent triads. In this way, the human ortholog of 
murine Zic3, which causes the NTD phenotype of Bn, was studied for its 
involvement in human NTDs, as were the human orthologs of two other Zic 
family members, Zic1 and Zic2, which had previously been shown to cause 
murine NTDs (chapter 4.1). In chapter 4.2 we investigated the involvement of 
the genes TFAP2A, coding for a transcription factor, and MLP, coding for 
MARCKS-like protein, which are substrates for PKC, a major component of the 
phosphatidylinositol signaling pathway. Apart from these PKC related genes we 
also investigated the candidate gene CSK, which codes for a protein involved in 
actin filament regulation. This process is particularly involved in the formation of 
the cranial neural tube and possibly under the regulation of PKC. Furthermore, in 
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chapter 5 we screened the gene SLC39A4, which codes for a zinc transporter, for 
its involvement in human NTDs using association testing of a frequent 
polymorphism in the coding region. The same was done for the gene KST1, 
which codes for a Na+/inositol cotransporter, and ISYNA1, which codes for 
inositol synthase. For the genetic variants in these genes we also describe a gene-
environment interaction study for human NTDs in chapter 5. To this end, we 
performed association testing for the genotypes of KST1, ISYNA1 and SLC39A4 
with inositol or zinc profiles in blood from spina bifida patients and their 
mothers. In chapter 6 the objectives, as described in this study are put into 
perspective in a general discussion. 
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CHAPTER 2.1 
 
 
A deletion encompassing Zic3 in Bent tail, a mouse 
model for X-linked neural tube defects 
 
 
R. Klootwijk, B. Franke, C.E.E.M. van der Zee, R.T. de 
Boer, W. Wilms, F.A. Hol and E.C.M. Mariman 
 
ABSTRACT 
Bent tail (Bn) is a mouse model for human neural tube defects (NTD). Bent tail mice are 
characterized by a shortened, kinked tail. We have observed numerous aberrations in Bent tail 
embryos including exencephaly, rotation defects and occasionally omphalocele, orofacial schisis 
and situs abnormalities. Exencephaly was seen in >10 % of all embryos and resulted from a 
closure defect of the hindbrain. Bent tail maps to the proximal part of the X chromosome. By 
haplotype analysis we have appointed the Bn locus to a 1.1 cM interval between markers DXMit159 
and DXMit143. Subsequent analysis has revealed the presence of a deletion in all affected animals. 
The deletion is approximately 1 Mb in size and encompasses the gene for Zic3, a zinc finger 
transcription factor expressed in murine neuroectoderm and dorsal axial mesoderm during 
neurulation. Zic3 is a homolog of the Drosophila segmentation gene odd-paired. Although the Bent 
tail phenotype probably is the result of the deletion of several genes, combining data on Zic3 
expression and function of Zic genes in the mouse shows that deletion of Zic3 alone is compatible 
with a major role of this gene in the congenital malformations of the Bent tail mouse. In man, 
mutations in ZIC3 are associated with situs abnormalities. These patients occasionally also show 
spina bifida, indicating that genetic variation in human ZIC3 may contribute to other congenital 
malformations, including neural tube defects.  
 
 
 
Published in Human Molecular Genetics 2000; 9(11): 1615-
1622. Some minor modifications were introduced to this 
chapter.
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Introduction 
 
Neural tube defects are congenital malformations with a relatively high incidence 
of 1-2 per 1000 births in humans. The cause of the defects is incomplete closure 
of the neural tube in the early stages of embryogenesis, which results in abnormal 
development of the central nervous system and the surrounding skeletal 
structures. The most frequently observed phenotypes are spina bifida, a closure 
defect in the spinal cord, and anencephaly, resulting from impaired closure of 
cranial structures. Neural tube defects belong to the category of multifactorial 
disorders, which implies that they are caused by an interaction of predisposing 
genetic factors with unfavorable environmental influences, like intake of drugs, 
maternal illness or a poor nutritional status (Campbell et al., 1986; Hall et al., 
1988; Shaw et al., 1998; Botto et al., 1999). In view of the diversity of factors 
that can induce neural tube defects it is not surprising to find that >80 % of all 
neural tube defects in humans arise spontaneously. The impact of a genetic 
component in the development of these defects, however, is clearly seen in 
patients who are members of multiple-case families, occasionally even with 
apparent mendelian inheritance (Mariman and Hamel, 1992; Hall and Solehdin, 
1998). 
The diversity of genetic abnormalities that can result in impaired neural tube 
closure becomes increasingly clear when considering mouse models. About 50 
different mouse strains displaying neural tube defects have been described in 
which the defects arise from spontaneous mutation, trisomy or the targeted 
disruption of specific genes (Harris and Juriloff, 1997). In the majority of strains 
resulting from a spontaneous mutation, the responsible gene has not been 
identified yet. An interesting example is the Bent tail mouse, which was first 
described in a male in the F1 of a cross of a Namru strain female and a bald 
hrba/hrba male (Garber, 1952). Mice carrying the Bent tail mutation are 
discernable through a short tail with one or more bends (Garber, 1952). The 
mutation follows semidominant inheritance with incomplete penetrance in 
heterozygous females and has previously been mapped to the X chromosome, 
between Hprt and G6pd (Falconer, 1954; Lyon et al., 1987). The occurrence of 
spina bifida and exencephaly (the mouse equivalent of human anencephaly) in 
utero in an unknown percentage of cases has been reported (Johnson, 1976). As 
such the human homolog of the Bent tail gene is a candidate disease gene for 
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families with an X-linked form of NTD (Toriello et al., 1980; Toriello, 1984; 
Baraitser and Burn, 1984; Jensson et al., 1988; Goerrs et al., 1993). 
Interestingly, in most of the cases in which the gene underlying the neural tube 
defect is known it codes for a protein with a function in signal transduction. 
Classical oncogenes, transcription factors and proteins involved in cytoskeleton 
reorganization, for example, are able to cause defective neural tube development 
when mutated or knocked out (Harris and Juriloff, 1997). This sheds some light 
on the diverse processes that are necessary for proper neural tube closure: cell 
proliferation and differentiation are required, but also the reorganization of the 
(actin-based) cytoskeleton is clearly involved (Ybot-Gonzales and Copp, 1999; 
Hildebrand and Soriano, 1999). 
In this paper we describe in detail the phenotype of the Bent tail mouse and 
confirm the existence of neural tube defects in utero. We report additional 
developmental defects of the examined embryos, some of which are associated 
with abnormal transition from lordotic to kyphotic curvature of the embryo 
during neurulation, occasionally resulting in omphalocele, a ventral midline 
closure defect. Another defect of midline closure, cleft lip, was also observed. 
Apart from the neurulation and midline defects we found situs abnormalities in 
Bent tail. Using interstrain crossing with DBA and BALB/c followed by 
haplotype analysis we have been able to narrow the Bn locus to a 1.1 cM interval 
between markers DXMit159 and DXMit143. Subsequent candidate gene analysis 
of two genes located in or near the critical region, Mcf-2 and Zic3, has revealed a 
deletion of approximately 1 Mb in size, encompassing all protein-coding exons of 
Zic3. 
 
Results and Discussion 
 
Phenotype of the Bent tail mouse 
Bent tail mice are characterized by a shortened tail with irregular kinks. The 
kinks are caused by asymmetric growth of some of the caudal vertebrae. The 
phenotype ranges from a slight kink at the end of the tail to several pronounced 
kinks along the entire tail, occasionally resulting in curling up of the tail (Fig. 
1A,C). Typically, hemizygous males are more severely affected than 
heterozygous females. The penetrance in these heterozygous females in our 
matings was 87.5 % (n=56). The shortening of the tail in Bent tail mice is shown 
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in Fig. 1B: normal female mice had 72.2 ± 4.2 mm of total tail bone length, 
whereas in heterozygous Bent tail females this length was significantly reduced 
 
 
 
 
 
 
Figure 1: Abnormalities observed in adult Bent tail mice. (A) Male adult Bent tail mouse. 
(B) Total tail bone length (± SD) in normal (C57BL/6J) and Bn mice. (** indicates 
significant difference with p<0.0001) (C) X-rays of the tail of two normal (left) and 
three Bent tail mice of both sexes as used in (B) for analysis of the tail bones. Upper 
panel, heterozygous females; lower panel, hemizygous males.  
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to 65.8 ± 3.8 mm (p<0.005). In males the normal length was 81 ± 1.4 mm, 
whereas Bent tail males had significantly shorter tails with 49.2 ± 5.1 mm of tail 
bone (p<0.005). The shortening was partly due to a reduction in the number of 
caudal vertebrae: unaffected male and female mice possessed 28 (n=15) caudal 
vertebrae, whereas heterozygous females had between 24 and 28 (n=13) with a 
mean (± SD) of 26.2 ± 1.2. In male Bent tail mice the reduction was even more 
pronounced in that they had between 20 and 24 tail vertebrae (n=5) with a mean 
of 22 ± 1.9. Apart from a reduction in number the vertebrae of Bent tail mice 
were often smaller than those of normal mice. This did not only concern 
asymmetrical vertebrae, but was also apparent in the normally shaped tail bones 
(Fig. 1C). These data are in agreement with data published by Grüneberg in 
1955. As already suggested by Grüneberg the tail malformation might be due to a 
retarded outgrowth of the tail bud in Bent tail embryos compared with normal 
embryos, generating an insufficient number of cells in the tail bud to allow full 
development of all vertebrae. According to Copp (1994) growth retardation in the 
tail might be the result of a delay in the closure of the posterior neuropore in the 
upper sacral region. In this respect, a slight variation in the timing of posterior 
neuropore closure between individual Bent tail mice might correlate with the 
observed variation in the number of tail vertebrae.  
In 1976, Johnson was the first to mention the occurrence of an open neural tube 
in the sacral region and cranioschisis in utero in hemizygous Bent tail males and 
homozygous females. However, no detailed information was provided. In our 
study, 24 matings of Bn/+ females with Bn/- males produced exencephaly in 16 
(11.6 %) out of 138 E11.5 to E15.5 embryos (Fig. 2A). In all cases the 
exencephaly was due to a closure defect of the hindbrain-region (Fig. 2B and data 
not shown). Neither in these 138 embryos nor in 39 E16.5 to E19.5 embryos that 
were cleared and alizarin-stained were found any cases of spina bifida. In 12 
embryos (6.8 %) we observed a torsion or a lordosis in the embryo’s trunk (Fig. 
2C and D). The defects appeared to result from abnormalities in the transition 
from a lordotic to a kyphotic curvature of the embryo during neurulation. In 
addition 6 of them displayed omphalocele, a ventral midline closure defect, which 
could be caused by a delayed rotation of the embryo or the loss of expression of a 
gene important for ventral body wall closure (Lu et al., 1999; Lin et al., 1999). 
In 3 out of 85 embryos, we observed another midline closure defect, a unilateral 
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cleft lip, in 2 cases combined with a defect in eye development on the same side 
of the body (Fig. 2E). In addition, in 1 embryo of E13.5 a combination of 
exencephaly, omphalocele and unilateral schisis was observed. Furthermore, we 
found a single E18 embryo with dextrocardia as well as 1 adult heterozygous 
female (out of 28) with a situs abnormality of the spleen. Most of the strongly 
affected embryos displayed a severe growth retardation (not shown). Judging 
from the number of resorptions observed, approximately 24 % of the embryos 
were lost due to early lethality. 
 
 
 
Figure 2: Abnormalities observed in Bent tail embryos: (A) exencephaly in an embryo of 
E15.5, (B) scanning electron microscopy of an exencephalic embryo of E13.5, (C) 
rotation defect with omphalocele and (D) rotation defect without omphalocele in embryos 
of E15.5 [embryos in (C) and (D) came from the same litter], (E) unilateral cleft lip in an 
embryo of E17.5. Scale bars corresponds to 1 mm.  
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Mapping of the Bent tail locus 
For the mapping of the Bent tail locus matings were performed with either DBA 
or BALB/c inbred mice. Both crossings produced progeny with Bent tail 
phenotype at least up to the fourth generation. DNA of affected mice was 
analyzed for recombinations of the X chromosome between Hprt and G6pd by 
haplotype analysis using polymorphic DXMit markers. Out of 60 mice analyzed 7 
showed recombination in the region of interest (Fig. 3). Six recombinants 
determined the proximal boundary of the critical region, whereas only one was 
found to determine the distal boundary. This heterozygous female (mouse VII 
female in Fig. 3) displayed a very mild phenotype with a single minor kink near 
the end of the tail. However, she produced clearly affected offspring when mated 
to a DBA male, confirming her carrier status. 
The results of these analyses placed the Bent tail locus between markers 
DXMit159 and DXMit143, in a region of 1.1 cM on the MIT genetic map (Fig. 
3). 
 
 
 
 
 
Figure 3: Localization of the Bent tail locus. The upper part shows a map of the X 
chromosome including the names and positions of the DXMit markers used for 
localization of Bent tail. The position of the markers is listed both according to the 
Chromosome Committee, Mouse Genome Database and Massachusetts Institute of 
Technology maps. The lower part shows informative recombinations in individual mice in 
the DBA and BALB/c backgrounds. The black bars represent the Bent tail genotype. 
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Screening of mouse Mcf-2 and Zic3 
The mouse X chromosomal region between Hprt and G6pd is homologous to 
Xq26.1-q28 in man. Moreover, the order of genes in this interval shows strong 
conservation. Mcf-2 (Dbl) and Zic3 are two genes that have been mapped in or 
near the Bn critical region and were considered likely candidates for causing the 
Bent tail phenotype. Mcf-2 is a protooncogene genetically mapped at a distance of 
22.5 cM distal to the centromere (Grant et al., 1990). The gene is expressed in 
neuroectodermal tissue and codes for a protein that is able to activate the small 
GTPase Rho (Galland et al., 1991). Rho is involved both in the reorganization of 
the actin cytoskeleton and in cell proliferation (Van Aelst and D’Souza-Schorey, 
1997; Hall, 1998), two mechanisms important in neural tube closure (Smith and 
Schoenwolf, 1997; Ybot-Gonzales and Copp, 1999; Hildebrand and Soriano, 
1999). 
Members of the Zic gene family in vertebrates are the homologues of the 
Drosophila pair-rule segmentation gene odd-paired, which is involved in 
parasegmental subdivision and visceral mesoderm development (Aruga et al., 
1996; Nagai et al., 1997). Zic3 codes for a zinc finger transcription factor that is 
expressed from embryonic day 7 (E7) onward in the primitive streak area of the 
mouse. During neurulation, Zic3 expression is found predominantly in dorsal 
axial tissues along the midline, especially in the brain and tail bud, both in 
mesoderm and neuroectodermal structures (Nagai et al., 1997). A similar 
expression pattern has been observed in the developing chick embryo (Lin et al. 
1998). 
The role of Zic3 in signal transduction has been studied in Xenopus. Here, Zic3 is 
one of the first genes to be expressed after relief of the BMP4 block by neural 
inducers. Expression of Zic3 induces transcription of the proneural genes leading 
to neural development and neural crest formation. In an overexpression system, 
the Zic3 gene product caused expansion of the neural plate and hyperplasia of 
neural tissue (Nakata et al., 1997). In the mouse physical mapping by the MRC 
UK Mouse Genome Centre (Harwell, UK) has shown the presence of Zic3 
between the sequence tagged sites (STS) px-65f3 and px-44c10. In humans ZIC3 
has been mapped at Xq26.2. Mutations in human ZIC3 and a deletion of 0.6 – 1 
Mb in size encompassing the ZIC3 gene have been reported in patients with 
defects in left-right asymmetry, in some cases in combination with a lumbosacral 
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neural tube defect (Gebbia et al, 1997). Mutations in another member of the Zic 
family, ZIC2, have recently been shown to be associated with holoprosencephaly 
in humans (Brown et al., 1998). In mice, Zic2 is expressed in the developing 
spinal cord and brain together with Zic3 (Nagai et al., 1997), and a knockdown 
of Zic2 shows skeletal abnormalities, holoprosencephaly, exencephaly and spina 
bifida (Nagai et al. 2000). 
PCR analysis was performed on cDNA isolated from brain tissue of unaffected 
mice, hemizygous males and heterozygous females using primers within the 
coding region of Mcf-2. The murine Mcf-2 cDNA sequence is only partially 
known. The known part corresponds to the 3' half of the human MCF-2 cDNA 
(Fig. 4A). No differences were seen when comparing the size of the PCR 
products from unaffected mice, heterozygotes and hemizygotes. PCR analysis on 
the genomic sequence of Zic3, however, revealed a deletion encompassing the 
entire coding region of the gene in affected males (Fig. 4A). Absence of the Zic3 
gene from Bn males was confirmed by Southern analysis using a PCR fragment 
derived from the 5’ part of the first exon as a probe (Fig. 4B). The carrier status 
of the embryos described above was confirmed by PCR (not shown). To estimate 
the size of the deletion we examined the presence or absence of several STS and 
DXMit markers physically mapped to the region surrounding the Zic3 gene. On 
average, the spacing between markers on this map is 224 kb (Nusbaum et al., 
1999). Px-44c10 is the nearest STS proximally to Zic3 and was shown not to be 
deleted. Distal to Zic3 two STS, px-65f3 and px-35al, were found to be deleted, 
whereas a third STS, px-41g10, was present in Bent tail males (Fig. 4C). Px-
41g10 and px-44c10 have been mapped to part of a YAC contig consisting of 3 
overlapping YAC clones, 321D2, 105A10 and 391F6, with insert sizes of 780, 
890 and >2200 kb, respectively. From the average spacing of the markers and 
the size of the YACs, we estimate that the area deleted in the Bent tail mouse 
spans about 1 Mb. Therefore, additional genes have probably been deleted as 
well, especially since (putative) CpG islands are present near the ZIC3 locus in 
man (Wray, 1999; Gebbia et al. 1997). As outlined above, Zic3 is expressed in 
brain, dorsal axial tissues and tail bud. Additional sites of Zic3 expression in the 
mouse embryo are the developing eye and limb (Nagai et al., 1997). In this study 
no signs of abnormal limb development were observed. However, Garber (1952) 
reported several Bent tail males with abnormalities in the forelimbs. Hence, the 
abnormalities observed in the Bent tail mice fit well with the expression pattern of 
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Zic3 during embryonic development, suggesting that Zic3 is one of the major 
genes involved in Bent tail. This is also supported by the fact that a family 
descibed by Gebbia et al. (1997) which has a deletion encompassing the ZIC3 
gene of a size comparable with the Bent tail deletion has no defects additional to 
the ones associated with ZIC3 mutation. 
Furthermore, recent papers by Mikoshiba and coworkers (Nagai et al. 2000; 
Aruga et al. 1998; Aruga et al. 1999) indicate that deficiency of expression in 
other members of the Zic family of genes in the mouse results in phenotypes with 
skeletal abnormalities and neurulation defects, as well: a knockdown of Zic2 
shows skeletal abnormalities, holoprosencephaly and several neural tube defects 
like exencephaly and spina bifida. Targeted disruption of Zic1 resulted in mice 
with dysgenesis of the cerebellum, which also had multiple problems in the 
segmentation of the axial skeleton. This was often combined with the occurrence 
of a spina bifida occulta. 
 
 
 
Figure 4: Candidate gene analysis of Mcf-2 and Zic3. (A) PCR analysis: in the left panel 
the analysis of the Mcf-2 cDNA is shown. The upper part shows a schematic 
representation of the cDNA of human MCF-2 and the part of the cDNA for which the 
murine sequence is known. Below, the results of a PCR amplifying this part of Mcf-2 
using cDNA isolated from brains of unaffected, heterozygous and hemizygous mice is 
shown. Genomic contamination in the RT-PCR was excluded. The right panel shows the 
results of the analysis of Zic3: three primersets were used on genomic DNA templates 
isolated from unaffected, heterozygous and Bent tail male mice. The position of the 
primers is shown to the left in a schematic drawing of the genomic organization of Zic3 
(non-coding regions of the gene are indicated as white boxes, coding regions are shown 
as shaded boxes, introns are in black; adapted from Aruga et al., 1996). As a control, 
PCR of the marker DXMit159 is shown. Below this control the PCR analysis using 
primerset D on Zic3 cDNA generated from brains of control and Bent tail mice is shown. 
All PCR fragments were sequenced to confirm their identity. (B) Southern blot analysis 
of DNA isolated from a homozygous wild type female, a heterozygous female and a Bent 
tail male mouse hybridized with a probe derived from the 5’ part of the Zic3 coding 
region as described in Materials and Methods. (C) Analysis of STS near Zic3 on the 
physical map. Results of PCRs using primersets for the indicated STS and Zic3 are shown 
together with a schematic presentation of the physical map of the critical region. Below, 
the positions of several YACs are shown. The sizes of these YACs are >2200 kb for 
391F6, 890 bk for 105A10 and 780 kb for 321D2. 
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Regarding the great importance of ZIC3 in left-right asymmetry in man (Gebbia 
et al. 1997) it is somewhat surprising that the number of situs abnormalities 
observed in Bent tail embryos was so low. May be the proportion of Bent tail 
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embryos with severe situs abnormalities is reflected by the high number of 
resorptions (24 %, as mentioned above). To investigate this, studies of early 
embryonic development are in progress. In mice, one of the earliest 
manifestations of left-right asymmetry is the embryonic rotation, and this process 
is clearly affected in Bent tail embryos. Interestingly, targeted deletion of Pitx2, 
another gene involved in left-right asymmetry, resembles to some extent the 
features seen in Bent tail mice, as far as defective embryonic rotation, 
omphalocele and facial clefting are concerned, which suggests that rotation, 
positioning of organs and midline closure in the embryo are linked processes (Lu 
et al., 1999; Lin et al., 1999). On the other hand, the defects in midline closure 
might also be linked to neural tube defects, since in man omphalocele and cleft 
lip can occur associated with NTD (Calzolari et al., 1995 and 1997; Czeizel, 
1981) in the absence of defects in left-right asymmetry. 
In the Bent tail mouse the genetic defect obviously generates a risk of neural tube 
defects. In humans, NTD was occasionally observed in carriers of ZIC3 
mutations with situs abnormalities (Gebbia et al., 1997). This suggests that ZIC3 
mutations might produce a slightly increased risk of NTD, similar to the situation 
observed with PAX3 mutations in patients with Waardenburg syndrome (Hol et 
al., 1995; Baldwin et al., 1995; Read and Newton, 1997). Interestingly, the 
occurrence of NTD in a patient with an X/autosomal translocation 
[t(X;22)(q27;q121)] (Fryns et al., 1996) as well as in a family with a duplication 
in Xq27 (Goerrs et al., 1993; Hol et al., submitted), provides evidence of the 
presence of a gene for NTD in the corresponding region of the human X 
chromosome. In this context, we are presently analyzing the latter family for the 
possible disruption of the ZIC3 gene. Some families with X-linked recessive 
inheritance of NTD have been reported (Toriello et al., 1980; Toriello 1984; 
Baraitser and Burn, 1984; Jensson et al., 1988) and it is tempting to speculate 
that specific ZIC3 mutations could be involved. However, in the Icelandic 
pedigree reported by Jensson et al. (1988) we have previously excluded the 
relevant region of the X chromosome, indicating the existence of yet another 
NTD-gene on the human X chromosome (Hol et al., 1994). To assess the 
relevance of ZIC3 as a risk factor for human NTD, association studies are 
underway. 
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Materials and Methods 
 
Animals, crosses and DNA/RNA isolation 
Animal studies were carried out at the animal facility at the University Hospital in 
Nijmegen. The study was approved by the local committee for animal research. 
Bent tail (inbred to F27, then one outcross to C57BL/6J x CBA/Ca F1, followed 
by brother x sister cross), DBA/2J and BALB/c mice were obtained from the 
Jackson Laboratory (Bar Harbor, ME, USA). To generate progeny for genetic 
mapping of Bn, affected males were mated to DBA/2J as well as to BALB/c 
females. Bn animals were identified  by the presence of a bent tail. To produce 
F2 progeny affected Bn females from the Bn x DBA/2J cross were mated to 
DBA/2J males, those from the Bn x BALB/c cross were mated to BALB/c males. 
Genomic DNA was isolated from mouse toes and livers by SDS/proteinase K 
treatment and phenol/chloroform extraction. Total RNA was isolated from mouse 
brain using the RNAzolTM B-kit (Tel-Test Inc., Veenendaal, The Netherlands) 
according to the protocol provided by the manufacturer. RT-PCR was carried out 
as described previously (Hol et al., 1998). 
 
Haplotype analysis 
The polymorphic markers DXMit124, DXMit166, DXMit22, DXMit159, 
DXMit193, DXMit73, DXMit144, DXMit46, DXMit143, DXMit120, DXMit1, 
DXMit45 and DXMit135 were used for haplotype analysis. Primer sequences 
were retrieved from the Jackson Laboratory Mouse Genome Database (MGD; 
http://www.informatics.jax.org/). The PCRs (25 µl) contained 10 mM Tris, pH 
9.0, 50 mM KCl, 1.5 mM MgCl2, 155 µM dATP, dGTP and dTTP, 1,8 µM 
dCTP, 0.01 % (w/v) gelatin, 2.5 nM of each primer, 100-200 ng of mouse 
genomic DNA and 0.5 U Taq polymerase (Gibco, Breda, The Netherlands). 
Radiolabeled [α-32P]dCTP (200 µM; ICN Biomedicals B.V., Zoetermeer, The 
Netherlands) was included in the PCRs. Amplifications were performed in a 
PTC-100 thermal cycler (MJ-Research, Landgraaf, The Netherlands). PCR 
conditions were as follows: initial denaturation at 94°C for 4 min followed by 35 
cycles of 94°C for 1 min, 55°C for 2 min, 72°C for 3 min. PCR-products were 
analyzed on 6.6 % denaturing acrylamide gels and films were exposed overnight. 
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Candidate gene analysis 
Primersets used to amplify the coding regions of Zic3 using PCR were as 
follows: A, 5’-CTGCACCCTTGCTCACTTCG-3’ and 5’-
GATCTTGAGGTTCTCAGAGCG-3’; B, 5’-CACTGGCGAGAAACCCTTCC-
3’ and 5’-GGTGTGTGTAGGACTTGTCG-3’; C, 5’-
GCTGTGACAGACGGTTTGC-3’ and 5’-GCAGTTACCAAGATGTAGCC-3’. 
If cDNA was used as a template, the forward primer of primerset B was 
combined with the reverse primer of primerset C (=primerset D; Fig. 4A). The 
primerset used to amplify part of the coding region of Mcf-2 from cDNA was as 
follows: 5’-GATCAGTCTCCCAAATTGGAC-3’ and 5’-
TTAGCCATAACATCTTCACATC-3’.  
PCRs (25 µl) containing 10 mM Tris pH 9.0, 50 mM KCl, 1.5 mM MgCl2, 300 
µM dATP, dGTP, dCTP and dTTP, 0.01 % (w/v) gelatin, 2.5 nM of each 
primer, 100-200 ng of mouse genomic DNA and 0.5 U Taq polymerase (Gibco) 
were performed in a PTC-200 thermal cycler (MJ-Research). Cycling conditions 
were as described above.  
PCR products (2.5 µl) were purified by incubation (20 min at 37°C) with 5 U 
exonuclease I and 1 U Shrimp alkaline phosphatase (both from USB Corporation, 
Cleveland, OH, USA). Enzymes were inactivated by incubation at 65°C for 10 
min. Sequence analysis was performed using the forward primers from the PCR 
and the ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit 
(PE Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) according to 
the manufacturer’s protocol. Sequences were analyzed on an ABI PRISM 3700 
sequencer. 
Sequences of primers used for screening of the STS flanking Zic3 were obtained 
from MRC UK Mouse Genome Centre (http://www.mgc.har.mrc.ac.uk). PCRs 
and cycling conditions were as described above, except for the annealing 
temperature of 50°C. 
For southern blot analysis, DNA isolated from different mice was digested with 
BamH1 and EcoRI, fragments were separated by gel electrophoresis and 
transferred to GeneScreen Plus Hybridization Transfer Membrane (NEN 
Research Products, Boston, MA, USA) by alkaline blotting (Sambrook et al. 
1989). The primers used to prepare the Zic3 probe by PCR were 5’-
CTGCACCCTTGCTCACTTCG-3’ and 5’-GCTGAGCCTCCTCGATCC-3’. 
PCRs and cycling conditions were as described above. Radiolabeling of the probe 
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was by random priming using [α-32P]dCTP, and hybridization of the blot was 
performed in buffer containing 0.5 M PO4, 7 % SDS and 1 mM EDTA overnight 
at 65°C 
The YACs 321D2, 105A10 and 391F6 containing part of the mouse X 
chromosome are part of the WI/MIT genomic mouse YAC library consisting of 
38400 clones with an average size of 820 kb, constructed by Haldi et al. (1996), 
and were purchased from Research Genetics, Inc. (Huntsville, AL, USA). At 
least two yeast colonies containing each of the YACs were grown in selective 
medium and total yeast DNA was isolated according to the protocols supplied by 
Research Genetics. DNA was separated by pulsed field gel electrophoresis, 
transferred to GeneScreen Plus Hybridization Transfer Membrane (NEN 
Research Products) and hybridized with sonicated mouse total DNA labeled by 
random priming using [α-32P]dCTP. 
 
Phenotypic analysis 
X-rays of wild type, Bn/+ and Bn/y mice were performed. The amount and the 
length of individual tail bones was measured by hand. Data are expressed as 
means ± SD. Differences were analyzed using the Student’s t-test for unpaired 
observations. For the study of embryos, Bn/+ female mice were mated with Bn/y 
male mice. Pregnant females were killed between E11.5 and E19.5 and embryos 
were surgically removed for analysis. Embryos were fixed in buffered 4 % 
paraformaldehyde in PBS and photographed. A second group of embryos was 
first analyzed for the presence of situs abnormalities of the heart, the embryos 
were then cleared by dehydration in 95 % ethanol for 3 days, inner organs of 
thorax and abdomen were removed and embryos were cleared in 1 % KOH 
overnight. After staining with Alizarin red S (Hopkin and Williams, Chadwell 
Health, UK) the embryos were analyzed for defects in bone formation. 
 
Electronic database information 
The following electronic databases were used during the course of this study: 
Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/OMIM/; the 
UK MRC Mouse Genome Centre, http://www.mgc.har.mrc.ac.uk; MGD, Mouse 
Genome Informatics, The Jackson Laboratory, http://www.informatics.jax.org/.  
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CHAPTER 2.2 
 
Further characterization of the genetic defect of the 
Bent tail mouse, a mouse model for human neural 
tube defects 
 
R. Klootwijk, M.M.V.A.P. Schijvenaars, E.C.M. Mariman & 
B. Franke 
 
ABSTRACT 
Neural tube defects are congenital malformations arising from incomplete neural tube closure 
during early embryogenesis. Most neural tube defects in humans have a complex etiology, with 
involvement of both genetic and environmental factors. More than 120 mouse models for human 
neural tube defects exist. Bent tail is one of these models. The mouse mutant is caused by a 
submicroscopic deletion on Xq which completely encompasses the Zic3 gene. The deletion has been 
estimated to be 60-170 kb in size. However, in the study presented here we show that the deletion 
is at least 300 kb in size, encompassing a processed pseudogene and a number of expressed 
sequence tags in addition to Zic3. The pseudogene is a member of the ribosomal protein L7a gene 
family. Two single expressed sequence tags and a cluster of expressed sequence tags, none of them 
with significant similarity to known genes, are deleted in Bent tail. Although more research is 
needed to clarify the identity and function of the deleted transcripts, most of them are expressed 
during embryonic development and might therefore contribute to the phenotype of the Bent tail 
mouse. This study indicates that the Bent tail allele is not merely a Zic3 knockout allele. 
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The Bent tail (Bn) mouse mutant, caused by a spontaneous mutation of the X 
chromosome, has been used as a mouse model for human neural tube defects 
(NTDs). Mapping of the Bn critical region demonstrated a submicroscopic 
deletion in the distal part of Xq. The deletion includes the Zic3 locus, as 
determined by us and others (Carrel et al. 2000; Klootwijk et al. 2000). The 
phenotype of the Bn mouse is characterized by a short kinked tail, abnormalities 
of thoracic situs and cranial and spinal neural tube defects with varying 
penetrance in different types of genetic background (Carrel et al. 2000; Franke et 
al. 2003; Garber 1955; Grüneberg 1955; Johnson 1976; Klootwijk et al. 2000). 
In addition, cleft lip, orofacial schisis and omphalocele have been observed, 
occasionally (Klootwijk et al. 2000). Recently, a Zic3 knockout mouse has been 
generated (Purandare et al. 2002), which sheds light on the contribution of the 
Zic3 gene to the phenotypic defects of the Bn mouse. Like Bn, Zic3 knockout 
mice have short kinked tails, situs abnormalities and neural tube defects, 
suggesting that the Bn phenotype is mainly caused by the deletion of Zic3. 
However, we report here that Bn is not merely a Zic3 knockout, since several 
expressed sequence tags (ESTs) and a pseudogene are deleted in this mouse 
mutant in addition to the Zic3 gene.  
The X-chromosomal genomic region near the Zic3 locus is homologous in 
humans and mice. This region is poor of known genes and ESTs. Carrel and 
coworkers reported that the mouse ortholog of the gene 5’ closest to human ZIC3, 
p21-RAC1, was not deleted in the Bn mouse, and no genes or ESTs were present 
within at least 37 kb of the sequence 3' of human ZIC3. The size of the Bn 
deletion was estimated to be 60-170 kb (Carrel et al. 2000) by them and about 1 
Mb by us (Klootwijk et al., 2000).  
By data mining a recent draft version of the genomic sequence assembly of the 
mouse X-chromosome (http://www.ensembl.org/) as well as the NCBI database 
(http://www.ncbi.nlm.nih.gov/dbEST/; 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene), we have identified 
two single ESTs, an EST cluster and a processed pseudogene within the Bn locus 
on Xq. Fig IA shows a physical map of the murine X chromosome near Zic3 
providing the approximate locations of genes, ESTs, and sequence tagged sites 
(STSs) used earlier by us and others (Carrel et al. 2000; Klootwijk et al. 2000) to 
characterize the Bn deletion.  
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An EST cluster (UniGene cluster Mm.172891) and two single ESTs (EST 
2424689 and EST 111725) located in between the Zic3 gene and the STS px-35a1 
(Fig IA) were found to be deleted in Bn (Fig IB). The EST cluster Mm.172891 
and EST 2424689 are derived from ED3.5 blastocyst and C57Bl/6 skin RNA, 
respectively. We found both transcripts to be expressed in C57Bl/6 embryos at 
ED12.5, as well (Fig IB). The other newly identified EST is a rat EST (EST 
111725), highly homologous to a sequence approximately 65 kb proximal to 
Zic3. The EST is derived from a cDNA library of rat PC-12 cells treated with 
neural growth factor for 9 days (Lee et al. 1995). Since we were especially 
interested in the etiology of the neural phenotype of Bent tail, we examined this 
EST in further detail. Reverse transcription-PCR (RT-PCR) showed that a 
sequence corresponding to the rat EST is expressed in adult mouse brain (Fig 
IB). To investigate if the transcript corresponding to EST 111725 is expressed 
during embryonic development and therefore might cause congenital 
malformations, we performed RT-PCR analysis in embryos at ED10.5, ED11.5 
and ED12.5 as well as Northern blot analysis on a blot carrying RNA from 
mouse embryos at different embryonic stages (ED 4.5-18.5). The transcript was 
detected by RT-PCR (Fig IC) but not on the Northern blot (data not shown), 
probably due to the lower sensitivity of the latter analysis. We further explored 
the expression pattern of the novel transcript in adult mouse tissues by Northern 
blot analysis. This analysis showed expression of a 6 kb transcript in most of the 
tissues present on the blot, including liver, kidney, testis and skeletal muscle (Fig 
ID). Expression appeared to be lower in lung, brain and heart, no expression 
could be detected in mouse spleen. A comparable expression pattern was seen in 
human tissues (Fig ID). The expression pattern of the transcript in the mouse is 
completely different from that of Zic3, which is expressed specifically in adult 
cerebellum, but not other tissues (Nagai et al. 1997).   
To determine the RNA sequence of the gene from which the EST 111725 was 
derived, rapid amplification of cDNA ends (RACE) was performed using cDNA 
from adult mouse brain. No specific 5’-RACE fragments were identified. 
However, a specific 3’-RACE fragment produced 900 bp of additional 
information about the transcript (Fig IE; GenBank accession: AY339874). The 
sequence of the RACE clone perfectly overlapped the mouse genomic sequence 
(GenBank accession: AL672124) with no interspersed intronic sequences. 
Chapter 2.2 
68 
Sequence comparisons at the NCBI did not reveal significant similarity of the 
transcripts (UniGene cluster Mm.172891, EST 2424689, and EST 111725, 
extended by RACE) with any known genes. The exon-intron coding prediction 
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Fig I Further characterization of the Bn deletion. (A) The mouse genomic region near 
Zic3. Known genes, STSs used earlier to characterize the deletion, as well as newly 
identified ESTs and a pseudogene are shown, as are BAC clones covering the deletion. 
The dotted lines represent the genomic borders of the deletion in the Bent tail mouse. 
Complete sequences are known for BAC clones 80H12, 392H8 and 448G13 (GenBank 
accessions: BX294124, AC087560 and AL672124). The primers for the STSs px-41g10 
and px-35a1 were obtained from MRC UK Mouse Genome Center 
(http://www.mgc.har.mrc.ac.uk/). DXChri4 represent a STS described by Carrel et al. 
(2000). (B-E) Molecular analysis of transcripts mapped to the mouse genomic region near 
Zic3. (B) PCR-analysis of the pseudogene ENSMUSG00000048861, two ESTs (EST 
111725 and EST 2424689) and an EST cluster (Mm. 172891, represented by EST 
1335151) on genomic DNA isolated from toes of heterozygous Bn females (Bn/+) and 
hemizygous Bn males (Bn/Y). The right panel shows the RT-PCR analysis of the 
transcripts using adult brain RNA (Clontech Laboratories Inc., Palo Alto, CA, USA) or 
total RNA of C57Bl/6 embryos at ED12.5 as a template. The STS px-41g10 was used as 
a positive control for the RT-PCR (data not shown). (C) RT-PCR analysis of the mouse 
transcript orthologous to EST 111725 on total RNA of C57Bl/6 embryos isolated at 
ED10.5, ED11.5 and ED12.5. (D)  Northern blot analysis showing a mouse multiple 
tissue Northern blot (Clontech) hybridized with a probe derived from the mouse sequence 
corresponding to rat EST 111725 on the left and a human multiple tissue Northern blot 
(Clontech) hybridized with a probe derived from the corresponding human sequence on 
the right. The blots were also hybridized with a β-actin probe to assess the relative 
amounts of RNA present in each lane. (E) Nucleotide sequence of the mouse ortholog of 
rat EST 111725 and the specific 3’-RACE fragment (GenBank accession: AY339874). 
RACE was performed using Marathon-ReadyTM cDNA from adult mouse brain 
(Clontech). The sequence of the EST is underlined. Information about primers as well as 
PCR and cloning conditions are available on request.  
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program, GENSCAN (Burge and Karlin 1997; 
http://genes.mit.edu/GENSCAN.html) and GRAIL (version 1.3; 
http://compbio.ornl.gov/Grail-bin/EmptyGrailForm) revealed no significant gene 
predictions for the single ESTs and only homology with line-1 elements in the 
genomic region surrounding the EST cluster Mm.172891 (data not shown). The 
ORF Reader at the NCBI (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) 
predicted only short open reading frames in all cases (data not shown). Further 
studies will be necessary to determine whether these ESTs in the Bn deletion are 
part of the same gene or represent separate genes, and to find out what the 
function of the gene(s) might be. 
A murine pseudogene (Ensembl Gene ID: ENSMUSG00000048861), belonging 
to the rpL7a gene family, also falls into the Bn deletion. The rpL7a gene codes 
for the ribosomal protein L7a. To date, approximately 100 family members of 
rpL7a are known. Most of the members of this family are intronless 
pseudogenes, predominantly generated by reverse transcription, like 
ENSMUSG00000048861. This pseudogene appears to be expressed in total RNA 
of C57Bl/6 embryos at ED12.5 (Fig IB). The finding of the deletion of 
ENSMUSG00000048861 provides new information regarding the proximal 
border of the Bn deletion. The deletion appears to be larger than estimated earlier 
and is at least 300 kb in size. 
In conclusion, we determined that two ESTs, an EST cluster and a pseudogene 
are deleted in the Bn mouse in addition to Zic3. The Bn deletion comprises at 
least 300 kb of X-chromosomal material. Though the identity of the transcripts 
needs further investigation, the Bn mouse should not be viewed merely as a Zic3 
knockout. 
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CHAPTER 2.3 
 
Analysis of the embryonic phenotype of Bent tail 
 
B. Franke, R. Klootwijk, J.W.M. Hekking, R.T. de Boer, 
H.J. ten Donkelaar, E.C.M. Mariman and  
H.W.M. van Straaten 
 
ABSTRACT 
Neural tube defects, mostly believed to result from closure defects of the neural tube during 
embryonic development, are frequently observed congenital malformations in humans. Since the 
etiology of these defects is not well understood yet, many animal models for neural tube defects, 
either arisen by spontaneous mutations or generated by gene targeting, are being studied. The Bent 
tail mouse is a model for X-linked neural tube defects. This mutant has a  characteristic short and 
kinked tail. Exencephaly occurs in Bent tail embryos with a frequency of  11 - 16%. Laterality 
defects also belong to the phenotypic spectrum. In this study, we analyzed the embryonic phenotype 
in further detail using scanning electron microscopy during the stages of neurulation. We observed 
a number of defects in both wild type and Bent tail embryos including a kinked neural tube, tight 
amnion, delay in axial rotation and even malrotation. The severity or frequency of most defects, the 
delay in axial rotation excluded, was significantly higher in Bent tail embryos compared to wild 
type embryos. Other abnormalities were seen in Bent tail embryos only. These defects were related 
to anterior and posterior neural tube closure and resulted in exencephaly and a closure delay of the 
posterior neuropore, respectively. The exencephalic phenotype was further analyzed by light 
microscopy in ED14 embryos, showing disorganization and overgrowth in the mesencephalon and 
rhombencephalon. In conclusion, the anterior and posterior neural tube closure defects in the Bent 
tail are strictly linked to the genetic defect in this mouse. Other phenotypic features described in 
this study also occur in the wild type genetic background of the Bent tail strain. Apparently, the 
genetic background contains elements conducive to these developmental abnormalities. 
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INTRODUCTION 
Neural tube defects (NTDs) are congenital malformations most of which are 
believed to be due to closure defects of the neural tube during embryonic 
development. In humans the incidence of NTDs is one to two in 1000 live births. 
Most of the human NTDs belong to the class of multifactorial diseases that are 
caused by genetic predisposition in combination with unfavorable environmental 
conditions. The genetic mechanism leading to the appearance of most of the 
neural tube defects in humans is still poorly understood. A possible way to learn 
more about these defects is the study of animal models for neural tube defects. In 
2000, Juriloff and Harris described more than 60 mouse models for neural tube 
defects (Juriloff and Harris 2000). In 2001, the count had reached 100 (Harris 
2001), with the majority being due to the deficiency of a specific gene(product). 
The affected genes encode proteins involved in a large variety of cellular 
processes. Together with the high variability of the neural phenotype of the NTD 
models this has made the search for common denominators in neural tube closure 
between humans and mice quite difficult. A better characterization of the etiology 
and phenotype of the NTDs of the different mouse models seems a prerequisite 
for a successful comparison between the animal models and the human situation.  
The Bent tail (Bn) mouse is a model for X-linked neural tube defects. The genetic 
defect of this mutant was recently identified by our research group (Klootwijk et 
al. 2000) and others (Carrel et al. 2000) as a deletion encompassing the gene 
encoding the zinc finger transcription factor Zic3. The phenotype resulting from 
this deletion is characterized by the presence of a relatively short tail with kinks 
in 100% of the homozygous and 87% of the heterozygous animals. In 11 - 16% 
of embryos from matings of heterozygous Bn females and hemizygous Bn males a 
cranial neural tube defect, exencephaly, was observed (Klootwijk et al. 2000). In 
an earlier study, spina bifida was also described in an unknown percentage of 
embryos (Johnson 1976) but no caudal neural tube defect was observed in the 
embryos analyzed in our own studies up to now. Carrel and coworkers showed 
that about 50% of the Bent tail mice have situs abnormalities of vital organs 
(lung, liver, heart, stomach and spleen) (Carrel et al. 2000), but we observed 
such laterality defects only in a few cases (Klootwijk et al. 2000). About 24% of 
all Bent tail embryos from matings of heterozygous females with hemizygous 
males are lost due to prenatal mortality and subsequent resorption; most of these 
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embryos are believed to be phenotypically severely affected homozygous females 
and hemizygous males (Klootwijk et al. 2000; Carrel et al. 2000). 
In the present study, we examined the phenotypes of embryos from matings of 
affected Bent tail mice during the stages of neurulation and at ED14 by scanning 
electron and light microscopy. To discriminate between phenotypic features 
related to the Bn mutation and features intrinsic to the genetic background, we 
analyzed embryos from wild type matings as controls. 
 
MATERIALS AND METHODS 
Animals 
The spontaneous mutation Bn, first described in 1952 by Garber, originally 
occurred in a male in the F1 of a cross of a Namru strain female and a bald 
hrba/hrba male (Garber 1952). Bent tail mice for the current study were obtained 
from The Jackson Laboratory (Bar Harbor, Maine, U.S.A.). The strain present 
there since 1960 was derived from C57BL/6J congenic breeder pairs (at least at 
N10, possibly N12), was inbred by brother-sister matings to F27, then a male 
was outcrossed to a C57Bl/6J x CBA/Ca F1-female, once (in 1968). The 
offspring has been maintained by brother-sister matings and reached F83 in 1986, 
at which time embryos were frozen. (URL: http://jaxmice.jax.org/jaxmice-
cgi/jaxmicedb.cgi?objtype=pricedetail&stock=000250). Two breeder pairs 
derived from these frozen embryos were obtained in 1999 and inbred further in 
our lab. All studies described here were approved by the local committee for 
animal research and were performed according to the current principles of 
laboratory animal care under the laws on animal protection applicable to the 
Central Animal Facilities of universities in The Netherlands. 
Embryos were collected at embryonic day (ED) 8 to 10 from timed matings in 
which a vaginal plug indicated the time of conception. Bn embryos (and male 
wild type embryos) were obtained from matings between heterozygous Bn 
females (Bn/+) and hemizygous Bn males (Bn/Y). As controls, embryos were 
collected from crosses between mice with the same genetic background but 
carrying wild type alleles for the X-chromosomal deletion. These mice will be 
referred to as wild type mice. For simplicity reasons, the matings between 
heterozygous Bn females and hemizygous males will be referred to as ‘Bn 
matings’ throughout the text and the matings between wild type mice will be 
called ‘wild type matings’. Embryos were staged according to Theiler (Theiler 
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1972) and analyzed using a stereo-microscope. Scanning electron microcopy 
(SEM) was performed as described previously (Peeters et al. 1998). The rate of 
turning, axial rotation defects and the position of the caudal region were 
determined during embryo preparation in embryos which were within Reichert´s 
membrane, as well as from SEM images of these embryos. The ratio of the 
crown-rump (CR) and posterior neuropore (PNP) length (PNP/CR-ratio) was 
determined from the SEM images. 
Histological analysis of wild type and exencephalic embryos was performed as 
follows: embryos were isolated at ED14 and fixed overnight in Bouin’s fixative 
(water-saturated picric acid, 75 ml; 40% formaldehyde, 25 ml; glacial acetic 
acid, 5 ml), dehydrated via 50% to 70% ethanol, photographed, further 
dehydrated to absolute alcohol, and cleared in methylbenzoate. Subsequently, the 
embryos were embedded in paraffin, and cut into seven µm serial sections. The 
sections were mounted on coated slides, dewaxed in xylene, rehydrated through a 
decreasing series (100% - 50%) of ethanol, and stained with 2% cresylviolet. The 
sections were coverslipped with DEPEX. 
 
Genotyping 
Genomic DNA was isolated from the embryonic yolk sac. The yolk sac was 
washed once in PBS, followed by lysis in 100  µl lysis buffer (0.1 M Tris-HCl 
pH 7.4, 200 mM NaCl, 5 mM EDTA, 0.2% SDS, and 0.1 mg/ml Proteinase K) 
at 55°C for several hours. The lysate was centrifuged at 4°C for 30 minutes in an 
Eppendorf centrifuge at 11,000 x g to remove possible debris. After addition of 
two volumes of ethanol (96%) to the supernatant, precipitated DNA was removed 
from the fluid using a loopneedle, washed twice in 80% ethanol and dried, 
followed by solubilization in 25 µl TE (10 mM Tris-HCl pH 8, 1 mM EDTA pH 
8) at 65°C. If the amount of DNA was too small to recover by this method, 10 µl 
NaAc (3.5 M pH 5.2) was added to the lysate. After incubation at –20°C for 
several hours the lysate was centrifuged at 4°C for 30 minutes in an Eppendorf 
centrifuge (11,000 x g) and the pellet was treated as indicated above. 
Genotyping was performed as described earlier (Klootwijk et al. 2000) using px-
35a1, a STS flanking Zic3 which is deleted in Bent tail. The X-chromosomal STS 
px-41g10 served as a positive control for the PCR. The Y-chromosome marker 
DYzEms12 was used for sex determination of the embryos (Navin et al. 1996). 
Sequences of the primers were as follows:  
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px-41g10-for:5’GAAATAAACCTCCAAAACTG3’,px-41g10-rev: 
5’GCAAGAGAACTACAAGTTCAGT3’,px-35a1-
for:5’CTCCTCTCTTGCTTAGCTAG3’, px-35a1-rev: 
5’GAGTAGTAATAGTTGCTGAACC3’, DYzEms12-for: 
5’CTACTAATGAAGGTGGCATCCC3’,DYzEms12-rev: 
5’CTTACCCCCCTACACAAAAGC3’. 
 
RESULTS 
Thirty-two embryos were isolated from four wild type matings. Additional pre-
somite stage embryos (n=1) and resorptions (n=4) were discarded. Thirty-six 
embryos were isolated from six Bn matings. Additionally, pre-somite stage 
embryos (n=3) and resorptions (n=11) were discarded.  
In the embryos isolated from the Bn matings, all expected genotypes (Bn/Bn, 
Bn/+, Bn/Y and +/Y) were observed in the litters, but the distribution indicated 
a trend towards under-representation of the Bn/Y and Bn/Bn genotypes (Fig. 1).  
 
 
 
 
 
Figure 1: Bar chart showing the distribution of genotypes in the embryos isolated from 
Bn matings. On the X-axis are the 4 possible genotypes, on the Y-axis the percentage of 
the total for a particular genotype. The numbers in the bars represent the number of 
embryos analyzed for each genotype. 
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The isolated embryos represented several developmental stages with the number 
of somites varying between five and 31 (ED8 - 10; Theiler stage 12 - 16) for the 
Bn matings and between five and 22 somites (ED8 - 9.5; Theiler stage 12 - 15) 
for the wild type matings. The maximum intra-litter variation amounted to 16 
somites in the former, and 12 in the latter group.  
The phenotypic abnormalities observed in the embryos from the Bn matings and 
from wild type matings as grouped per developmental stage and per genotype are 
summarized in Table 1 and are described below. 
 
 
 
 
 Stage (somites) Genotype 
 5-9 11-15 16-22 26-31 
 wt aff wt aff wt aff wt aff 
Bn/Bn Bn/+ Bn/Y +/Y 
Number of embryos analyzed 9 5 4 7 19 12 0 11 8 9 7 11 
Tight amnion - - 0 3 2 0 0 1 1 0 2 1 
Kinked neural tube* - - 2 7 2 9 0 6 6 4 4 7 
Neural tube closure defect  
at RNP 
- - 0 2 0 2 0 1 1 2 2 0 
Axial torque during turning - - 2 7 5 5 0 3 3 5 3 4 
Malrotation 0 0 0 1 0 2 0 1 1 1 1 1 
* one genotype missing 
 
 
 
Table 1: Phenotypic abnormalities as observed by light microscopy and/or scanning  
electron microscopy in embryos from the mating of wild   type (wt) and affected Bent tail 
mice (aff). Embryos are ordered according to their embryonic stages and according to 
their genotypes (only for offspring from Bn matings). The (-) indicates that this feature is 
not relevant for the particular developmental stage. The phenotypes marked in bold were 
only observed in embryos from Bn matings. 
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Tight amnion and kinked neural tube 
During preparation of the embryos from Bn matings we observed several 
embryos enveloped in an extremely tight amnion. One embryo with 28 somites 
was largely bent, probably due to this amniotic constriction (Fig. 2a). From the 
stage of 11 somites (Theiler stage 13) onwards, many embryos demonstrated 
irregular kinks of their neural tube at somite levels 3 - 9 (Fig. 2b), which is at the 
base of the U-shape before turning of the embryo (see below). In two cases these 
kinks were observed in combination with scoliosis (not shown). The kinks were 
the most consistently observed malformation in embryos isolated from Bn 
matings and were found in 22 out of 36 embryos, of which seven embryos had a 
wild type +/Y genotype (Table 1). 
Only two embryos isolated from the wild type matings had a tight amnion, and in 
these cases the tightness was less extreme than in the embryos from Bn matings 
(data not shown). Kinks of the neural tube, especially around the level of somite 
5, were observed in four out of 32 embryos from wild type matings as well, 
although they were mild in comparison to those observed in the embryos from Bn 
matings. 
 
Axial rotation 
Up to the stages of six to eight somites (Theiler stage 12 - 13), the rodent embryo 
is U-shaped (lordotic), with the base of the U at the axial level of 3 - 8 somites 
and the dorsal side of the embryo in the concavity of the U-shape. From this 
stage onwards, the whole embryo turns 180° around its long axis. This results in 
the common "fetal" C-shape, with the dorsal side of the embryo at the convexity. 
The process is called axial rotation or turning and is completed at the stages of 14 
- 16 somites (Poelmann et al 1987; Kaufman 1992) (Theiler stage 14). In the rat 
embryo, which shows a development very comparable to the mouse embryo, 
axial rotation begins in the cranial part, continues in the base of the U-shape and 
ends in the caudal part (Deuchar 1975; Fujinaga et al. 1995). After rotation, the 
tail region is in front of the head with its tip pointing towards the head. 
Subsequently, the tail passes the head on the right side during further axial 
growth. The axial rotation occurs clockwise when viewed in cranio-caudal 
direction. 
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Embryos from both wild type matings and Bn matings started axial rotation 
between the stages of  8 - 11 somites (Theiler stage 13), which is within the 
normal developmental range. However, in many embryos, from both mating 
schemes, that were in the process of turning we observed an axial torque of the 
caudal versus the cranial part. At the stages of 11 - 15 somites (Theiler stage 13 - 
14), the base and cranial half of all assessable embryos from wild type matings 
(n=3) were rotated completely in a normal fashion. The turning of the caudal 
half, however, was lagging behind and incomplete, resulting in a left-pitched 
torque of 30 – 90° between the completely rotated base and the partially rotated 
tail bud region. As a result, the posterior neuropore faced to the right and the tail 
tip pointed to the left in cranio-caudal view (Fig. 2c). This axial torque feature 
can be interpreted as a delay in rotation of the posterior neuropore and tail 
region. At the stages of 16 - 22 somites (Theiler stage 14 - 15), the rotation of the 
base and cranial half of the embryo was complete in all 18 wild type embryos 
analyzed for this feature. The caudal rotation was completed in 13 embryos, and 
in cranio-caudal view their tail region was in front of the head or passed the head 
at the right side. In five embryos, mild to marked torques were noted, with 
angles of 20 – 180°. In the most affected embryo, the posterior neuropore and 
tail bud region were actually not turned at all (Fig. 2d). In all cases with 
incomplete axial rotation of the caudal part, the posterior neuropore faced to the 
right and the tail bud pointed to the left in cranio-caudal view. In embryos at 20 - 
 
 
 
 
Figure 2: SEM images of Bent tail embryos (ED8 - 10) showing characteristic features. 
In (a) a largely deformed embryo (genotype Bn/Y; 28 somites) with a sharp Z-bend at the 
level of the turning point is shown. The Z-bend seems to have prevented the proper 
formation of the cardiac swelling. In (b) the kinked neural tube feature is shown in an 
embryo of genotype Bn/Y (12 somites). Black arrowheads indicate the kinks. 
Furthermore, this embryo also displays a RNP closure defect. Images (c), (d) and (e) 
show wild type embryos with 13, 16 and 20 somites, respectively, with a delay in axial 
rotation. This delay is indicated by different degrees of an axial torque of the caudal 
versus the cranial part of the embryo, resulting in the tail tip of the embryo pointing to 
the left (in cranio-caudal view) in (c) and (e). Image (f) shows an embryo (genotype 
Bn/Bn; 22 somites) in which the caudal torque is wrongly directed when compared to (c), 
indicating axial malrotation. Image (g) shows the RNP of a wild type embryo (13 
somites) with sharp-edged caudal and rostral borders, images (h) and (i) show embryos 
(both of genotype Bn/+, with 12 and 19 somites, respctively) in which the RNP has 
blunt-edged borders and in which closure has failed. Scale bars correspond to 200 µm. 
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22 somite stages, this resulted in the tail region passing the head on the left side 
(Fig. 2e).  
In embryos from Bn matings, the following phenotypes were observed: at the 
stages of 11 - 15 somites, the caudal parts of all seven embryos analyzed 
appeared in a torque, but one of them (with genotype Bn/Bn) had, surprisingly, a 
right pitch (Fig. 2f). This indicates an axial malrotation, i.e. turning in counter-
clockwise instead of the normal clockwise direction. At the stages of 16 - 22 
somites, seven out of 12 embryos were completely and normally turned, with 
their tail in front of the head or passing it at the correct side. In one embryo, 
there still was a slight caudal torque, in two others their caudal parts still showed 
a left-pitched torque of about 60 – 70°, with the tail tip pointing to the left. Two 
embryos (genotypes Bn/+ and +/Y) were clearly aberrant, displaying right-
pitched torques of 90° which were present in the caudal part. At the stages of 26 
- 31 somites, seven out of 11 embryos were completely turned. In three cases, the 
tail passed the head at the left side. In the one Bn/Y embryo with two 
considerable axial kinks (Fig. 2a), the tail tip pointed to the right. 
 
Closure of the neural tube 
No deviations were seen in the initiation and progression of closure of the neural 
tube in the cervical region in embryos from both wild type and Bn matings. 
Initiation of closure at the pros-mesencephalic border also appeared unaffected. 
Subsequent closure of the anterior neuropore (ANP) occurred between the 
developmental stages of 13 to 17 somites (Theiler stage 14) in embryos from the 
wild type matings, and the ANP was found to be closed from 15 somites onwards 
in embryos from Bn matings. No closure defects were observed in this region 
(data not shown). 
Closure of the rhombencephalic neuropore (RNP) also occurred between 13 to 17 
somites (Theiler stage 14) in embryos from the wild type and most of the Bn 
matings. The RNP was characterized by sharp-edged caudal and rostral borders, 
with their walls upright and the neural folds converging, both in the embryos 
from wild type matings and in most of the embryos from the Bn matings (Fig. 
2g). In two Bn/+ embryos, however, the caudal and rostral borders of the RNP 
were rounded, the walls of the open neural tube were upright and the neural folds 
diverging (Fig. 2b and 2h). In three additional affected embryos (genotypes 
Bn/Bn, Bn/+ and Bn/Y) a definitive closure defect of the rhombencephalon was 
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seen. An example is shown in Fig. 2i. In summary, RNP closure defects were 
observed in five out of 31 embryos (16%) of somite stages 11 or higher from the 
Bn matings. All of them were present in embryos with affected genotypes 
(Bn/Bn, Bn/+ and Bn/Y; Table 1). Apart from the RNP, variable parts of the 
mesencephalon were involved in the closure defect in these embryos (compare 
Fig 2b and 2h). Importantly, no closure defects of the RNP were observed in the 
23 embryos from wild type matings at comparable stages of embryonic 
development. 
The PNP was present in all embryos in our study. To identify possible 
differences between embryos with an affected genotype and wild type embryos, 
embryos from the Bn matings were analyzed in further detail. For those embryos 
with at least 19 somites (n=22) we determined from SEM images the ratio of the 
crown-rump (CR) and PNP length (PNP/CR-ratio). The results are summarized 
in Fig. 3.  
 
 
 
 
Figure 3: Scatter diagram of the analysis of PNP closure in embryos isolated from Bn 
matings. The diamond-shaped symbols represent measurements from embryos with the 
Bn allele, the quadrangular symbols represent measurements from embryos with a wild 
type (+/Y) genotype. As a reference, the triangular symbols represent the mean values 
found in wild type Swiss mice (van Straaten et al. 1992). 
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There was no difference in the PNP/CR ratio in embryos with less than 19 
somites. However, PNP closure was clearly delayed in embryos with more than 
25 somites: in four out of five embryos carrying the Bn allele the PNP/CR-ratio 
was much larger than in all embryos carrying wild type alleles only. The 
PNP/CR-ratios of wild type and affected embryos were arc-sine-transformed and 
analyzed using ANCOVA with somite number as a covariant. Although the 
sample number was small, the difference in the arc-sine-transformed PNP/CR-
ratios of wild type and affected embryos was found to be significant (p=0.046). 
 
Further characterization of the exencephaly phenotype 
To study the neural tube defect in the Bent tail mouse in more detail, we isolated 
embryos at later stages of development (ED14) and prepared sagittal and 
transverse paraffin sections. 
Exencephaly in the Bent tail embryos showed a very characteristic shape with 
involvement of variable parts of the mesencephalon and the entire 
rhombencephalon (Fig. 4a,b,g). Transverse sections (Fig. 4c-e) showed that 
mesencephalic tissue extended over the diencephalon, with large protrusions of 
the tegmentum into the ventricular system.  There also appeared to be asymmetry 
in the brain, probably caused by the protrusion of the mesencephalon (Fig. 4d).  
Massive overgrowth of neural tissue was seen in the open parts of the 
rhombencephalon and mesencephalon. This was visible both in transverse and 
sagittal sections (Fig. 4c-e,g). From the latter it also became clear that the rostral 
part of the mesencephalon in which the neural tube appeared to be closed was 
also expanded (Fig. 4g). The cerebrum appeared too small and was mainly 
occupied by the ganglionic eminences (Fig. 4g). The cerebellum anlage was not 
visible in the transverse sections (data not shown) and was not clearly identifiable 
in the sagittal sections, although there appeared to be a small protrusion directly 
opposite of the pontine flexure (compare Fig. 4f and 4g). Zic genes are known to 
be involved in the development of the cerebellum, as shown by its malformation 
in mice with reduced Zic1 or Zic2 function (Aruga et al. 2002). Moreover, no 
cerebellum is formed in exencephalic Zic3 knock out mice (Purandare et al. 
2002). However, examination of the cerebellum in adult Bn males did not show 
any abnormalities (data not shown). 
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DISCUSSION 
In this study we analyzed the embryonic development during the period of neural 
tube closure (ED8 - 10) and at ED14 in the NTD mouse model Bent tail. For this 
purpose, embryos were isolated from matings of affected animals (Bn matings) 
and from wild type matings. The percentage of resorptions and pre-somite stage 
embryos observed was higher in embryos derived from Bn matings (28%) than in 
those from wild type matings (14%). The percentage found in Bn matings was in 
accordance with the results of studies at later embryonic stages (Klootwijk et al. 
2000, and unpublished results), indicating that most of the resorbed embryos 
already died before ED10. The loss of embryos due to resorption appeared to be 
linked to the most affected genotypes generating a trend towards under-
representation of Bn/Bn and Bn/Y genotypes, consistent with the results of other 
studies (Carrel et al. 2000; Franke et al. 2003).  
The intra-litter range of embryonic developmental stages was larger in litters 
from affected dams than in those from wild type dams, but in both cases within a 
normal range (Theiler 1972), suggesting that the genetic defect causes delay in 
development in addition to embryonic death.  
From Table 1 and the results presented above it is clear that several ‘abnormal’ 
features of the Bn embryos, such as a kinked neural tube, a tight amnion, axial 
torquing during turning, and even the axial malrotation are also present in wild 
type embryos. Thus, these features can not be attributed solely to the genetic 
defect of Bent tail, which is the deletion of part of chromosome X, including the 
Zic3 gene.  
The kinked neural tube occurred in both groups of embryos, although in embryos 
from the wild type matings this feature was observed with a lower frequency and 
appeared very mild. The occurrence of such axis deformations might have been 
the result of an instable axial structure of the embryos. Interestingly, the location 
of most consistent axis deformations at somites 3-7, which is at the bottom of the 
U-shape of the unrotated embryo, is also the place where the first closure of the 
neural tube takes place in the mouse embryo. There is probably a correlation 
between these two facts, since at this location most of the torsion forces applied 
during development concentrate. 
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Figure 4: Bent tail embryos of ED14. Images (a) and (b) show embryos with the 
characteristic exencephaly phenotype after fixation. Light microscopical cresylviolet-
stained transverse sections of an exencephalic embryo (c-e) and midsagittal sections of a 
normal (f) and an exencephalic embryo (g). The blue lines in (g) marked with ‘c’, ‘d’ and 
‘e’ indicate the approximate positions of the transverse sections. The black arrowheads in 
(f) mark the frontal and caudal borders of the mesencephalon and rhombencephalon, the 
red arrowheads in (g) mark the borders of the exencephaly. Abbreviations mark the 
following structures: rhombencephalon [rh], mesencephalon [me], diencephalon [di], 
cerebellum [cb], exencephaly [ex], ganglionic eminence(s) [ge], lateral ventricle [lv], 
mesencephalic ventricle [mv], cerebral cortex [cc]. The asterisk [*] marks an asymmetric 
structure in the exencephalic brain. The position of the dorsal [d] and ventral [v] sides of 
the transverse sections are indicated. Scale bars correspond to 1 mm. 
 
A correlation between the axis deformation and the tight amnion phenotype might 
also exist, since in some embryos both phenotypes were seen combined. The tight 
amnion phenotype was also predominantly, but not exclusively, observed in 
embryos from the Bn matings and occurred independently of the embryonic 
genotype in the latter. These findings indicate that predisposition for a tight 
amnion is present in the background of the Bent tail strain, but that its severity is 
likely increased by the presence of the genetic defect of this mouse. The axial 
torque phenotype was observed in genotypically affected as well as in wild type 
embryos, both from Bn and from wild type matings. During axial turning, we 
frequently found that a left-pitched torque in the caudal part of the embryo 
occurred. This torque likely arose due to a delay in axial rotation of the tail bud 
region with respect to the base region at the level of somites 3 - 8. Such a torque 
is physiological initially (Fujinaga et al. 1995), and may indicate that the rotation 
of the caudal part has to overcome the strain due to its connection with the yolk 
sac, amnion, and/or connecting stalk. However, from the stage of 16 somites 
onwards, it seems pathological, since axial rotation should have been completed 
by then (Kaufman 1992; Fujinaga et al. 1995). The finding that the delay in 
caudal rotation was visible in embryos from both wild type matings and Bn 
matings indicates that this feature can be ascribed to the genetic background of 
the Bent tail strain. 
During axial rotation the embryo turns clockwise when viewed in cranio-caudal 
direction. However, in four embryos from Bn matings, three of them with an 
effected genotype and one wild type, axial turning of the embryo had occurred 
counter-clockwise, indicating that axial malrotation had occurred. Axial rotation 
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is a morphological sign of body asymmetry. This asymmetry is strongly biased, 
in that the tail almost always finishes up on the right side of the embryo for 
reasons that are still unknown (Fujinaga et al. 1995). Studies in Bent tail by 
others (Carrel et al. 2000) as well as in Zic3 deficient mice (Purandare et al. 
2002) suggest that Zic3 is an important gene involved in establishing left-right 
(L/R) asymmetry. Axial malrotation has frequently been observed in the Zic3 
deficient mice (Purandare et al. 2002), and other situs defects were found to be 
present in the Bent tail strain studied by Carrel (Carrel et al. 2000). This is 
corroborated by studies in humans, where mutations and deletions of ZIC3 cause 
severe laterality defects (Gebbia et al. 1997). Since laterality defects including 
axial malrotation are such a well-known phenotype caused by Zic3 deficiency, the 
observation of axial malrotation in a +/Y embryo is inexplicable thus far. 
Potentially, this might be a maternally (Bn/+) induced phenotype, as it was never 
observed in wild type crosses. Another possible explanation for the observed 
rotation abnormality is the fact that not counter-clockwise rotation has occurred, 
but that the phenotype of all four embryos results from an extreme clockwise 
rotation. However, although we can not formally exclude this possibility, the 
relative large number of embryos in this study with a delayed rotation of their 
caudal part indicates that extreme rotation is not likely to occur in this strain. 
The only phenotypes which showed an absolute correlation with genotype in our 
study were the neural tube closure defects including delayed PNP closure and 
exencephaly at the level of the RNP. Delayed closure of the posterior neuropore 
was observed in most embryos from Bn matings carrying an affected genotype. In 
studies of older Bent tail embryos we did not observe cases of spina bifida 
(Klootwijk et al. 2000, and unpublished results). Therefore, the observed delay in 
PNP closure appears transient in our studies, but is very likely related to spina 
bifida observed in Bent tail in an earlier study described by Johnson (Johnson 
1976). Consistent with this, spina bifida is also part of the phenotypic spectrum 
of Zic3 deficient mice (Purandare et al. 2002). The temporary PNP closure delay 
is also related to the kinky pattern seen in the tail of the Bent tail mouse, a similar 
pattern of the PNP closure delay is also observed in the Curly tail mouse mutant 
(Copp 1994; Peeters et al. 1996). 
The penetrance of exencephaly in embryos isolated from Bn mothers (16%) was 
even higher than the 11% we reported in an earlier study involving embryos at 
later stages of development (Klootwijk et al. 2000). The defect involves the 
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neural fold elevation zones B and C as defined by Harris and Juriloff (Harris and 
Juriloff 1999). All affected embryos displayed exencephaly resulting from a very 
characteristic closure defect involving the rhombencephalon and the caudal part 
of the mesencephalon. The walls of the neural tube elevated, but failed in the 
formation of dorsolateral hinges and subsequent closure of the neural folds. 
Therefore, the defect is a primary closure defect of the RNP, as opposed to a 
secondary defect resulting from a reopening of the tube. At a later stage of 
development (ED14), the defective closure was followed by massive overgrowth 
of brain tissue both in the open parts of the neural tube and in the more rostral 
parts of the mesencephalon, causing disorganization of these brain structures as 
well as inducing some aspects of asymmetry. This asymmetry may be due to an 
asymmetric protrusion of the mesencephalon. Overall, the disorganization of the 
exencephalic brain of the Bent tail mouse appeared less severe than the one 
observed in newborn pups from the Zic3 knock out strain, where a largely 
disorganized cortex, anteriorly displaced diencephalon, disorganized basal 
ganglia, thalamus and hippocampus, rudimentary olfactory nerves and an absent 
cerebellum were the most characteristic features (Purandare et al. 2002).  
Similar NTDs as the one described for Bent tail involving exencephaly of the 
rhombencephalon and part of the mesencephalon have been observed in mice 
deficient for Traf6 (Lomaga et al. 2000), Ikk1/Ikk2 (in a Tnfr1-/- background) (Li 
et al. 2000), Bcl10 (Ruland et al. 2001) and Jnk1 (in a Jnk2+/- background) 
(Sabapathy et al. 1999). Interestingly, all of the genes mentioned are involved in 
programmed cell death during development, which apparently is an important 
factor in the closure of the neural tube. Although no such function has been 
reported for Zic3 as of yet, it is interesting to speculate that Zic3 
malfunction/deletion might also cause neural tube closure defects through an 
involvement in the regulation of apoptosis during neurulation. 
In conclusion, the phenotypic comparison of Bent tail embryos with wild type 
controls has shown that exencephaly and a delayed closure of the posterior 
neuropore are phenotypes exclusively present in Bn. Axial malrotation, a tight 
amnion phenotype and a kinked neural tube are more severe and/or more frequent 
when the Bn allele is present, whereas a delay of the caudal rotation is observed 
with comparable frequency and severity in Bn and controls. Apparently, the 
genetic background of the Bent tail strain contains elements conducive to these 
developmental abnormalities. 
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CHAPTER 2.4 
 
Phenotype of the neural tube defect in the mouse 
model Bent tail is not sensitive to maternal folinic 
acid, myo-inositol, or zinc supplementation 
 
B. Franke, R. Klootwijk, B. Lemmers, C.G.F. de Kovel, 
R.P.M. Steegers-Theunissen, and E.C.M. Mariman 
 
ABSTRACT 
Background: Bent tail is a mouse model for X-linked neural tube defects, characterized by the 
occurrence of exencephaly, a delayed posterior neuropore closure and a tail phenotype. In addition 
to that, Bent tail shows laterality defects and increased prenatal mortality. The congenital 
malformations of this mouse are caused by a submicroscopic deletion, completely encompassing the 
gene coding for the zinc finger transcription factor Zic3. In this study we investigated the sensitivity 
of the phenotype of Bent tail to the nutrients folinic acid, myo-inositol and zinc. These nutrients are 
thought to be involved in the etiology of neural tube defects, in combination with a genetic 
predisposition.  
Methods: The most penetrant phenotype of the Bent tail mouse, the tail malformation, was used as 
a marker for the nutrient sensitivity of the neural phenotype. The size of the litters and the survival 
of the offspring, subdivided according to genotype, were analyzed as markers for the nutrient 
sensitivity of other phenotypic features of Bent tail. 
Results: We were able to confirm earlier studies showing the prenatal loss of a number of 
homozygous females and hemizygous males as well as the effect of genotype on the tail phenotype 
of Bent tail. Periconceptional supplementation of the maternal diet with folinic acid, myo-inositol or 
zinc, however, produced no significant effects on either the tail phenotype of the offspring or the 
size and genotypic composition of the litters.  
Conclusion: Bent tail appears to be a folinic acid-, myo-inositol- and zinc-insensitive mouse model 
for neural tube defects. 
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INTRODUCTION 
The Bent tail mouse (Bn) is a spontaneous mutant (Grüneberg, 1955) that carries 
a submicroscopic deletion on the X-chromosome (Carrel et al., 2000; Klootwijk 
et al., 2000). This deletion of 60-170 kb in size completely encompasses the gene 
encoding the zinc finger transcription factor Zic3. The phenotype of Bent tail is 
characterized by the presence of a characteristic short and kinked tail in 100% of 
the homozygotes and 87% of the heterozygote mice. Eleven to 16% of the 
embryos from matings of heterozygous females and hemizygous males exhibit a 
cranial neural tube defect (NTD), exencephaly of the hindbrain and caudal 
midbrain area (Franke et al., 2003). Embryos also show a delay in the closure of 
the posterior neuropore, which caused spina bifida in an earlier study on Bent tail 
(Johnson, 1976). The Bent tail colony described in the present study has a 
transient delay of closure of the posterior neuropore that does not manifest as 
spina bifida at detectable frequencies (Franke et al., 2003). Apart from the tail 
phenotype and the neural malformations, Bent tail mice also show laterality 
defects like axial malrotation and situs abnormalities, as well as an increased 
prenatal mortality (Klootwijk et al., 2000; Carrel et al., 2000; Franke et al., 
2003).  
Due to the neural phenotype of the Bent tail mouse, it is used as an animal model 
for research on human X-linked NTDs. In humans the birth prevalence rate of 
NTDs varies from 1 to 2 per 1,000 life births. Most human NTDs are 
multifactorial, caused by a combination of predisposing genetic factors and 
unfavorable environmental conditions, such as a poor nutritional status, maternal 
illness (e.g. diabetes mellitus), and the use of certain drugs like valproic acid and 
carbamazepine during early pregnancy (Botto et al., 1999). 
Up to now, several nutritional factors have been implicated in the etiology of 
NTDs. A functionally decreased folate status was identified as an important risk 
factor in humans (Steegers-Theunissen et al., 1991). This has led to preventive 
measures such as periconceptional folic acid supplementation and the introduction 
of food fortification with folic acid. These measures can reduce the NTD 
occurrence and recurrence rate by 50-85 and 70%, respectively (MRC Vitamin 
Study Research Group, 1991; Czeizel, 1998; Berry et al., 1999). 
At least two other compounds in the diet, myo-inositol and zinc, are thought to be 
involved in the etiology of NTDs, as well. Early studies showed that culturing rat 
embryos in myo-inositol-deficient medium resulted in cranial NTDs (Cockroft, 
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1988).  In vitro as well as in vivo studies indicated that NTDs in Curly tail (Ct), 
one of the mouse models for human neural tube defects with spina bifida and 
exencephaly in 50 to 60 % of the offspring (van Straaten and Copp, 2001), is 
sensitive to myo-inositol supplementation (Cockroft et al., 1992; Seller, 1994; 
Greene and Copp, 1997; Cogram et al., 2002). Furthermore, maternal diabetes 
mellitus is known to increase the risk of neural tube defects (Goto and Goldman, 
1994). Experiments in different diabetic animal models suggest that this increase 
in NTD risk is at least partially due to a hyperglycemia-induced decrease in the 
amount of myo-inositol in embryonic tissues (Sussman and Matschinsky, 1988; 
Hashimoto et al., 1990; Weigensberg et al., 1990; Strieleman et al., 1992). 
Supplementation with myo-inositol is able to reverse the glucose inhibition of 
neural tube fusion in these embryos (Hashimoto et al., 1990; Baker et al., 1990; 
Reece et al., 1997; Khandelwal et al., 1998). A recent case report suggests that 
periconceptional myo-inositol supplementation contributes to the prevention of 
folic acid-resistant NTDs in man (Cavalli and Copp, 2002). Furthermore, recent 
data of our own lab suggest that decreased maternal inositol levels are a risk 
factor for human NTD (Groenen et al., 2003). 
The third nutrient with a link to NTDs is zinc. Early animal studies showed that a 
zinc-deficient diet increased the prevalence of NTDs and other malformations 
(Warkany and Petering, 1972). In humans a higher prevalence of NTDs is 
observed in areas with zinc deficiency (Cavdar et al., 1991) as well as in 
offspring of women with acrodermatitis enteropathica, which represents a severe 
form of zinc deficiency with congenital malformations (Hambidge et al., 1975). 
In addition, zinc supplementation leading to normal offspring in zinc-deficient 
women with previous NTD-affected offspring has been reported (Akar, 1998). 
Recently, a population-based case-control study investigating the association 
between maternal preconceptional and dietary zinc intake and risk of NTDs, 
revealed an association between increased total preconceptional zinc intake and 
reduced NTD risk (Velie et al., 1999). Also in the case of zinc, our own data 
confirm this nutrient as a risk factor for human NTDs (Groenen et al., 2003). 
In an attempt to identify animal models with an etiology of NTDs that can be 
influenced by environmental factors, several NTD mouse models have been 
analyzed for their sensitivity to different nutrients. So far, several folate- and/or 
methionine-sensitive (Axd, Cart1, Cd, Folbp1, Sp, Cited2) and one inositol-
sensitive model (Ct) have been identified (Juriloff and Harris, 2000; Barbera et 
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al., 2002). In this paper we describe a study in the Bent tail mouse, investigating 
the sensitivity of its phenotype to maternal periconceptional supplementation with 
folinic acid (5-formyl-tetrahydrofolate, a derivative of folate), myo-inositol or 
zinc. The tail phenotype of the mouse was used as a marker for the sensitivity of 
the neural phenotype to supplementation with these nutrients. It is the most 
penetrant and therefore probably the most sensitive phenotype of Bent tail. A tail 
phenotype is observed in many NTD mouse models that have been analyzed in 
the postnatal state (e.g. Sp, Mthfr -/-, Ct, Cd, Lp, Fu, Vl,Tc+/+tw5, Zic2kd/kd,Zic3-/-
) and can be indicative of a delay in the timing of posterior neuropore (PNP) 
closure and subsequently in the tail bud outgrowth (Grüneberg, 1955; Copp, 
1994; Peeters et al., 1996; van Straaten and Copp, 2001). The transient delay of 
PNP closure in Bent tail (Franke et al., 2003) is most likely the cause of the tail 
defect in this mouse mutant, as well, consistent with the lack of a number of tail 
vertebrae. 
Apart from the tail phenotype we also analyzed the size of the litters and the 
survival of the offspring, subdivided according to genotype. Recent data from our 
lab suggest that most of the prenatal loss observed in Bent tail embryos already 
occurs before embryonic day (ED) 10 (Franke et al., 2003). Therefore, prenatal 
death does not seem related to the neural phenotype of Bent tail, but should be 
caused by other developmental problems, including the laterality defects. We 
included the mortality feature in the study described here to find out if other 
aspects of the Bent tail phenotype, apart from the neural anomalies, showed 
sensitivity to maternal periconceptional supplementation with folinic acid, myo-
inositol or zinc.  
 
MATERIALS AND METHODS 
The Bent tail mouse (Bn) 
The spontaneous mutation Bn, first described in 1952 by Garber, originally 
occurred in a F1-male from a cross of a Namru strain female and a bald hrba/hrba 
male (Garber, 1952). Bent tail mice for the current study were obtained from The 
Jackson Laboratory (Bar Harbor, Maine, U.S.A.). The genetic history of the 
strain present here since 1960 is as follows: It was maintained as C57BL/6J 
congenic breeder pairs, then inbred by brother-sister matings to F27, then 
outcrossed once to a C57Bl/6J x CBA/Ca F1-female (in 1968), then maintained 
by brother-sister matings reaching F83 in 1986, at which time embryos were 
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frozen. (URL: http://jaxmice.jax.org/jaxmice-
cgi/jaxmicedb.cgi?objtype=pricedetail&stock=000250). Two breeder pairs 
derived from these frozen embryos were obtained in 1999 and inbred further in 
our lab. For the supplementation experiments mice were kept under standard 
laboratory conditions in macrolon cages. Heterozygous (Bn/+) females were 
mated to hemizygous (Bn/Y) Bent tail males. The mating gave rise to the 
following genotypes in the offspring: wild type (+/Y) males, hemizygous (Bn/Y) 
males, heterozygous (Bn/+) females and homozygous (Bn/Bn) females. This type 
of mating was chosen above a mating of Bn/Bn with Bn/Y because of the 
opportunity to include less severely affected heterozygous females and wild type 
males in the analysis. Furthermore, Bn/Bn females breed poorly (unpublished 
observation). Matings were started at the age of 9 weeks. Males were removed 
from the cages two days after detection of a vaginal plug in the females. Males 
were used up to three times as fathers, but were switched between treatment 
groups to prevent unwanted interactions. Supplementation experiments started 7 
days before mating and continued for 14 days after the detection of the vaginal 
plug.  
This mouse study was approved by the local committee for animal research. 
 
Diet and supplements 
Mice were fed at liberty with a standard laboratory diet RMH-B (Hope Farms, 
Woerden, The Netherlands) which contains 863 mg/kg myo-inositol, 5.5 mg/kg 
folic acid and 69 mg/kg zinc.  Bodyweight was measured before the start of the 
experiment. The study was subdivided into two experiments: in experiment I the 
mice were fed the diet supplement by gastric intubation, solubilized in 0.2 ml 
drinking water; in experiment II the supplement was simply added to the drinking 
water, of which the mice consumed about 5 ml a day (as determined in a pilot 
experiment). Experiment I contained three experimental groups, one treated with 
25 mg/kg bodyweight folinic acid (5-formyl-tetrahydrofolate, Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany) per day, one treated with 2,000 mg/kg 
bodyweight myo-inositol (Sigma-Aldrich Chemie GmbH) per day, and a control 
group (control I), intubated with 0.2 ml drinking water alone. Experiment II 
contained two experimental groups, one treated with 0.5 mg/day of ZnCl2 
(Sigma-Aldrich Chemie GmbH), and one left untreated (control II). For each 
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experimental group in experiment I litters of 10 female mice were analyzed, for 
each experimental group in experiment II the offspring of 11 mice were analyzed. 
Supplementation was performed according to data in literature: the concentration 
of the supplements was comparable to earlier studies with different mouse and rat 
models in which this concentration was shown to have a physiological effect on 
the supplemented mice when compared to mice on a normal diet. The amount of 
folinic acid used in our study (25 mg/kg bodyweight) corresponded to a surplus 
of more than 18 times the daily intake of the mice. Comparable supplementation 
had been effective in reducing the penetrance of neural tube defects in mice 
lacking the folic acid-binding protein Folbp1 (Piedrahita et al., 1999). 
Myo-inositol supplementation (2000 mg/kg bodyweight) in our study 
corresponded to a surplus of 9 times the daily intake of the mice. Oral 
supplementation with as little as 0.08 mg myo-inositol per day had earlier been 
used in a diabetic rat model to successfully reduce the percentage of offspring 
with neural tube defects from 20.4% to 9.5% (Reece et al., 1997). Higher 
concentrations of up to 0.5 mg per day did not significantly influence this result. 
Furthermore, in a recent study by Copp and coworkers, a marked reduction 
(53%) in the frequency of NTDs was observed after oral supplementation of 
pregnant Curly tail mice with a total of 800 mg/kg bodyweight myo-inositol in a 
twice daily regimen from ED 8.5 to ED 10.5 (Cogram et al., 2002). 
Zinc supplementation of the Bent tail mice proved difficult since the mice did not 
thrive if ZnCl2 was given by daily gastric intubation of 1 mg or 0.5 mg. This 
corresponded to a surplus of about 3 and 1.4 times the daily zinc intake, 
respectively. There were no adverse effects if 0.5 mg ZnCl2 (corresponding to 
0.24 mg zinc) per day was given with the drinking water. We used this amount in 
our study since even lower amounts of zinc (0.11 mg per day) had shown 
physiological effects in a study evaluating the effect of melatonin on the 
production of nitric oxide in the mouse (Chen et al., 1999). A literature search 
yielded no papers discussing the effect of zinc surplus on NTDs in mice or rats. 
 
Data analysis 
The size of the litter of each female as well as the genotype and phenotypic 
features of the offspring were recorded. Phenotypic features included the total 
length of the tail and the number of tail kinks. Measurements were taken at 
weaning at the age of 4 weeks. 
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Statistical analysis was performed using the SPSS for Windows software package, 
version 10.0.  
For most analyses, the data were treated as two separate experiments, the first 
experiment involved gastric intubation of the mother with myo-inositol or with 
folinic acid; the second experiment involved oral supplementation with zinc. 
The effect of supplementation on litter size at weaning was tested with the non-
parametric Kruskall-Wallis or Mann-Whitney U test. 
The genotype distribution among the offspring was expected to be 1:1:1:1 for +/Y : 
Bn/Y : Bn/Bn : Bn/+. We tested whether the genotype distribution differed 
between treatments and, when not, a Chi square goodness of fit test with 3 degrees 
of freedom was performed on data pooled across experiments to test whether 
survival to weaning differed between offspring genotypes. This was done under the 
assumption that survival of the +/Y genotype was unaffected. Evaluation of tail 
kinks, all measured by the same person to prevent interobserver bias, was 
performed in the following way: As we were mainly interested in the effect of the 
intervention on the phenotype of genetically affected mice, the wild type males 
(+/Y) were left out of the evaluation of the tail kinks. This resulted in a bell-shaped 
distribution without differences in variances between the groups according to 
Levene’s test. On the remaining genotypes a two factor ANOVA was used to test 
for the effects of genotype and treatment of the mother, both as fixed factors. 
Genotype was taken into account, since earlier studies showed a difference in the 
severity of the tail phenotype between heterozygotes and homo- or hemizygotes 
(Grüneberg, 1955; Klootwijk et al., 2000; Carrel et al., 2000). A planned 
comparison tested the effect of supplementation versus control, whereas post-hoc 
Student-Newman-Keuls tests were used to study differences between genotypes. 
The effects of genotype and intervention on the length of the offspring tails were 
tested with ANOVA as well. Genotype and treatment of the mother were treated 
as fixed factors. Length of the mouse without the tail was treated as a covariant. 
Planned contrasts (deviation) were carried out between supplementation 
treatments and controls. 
 
Genotype analysis 
DNA was isolated from 1-2 toes of the mice that were clipped upon weaning for 
numbering purposes. DNA was isolated by SDS + Proteinase K treatment. 
Genotyping was performed as described earlier (Klootwijk et al., 2000) with a 
Chapter 2.4 
100  
STS flanking Zic3, px-35a1, which is deleted in Bent tail. The X-chromosomal 
STS px-41g10 served as a positive control for the PCR. Sequences of the primers 
were as follows: px-41g10-for: 5’GAAATAAACCTCCAAAACTG3’, px-41g10-
rev: 5’GCAAGAGAACTACAAGTTCAGT3’, px-35a1-for: 
5’CTCCTCTCTTGCTTAGCTAG3’, px-35a1-rev: 
5’GAGTAGTAATAGTTGCTGAACC3’, DYzEms12-for: 
5’CTACTAATGAAGGTGGCATCCC3’, DYzEms12-rev: 
5’CTTACCCCCCTACACAAAAGC3’. 
 
RESULTS 
Prenatal mortality 
Earlier studies have indicated that a percentage of embryos (up to 30%) is lost 
before birth and suggested that this is at least partly due to the loss of a number 
of the most severely affected genotypes (Carrel et al., 2000; Klootwijk et al., 
2000, and unpublished results). Recent studies show that most of the embryos are 
already lost before ED10 (Franke et al., 2003), suggesting that their death is 
related to developmental defects other than the neural tube defects.  
 
(A) Litter size: 
Litter size was compared between control and treatment groups at weaning, since 
we had found no evidence for postnatal wasting of offspring before weaning. 
Neither in experiment I, nor in experiment II, litter size differed between 
supplemented mothers and controls (Kruskall-Wallis, p=0.19, p=0.24 
respectively; see figure 1). Average litter size across both experiments was 3.7, 
varying from one to ten pups. The varying litter size led to unequal sample sizes 
in each treatment (table 1). 
 
(B) Genotypes in the litters: 
Following normal segregation of the X and Y-chromosomes, the genotypes +/Y, 
Bn/Y, Bn/+ and Bn/Bn were expected in equal numbers in the offspring of the 
mating between Bn/+ females and Bn/Y males. In this study, treatment of the 
mother did not significantly affect genotype of the offspring at weaning (p = 
0.71), so we pooled across treatments of both experiments. A significant 
deviation of genotype frequencies from the 1:1:1:1 expectation was found 
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(Chi2=11.65, p< 0.01). In particular, Bn/Bn females appeared to be 
underrepresented (table 1). 
 
 
 
Figure 1: Boxplot of the litter size for 5 different treatments of the mother. For treatment 
with folinic acid, myo-inositol and for control group I (indicated by striped boxes) 
numbers are derived from 10 litters, for treatment with zinc and Zn control (indicated by 
stippled boxes) numbers are derived from 11 litters. The box represents the interquartile 
range that contains 50% of values. The whiskers extend from the box to the highest and 
lowest values, excluding outliers (represented by a circle). The line across the box 
indicates the median. 
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 Experiment I Experiment II 
         Treatment
Genotype 
control I Folinic 
acid 
Myo- 
inositol 
Zinc (Zn) 
 
control II 
 
 
Total 
+/Y 12  
(24.5%) 
12 
(41.4%) 
13 
(38.2%) 
12 
(27.9%) 
10 
(27.8%) 
59 
(30.9%) 
Bn/Y 9 
(18.4%) 
4 
(13.8%) 
6 
(17.6%) 
13 
(30.2%) 
7 
(19.4%) 
39 
(20.4%) 
Bn/+ 21 
(42.9%) 
9 
(31.0%) 
11 
(32.4%) 
12 
(27.9%) 
11 
(30.6%) 
64 
(33.5%) 
Bn/Bn 7 
(14.3%) 
4 
(13.8%) 
4 
(11.8%) 
6 
(14.0%) 
8 
(22.2%) 
29 
(15.2%) 
total 49 29 34 43 36 191 
 
 
Table 1: Numbers of offspring mice of different genotypes at weaning for different 
supplementation treatments of the mother. Offspring was the yield of 10 litters each in 
control group I, folinic acid and myo-inositol treatments, and from 11 litters each in 
control II and zinc treatment. In brackets are the percentages of the total for each 
treatment. 
 
Tail phenotype 
The tail phenotype of Bent tail consists of the occurrence of kinks at various 
locations of the tail as well as a shortening of the total length of the tail compared 
to wild type mice. The tail kinks are caused by malformed tail vertebrae, the 
shortening of the tail length is caused by a reduction in the number of tail 
vertebrae (Klootwijk et al., 2000). Both are most likely the result of a delay in 
the timing of posterior neuropore closure and subsequently in the outgrowth of 
the tail bud. The tail features of the offspring of supplemented and control dams 
therefore can serve as a marker for the neural phenotype of Bent tail. 
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(A) Number of tail kinks: 
Though wild type (genotypically unaffected) males were expected to have no tail 
kinks, among the 59 mice in both experiments, two mice with one, one with two 
and one mouse with five kinks were found. Analysis was performed on 
genotypically affected mice only.  
In the folinic-acid/myo-inositol experiment, the number of tail kinks of the 
genotypes analyzed differed significantly (p = 0.01), with Bn/+ females having 
fewer kinks than Bn/Y males or Bn/Bn females. In the zinc experiment a similar 
result was found (p = 0.02) (Fig. 2). 
 
 
 
Figure 2: Number of tail kinks of different mouse genotypes for 5 different treatments of 
the mother. For number of subjects see table 1. Error bars show 95% confidence interval 
for the mean. 
 
As shown in figure 2 the supplementation did not affect the number of tail kinks 
in the offspring significantly in either experiment (p = 0.397 for folinic-
acid/myo-inositol, p = 0.680 for zinc). 
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(B) Tail length: 
After correction for length of the mouse (covariant, p ≤ 0.001), tail length 
differed between genotypes (Fig. 3) with Y/+ males having the longest (6.4 ± 
0.81 cm), and Bn/Y males (3.6 ± 0.82 cm) and Bn/Bn females (3.7 ± 0.85 cm) 
having the shortest tails (effect of genotype: p < 0.001 in both experiments). 
There was no significant effect of treatment in either experiment (p = 0.35 for 
folinic-acid/myo-inositol, p = 0.46 for zinc), nor was there a significant 
interaction of treatment of the mother with genotype of the offspring (p = 0.48 
and p = 0.29, respectively). 
 
 
 
 
Figure 3: Tail length (in cm) of different mouse genotypes for 5 different treatments of  
the mother. For number of subjects see table 1. Error bars show 95% confidence interval 
for the mean. 
 
DISCUSSION 
In the study presented here the nutrient sensitivity of different phenotypic features 
of the Bent tail mouse was examined. Supplementation of the maternal diet with 
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either folinic acid, myo-inositol or zinc did not affect the litter size or the survival 
of different genotypes prenatally and postnatally up to weaning, nor did it affect 
the tail phenotype of the offspring. 
Some genotypes were found to be underrepresented in the litters, in particular the 
Bn/Bn females, and to a lesser extent, the Bn/Y males. This result confirms 
earlier studies suggesting that the embryos that are lost before birth in this mutant 
belong to the most severely affected genotypes (Klootwijk et al., 2000; Carrel et 
al., 2000). In the surviving mice, as expected, the wild type mice rarely had 
kinks in their tails, and they also had longer tails than mice carrying one or two 
Bn-alleles. Heterozygous Bn/+ females had significantly longer tails and fewer 
kinks than mice with homozygous or hemizygous genotypes. Interestingly, we 
observed 4 wild type males with tail kinks. Whereas the occurrence of one or two 
kinks might be explained by external influences (like injuries caused by other 
mice), the presence of 5 kinks is a rare event in wild type mice. Genotyping was 
performed at least twice in these mice, suggesting that genotyping errors are not 
the cause of this finding. Carrel et al. (2000) noted in another genetic background 
several male mice with the characteristic Bent tail phenotype that carried parts of 
a second, normal X-chromosome due to chromosomal non-dysjunction. This 
phenomenon may also explain our observations. 
A weak point in our study is the fact that we could not directly analyze the NTD 
phenotype of Bent tail in embryos, but had to use the tail phenotype at weaning as 
a surrogate marker, especially since the only open neural tube defect in our Bent 
tail colony is exencephaly (cranial), whereas the PNP closure delay is only 
transient. It seemed not feasible to us to study the number of embryos with NTDs 
directly, due to the low incidence of NTDs in Bent tail (11 - 16%) and the large 
sample size needed to have enough power to detect significant differences 
between treatments and control. However, we think that the tail phenotype is a 
valid marker for the neural phenotype, since (1) the tail phenotype of Bent tail 
can be directly linked to primary neurulation and neural tube closure by the delay 
in PNP closure, as has been shown for another NTD mouse model, Ct (Copp, 
1994); (2) in at least one NTD mouse model, Cd, nutrient supplementation has 
already been shown to affect the tail phenotype, in addition to the NTD 
phenotype (Dr. M. E. Ross, personal communication); (3) the tail phenotype is 
the most penetrant and therefore probably the most sensitive phenotype of Bent 
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tail, as indicated by the fact that the tail length shows a strong inverse correlation 
with the number of wild type alleles present in the mice studied (this study).  
Since the amount of nutrients given as supplement in our study had shown 
biological effect in earlier studies (as indicated above), we conclude from our 
data that the lack of effect of the different nutrients on the Bent tail phenotype 
was most likely not due to insufficient supplementation of the mothers, but caused 
by the molecular defect underlying the phenotype of the Bent tail mouse.  
In conclusion, the results of this study suggest that supplementation with neither 
folinic acid, myo-inositol nor zinc affects the phenotype of the NTD mouse model 
Bent tail. 
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Gene expression profiling in neurulating curly tail 
embryos 
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W. van der Vliet, H. Straatman, R.P.M. Steegers-Theunissen, 
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ABSTRACT 
Neural tube defects are congenital malformations arising from incomplete neural tube 
closure during early embryogenesis. Most neural tube defects have a complex etiology, 
involving both genetic and environmental factors. The nutrient folate has been identified as 
one of the environmental factors involved. More than 120 mouse models for neural tube 
defects exist, some of which are folate-sensitive, whereas others are not. One folate-
resistant model is the  curly tail mouse for which supplementation with another nutrient, 
myo-inositol, reduces the incidence of neural tube defects. The mechanism underlying the 
protective effect of myo-inositol in curly tail is not known, but the effect is mediated 
through phosphoinositide signaling and stimulation of protein kinase C. To identify the 
genes involved in phosphoinositide signaling that are expressed during embryogenesis, we 
performed microarray-based expression analysis on whole wild type embryos of a C57Bl/6 
strain during and beyond spinal neural tube closure. All inositol-metabolism related genes 
on the microarray were expressed at this developmental phase. With this knowledge we 
performed microarray-based expression analysis on whole embryos of a BALB/c-curly tail 
recombinant strain and the wild type BALB/c strain during spinal neural tube closure to 
identify possible molecular perturbations in phosphoinositide signaling. Two different 
experimental set ups were chosen, one comparing gene expression in affected  BALB/c-
curly tail recombinant embryos with that in the wild type strain, the other comparing 
affected and nonaffected BALB/c-curly tail recombinant embryos. Neither experiment 
showed significant differences in the expression of any inositol metabolism-related gene. 
However, a number of other genes, not directly related to this metabolism, like the genes 
Fxy, Cort, Krox-20 and Rpa2, showed significant differential expression in the comparison 
of affected  BALB/c-curly tail recombinant embryos and the control strain BALB/c. 
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Introduction 
Neural tube defects (NTDs) arise due to improper closure of the neural tube 
during early embryogenesis. The two most common types of human NTDs are 
spina bifida and anencephaly, with an incidence of 1/1700 births and 1/1500 
births in the Netherlands, respectively [1]. Most human NTDs belong to the 
group of multifactorial diseases, which are caused by combinations of 
unfavorable environmental factors and genetic susceptibility. One environmental 
factor essential for proper neural tube closure is the nutrient folate. 
Periconceptional folic acid supplementation reduces the occurence and recurrence 
risk of human NTDs [2-4]. Another nutritional factor implicated in NTDs is 
inositol [5-9]. An association between maternal myo-inositol status and NTDs has 
been demonstrated in humans [6;9], but this relationship was first established in 
animal studies: in the curly tail (ct) mouse, a folic acid resistant mouse model for 
NTDs, the incidence of spina bifida in the offspring is reduced by maternal 
periconceptional supplementation with inositol [7;8]. The genetic defect of ct is a 
recessive mutation, which has not been identified yet.  
The etiology of the spinal NTD of ct has been investigated in great detail 
(reviewed in [10]). The phenotype of the ct mouse is variable and has incomplete 
penetrance. Homozygous mutants develop a curled tail in 50% and spina bifida 
aperta in 10% of cases, exencephaly is seen in approximately 3% of cases. 
Exencephaly predominates in female ct fetuses, whereas spina bifida exhibits a 
slight male preponderance, which reflects the human situation [11;12]. The 
primary pathogenic defect in ct mice is a reduced cell proliferation in the ventral 
tail bud region at the 22-26 somite stage [13] and subsequently in the hindgut 
endoderm and the notochord, underlying the posterior neuropore region at the 27-
29 somite stage. As a consequence, the axial curvature of this region is enhanced, 
which inhibits closure of the spinal neural tube. The protective effect of inositol, 
specifically of the stereoisomers myo-inositol and D-chiro-inositol, is mediated 
via the phospoinositide signal transduction pathway, which generates the second 
messengers diacylglycerol (DAG) and inositol-(3,4,5)-triphosphate [7;8]. 
Activation of protein kinase C, one of the downstream targets of DAG, is 
important for proper closure of the spinal neural tube in ct embryos. However, 
uptake and incorporation of myo-inositol appear unaffected in these embryos and 
the mechanism behind the protective effect of myo-inositol in ct is as yet unclear 
[7]. To explore the possibility of other steps in phosphoinositide cycling being 
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deregulated and leading to delayed spinal neural tube closure in ct, we performed 
expression profiling on a microarray in ct embryos and wild type embryos.  
 
Material and methods 
Embryonic material and RNA preparation 
This mouse study was approved by the local committee for animal research. 
Embryos were prepared from the following strains: fourth generation 
recombinant BALB/c-ct (fourth cross-intercross cycle, according to Peeters et al. 
[13]), BALB/c (Charles River Laboratories, Les Oncins, France), C57Bl/6 
(Charles River Laboratories,) and Bent tail (Bn) (Jackson Laboratory, Bar 
Harbor, ME, USA). The latter strain is another mouse model for NTDs and was 
used as a common reference for microarray analysis. All mice were mated 
overnight, after which females were checked for copulation plugs. The day of 
finding a plug was designated day 0 of gestation (embryonic day (ED) 0). 
Females were sacrificed by cervical dislocation at the appropriate gestational day 
and embryos were dissected as described previously [14]. Embryos from 
C57Bl/6, BALB/c and recombinant BALB/c-ct strains were harvested at ED10.5, 
Bn embryos were harvested at ED12.5-13.5. In addition, embryos from C57Bl/6 
were also harvested at ED11.5 and ED12.5. Embryos were pooled according to 
Table 1 (embryo pools I to XIV). Recombinant BALB/c-ct embryos were 
grouped in categories before pooling according to the severity of their posterior 
neuropore (PNP) closure delay, as described by Copp et al. [15]. Only the most 
extreme categories were used for the microarray experiments, so in our case 
category 1 contained embryos in which the PNP closure was unaffected, category 
5 contained embryos in which the PNP closure was strongly affected with the 
PNP in its rostral extends overlapping the most posterior somite rows. Total 
RNA was isolated from mouse embryos using the Trizol kit (Life Technologies, 
Breda, The Netherlands). Embryos were homogenized in the Trizol reagent. 
Total RNA was extracted and purified further using the RNeasy kit (Qiagen, 
Venlo, The Netherlands). Subsequently, polyA+ RNA was isolated using the 
Oligotex kit (Qiagen). All kits were used according to the protocols of the 
manufacturer. 
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Array design  
A microarray comprising most of the genes involved in inositol metabolism was 
designed from the 7.5 K oligonucleotide set of Sigma-Genosys (Cambridge, UK) 
with Clonetracker 1.4.11 (Biodiscovery, Ebersberg, Germany; metafile is 
available upon request). The oligonucleotides consisting of 65 bases with a 5’-C6 
amino modifier were dissolved in spotting solution (3x SSC (0.45 M NaCl, 45 
mM Na citrate, pH7.0), 1.5 M betaine) in a concentration of 20 µM. The set was 
spotted in duplo (12 fmol/spot) onto UltraGAPS glass slides coated with Corning 
Microarray Technology gamma-aminopropylsilane (Corning, Schiphol-rijk, The 
Netherlands) using a Prosys 5500TL arrayer (Genomic Solutions, Ann Arbor, 
MI, USA), 16 SMP3 pins (ArrayIt, Sunnyvale, CA, USA) and Axys-software 
(Genomic solutions). Throughout the spotting procedure the temperature and 
humidity conditions were set constant at 14°C and 60%, respectively. The center-
to-center spacing of the spots was 210 µm, the average diameter of the spots was 
116 µm and the array was subdivided into 48 blocks, which covered an area of 
8.8 cm2. Slides were dried overnight and the oligonucleotides were UV-
crosslinked to the slides at 600 mJ by use of a Stratalinker 2400 (Stratagene, 
Glenville, VA, USA).   
 
Experimental design 
The experimental design of our microarray analysis is summarized in Table 1. 
Four different types of comparisons were performed. Firstly, 3 self-self 
hybridizations were performed with embryo pool I consisting of Bn embryos 
isolated at ED12.5 and ED13.5, to determine the limits of differential gene 
expression that could be detected with our experimental procedure (Table 1: 
comparison I – I). Secondly, gene expression profiling was performed during and 
beyond PNP closure in C57Bl/6 embryos (ED10.5-12.5) (Table 1: comparisons I 
– II, I – III and I – IV). Thirdly, gene expression profiles of affected recombinant 
BALB/c-ct embryos at ED10.5 were compared with those of BALB/c embryos at 
ED10.5 (Table 1, comparisons V – VI, VII – VIII). Fourthly, gene expression 
profiling was performed in recombinant BALB/c-ct embryos with affected (PNP 
category 5) and unaffected (PNP category 1) PNP closure at ED10.5 (Table 1, 
comparisons IX – X, XI – XII and XIII – XIV).  
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Microarray experiment Group Strain 
Matings 
(n) 
Embryos 
(n) ED
Somites 
(n) 
PNP 
category Comparisons 
Slides 
(n) 
Self-self hybridisations I Bn 2 12 12,5 nd nd I - I  3 
    Bn 3 15 13,5 nd nd     
II C57Bl/6 1 9 10,5 30-37 nd I -II 2 
           nd     
III C57Bl/6 1 9 11,5 40-45 nd I - III 2 
           nd     
Gene expression 
profiling of wild type 
embryos during 
(ED10.5) and beyond 
(ED11.5 and ED12.5) 
PNP closure  
IV C57Bl/6 1 4 12,5 48-52 nd I - IV 2 
V BALB/c 2 6 10,5 28-32 nd V - VI 2 
VI ct  4 6 10,5 28-32 5     
                 
VII BALB/c 1 3 10,5 32-34 nd VII - VIII 1 
VIII ct  1 3 10,5 33-36 5     
Gene expression 
profiling in recombinant 
BALB/c-ct embryos with 
affected PNP closure and 
BALB/c embryos 
                 
IX ct  2 5 10,5 26-31 1 IX - X 2 
X ct  2 4 10,5 33-35 5     
                  
XI ct  1 3 10,5 37 1 XI - XII 2 
XII ct  1 3 10,5 37 5     
                  
XIII ct 1 3 10,5 29-32 1 XIII - XIV 2 
Gene expression 
profiling in recombinant 
BALB/c-ct embryos with 
unaffected and affected 
PNP closure 
XIV ct 1 3 10,5 28-30 5     
 
 
Table 1 Experimental design of the microarray analysis.  Abbreviations: ct=BALB/c-ct 
recombinant-4 line, nd=not determined, PNP=posterior neuropore, ED=embryonic 
day. 
 
Labeling procedures and parameters 
Label swap experiments were performed for all comparisons between different 
embryo pools, except for comparison VII – VIII. Labeling reactions were 
performed using the Cyscribe First Strand Labeling kit (Amersham, Little 
Chalfont, UK). For the first step, 1 µl anchored oligo-(dT) and 1 µl random 
nonamers were added to 9 µl polyA+ RNA. The mix was incubated for 5 min at 
70°C to denature the RNA, followed by incubation for 10 min at room 
temperature to allow annealing of the oligonucleotides. Then, the following 
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components of the First Strand Labeling kit were added to the mix: 4 µl 5x 
Cyscript buffer, 2 µl 0.1 M DTT, 1 µl dUTP-nucleotide mix, 1 µl Cyscript RT-
polymerase. Finally, 1 µl Cy-3- or Cy-5-dUTP (Amersham) was added to the 
reaction mix reaching a final volume of 20 µl per labeling reaction. The labeling 
reactions were performed for 2.5 hours at 42°C. To prevent aggregation of Cy-5 
labeled cDNAs, 5 µl 0.5 M EDTA (pH 8.0) was added to this reaction mix after 
incubation. Then, 1.5 µl 1 M NaOH was added to each reaction mix, followed by 
an incubation at 70°C for 10 min to hydrolyze the RNA. The reaction mix was 
neutralized by adding 25 µl 1 M Tris-HCl (pH 7.5). Next, 200 µl water was 
added and unincorporated nucleotides were removed from the synthesized Cy-3 
and Cy-5 labeled cDNAs using microconYM-30 micro-columns (Millipore, 
Bedford, MA, USA). The labeled cDNAs were concentrated in 56 µl water and 
labeling efficiencies were measured using an Ultraspec 3100 pro 
spectrophotometer (Biochrom Ltd, Cambridge, UK). Next, the Cy-3 and Cy-5 
labeled cDNAs were mixed with each other and 1.5 µl poly-dA (10 mg/ml; 
Amersham) plus 10 µl mouse Cot1 DNA (1 mg/ml; Life Technologies) was 
added to the mix to prevent aspecific hybridization to the microarray. The 
resulting mix was concentrated to a volume of 60 µl in water using a DNA110 
speed vac (Global Medical Instrumentation, Albertville, MN, USA). 
Subsequently, the labeled cDNAs in the mix were denatured for 2 min in boiling 
water, 60 µl 2x hybridization buffer (50% formamide, 5x SSC, 0.1% SDS) was 
added, and the final mix was incubated at 42°C for approximately 10 min before 
loading onto a Genetac hybridization station (Genomic Solutions). 
 
Hybridization procedure 
The slides carrying the microarray were incubated in a slide holder containing 
ethanolamine blocking buffer (50 mM ethanolamine, 100 mM Tris-HCl (pH 9.0) 
and 0.1% SDS) by gently rocking for 45 min at 50°C. Next, the slides were 
rinsed in water and incubated in wash/block buffer (4x SSC, 0.1% SDS) for 30 
min at 50°C. The slides were rinsed again, incubated in 0.8 µM-filter sterilised 
prehybridisation buffer (5x SSC, 0.1% SDS and 1% BSA (bovine albumin 
fraction V), Gibco, Breda, The Netherlands) at 42°C for 30-45 min, washed 
extensively in water and dried by centrifugation (10 min at 300x g). The slides 
were put into a hybridization module of the Genetac hybridization station 
(Genomic Solutions), 120 µl probe mix containing the labeled cDNAs was added 
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to the module and active hybridization was performed at 42°C for 16-20 hours. 
After hybridisation the slides were washed at 42°C in buffer 1 (1x SSC, 0.2% 
SDS) for 5 min and in buffer 2 (0.1x SSC, 0.2% SDS) for 4 min, then at room 
temperature in buffer 3 (0.1x SSC) for 5 min. Finally, the slides were rinsed in 
buffer 4 (0.01x SSC) and centrifuged to dryness for 10 min at 300x g. The slides 
were scanned on an Affymetrix 428 scanner (Affymetrix, Santaclara, CA, USA) 
using software package version 1.0 (Affymetrix). Cy-3 was scanned at a 
wavelength of 635 nm, Cy-5 at 532 nm. 
 
Image analysis and processing 
The acquired scanning images were analyzed with Genepix Pro 4.0 (Axon 
instruments, Union City, CA, USA). DNA spots were automatically segmented, 
local background (B635median and B532median) was subtracted and total 
intensities (F635median and F532median) as well as the fluorescence ratios of the 
two dyes were calculated for each spot. Spots were discarded if their intensities 
were low (F635median ≤ 1.4x B635 or F532median ≤ 1.4x B532), if the spots 
were flagged due to bad hybridization signals, or if the spots were saturated 
(F635median ≥ 65534 or F532median ≥ 65534). Ratios of Cy-3 and Cy-5 
fluorescence intensities (Cy3/Cy5) were normalized using linear regression on 
ratio intensity plots per array block as described by Dudoit and coworkers 
(http://www.stat.berkeley.edu/users/terry/zarray/Html/papersindex.html;[16]). 
For all calculations, we used the median of the pixel-by-pixel ratios of the pixel 
intensities with their median local background intensity subtracted. Genes with 
only one data point available of the duplos on each slide were included in the 
normalization procedure. Normalized datasets were analyzed using Significance 
Analysis of Microarrays (SAM). SAM analysis is a multiple t-testing method 
[17]. In brief, SAM assigns a q-value to each gene on the basis of the mean 
change in gene expression relative to the standard deviation of repeated 
measurements. The q-value is similar to the p-value in a t-test that is adopted to 
the analysis of a larger set of genes. The q-value is the smallest False Discovery 
Rate at which we are calling the expression of a gene significantly different 
between two or more conditions. We used three different types of SAM methods 
to analyze our normalized datasets. The first was multi-class response SAM, 
which is a method to detect genes that are different in mean gene expression level 
in any of the different conditions, in any combination. Multi-class response SAM 
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analysis was performed using 2 data sets for each of the following three classes: 
C57Bl/6 embryos at ED10.5, ED11.5 and ED12.5 (Table 1).  Secondly, we used 
two-class response SAM to determine differences in mean gene expression level 
between two defined classes. Two-class response SAM analysis was performed 
using all combinations of data sets with different embryonic age, for which each 
class included at least 2 data sets (Table 1; 2 slides) obtained from RNA of 
embryos with similar age (ED10.5, ED11.5 or ED12.5). Thirdly, one-class 
response SAM was performed to detect significant differences between the mean 
gene expression value for each gene and the number zero.  
Genes were included in SAM only if there was expression data available of two 
repeated measurements for each class analyzed. Input data for SAM included log2 
normalised gene expression values. The q-values obtained after SAM analysis for 
this study should be interpreted with caution, as they are based on only two 
repeated measurements for each class analyzed.  
 
Semi-quantitative RT-PCR 
Semi-quantitative RT-PCR was used to validate array results using a protocol 
previously described by Bussemakers et al. [18]. According to this protocol, 
cDNA concentrations were quantified by determination of [α-32P]dATP 
incorporation during reverse transcription. Corresponding amounts of material 
from parallel, non-radioactive cDNA synthesis reactions were then used for further 
analysis, achieving equal cDNA amounts in all samples. RT- samples were used as 
a negative control for PCR amplification. cDNA synthesis was performed using total 
RNA obtained from ED10.5, ED11.5, and ED12.5 C57Bl/6 embryos (Table 1, 
groups II - IV), ED10.5 BALB/c embryos (Table 1, groups V and VII) and 
recombinant BALB/c-ct embryos (Table 1, groups VI and VIII). PCR was 
performed in a 48 µl reaction mix containing 2.5 ng cDNA, 250 ng of each 
primer, 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 0.01% (w/v) 
gelatin, 0.2 mM dNTPs and 2 U Taq DNA polymerase (Invitrogen). The 
following primer pairs were used for PCR: 5’-GAGTTCCTTCCCTAAGCTGG-
3’ and 5’-CACTGCATGGCAGTCCTGC-3’ for Ship; 5’-
AACATGAGAAGCGCATGTCG-3’ and 5’-CTTAATGTCAGCTTCACTTGG-
3’ for NfI-a; 5’-CTCTGTCCCGCCTAGAACTG-3’ and 5’-
CTCGCCATCTCTTCCTTCAG-3’ for Prph1; 5’-
CTCATCTCGCAAGCGGAGC-3’ and 5’-GTGTCAAACGTGTCATTGAGG-3’ 
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for Fxy. The housekeeping gene Ship was used as a control to determine the 
quality of the cDNAs synthesized. PCR amplification was performed under the 
following conditions: samples were denatured at 92°C for 5 min and then 
subjected to 30 cycles of amplification (92°C for 1 min, 55°C for 1 min and 
72°C for 1 min). The PCR was followed by a final extension step of 72°C for 3 
min. Amplifications were performed in a PTC-200 thermal cycler (MJ-Research 
Inc. via Biozym, Landgraaf, The Netherlands).  
 
Results 
Expression of inositol metabolism-related genes during normal embryogenesis  
To assess the quality of the microarray slides and hybridization signals, 3 self-self 
hybridization experiments with RNA of group I embryos were performed. The 
results showed that 99.6% of all signals representing expressed genes lay within a 
2 fold induction range and none exceeded the 2.5 fold induction range, indicating 
a good quality of slides and hybridization signals. 
Next, we performed gene expression profiling on microarray on total C57Bl/6 
and BALB/c mouse embryos, groups II and V, to investigate which genes 
involved in the inositol metabolism could be detected on the 7.5 K mouse 
oligonucleotide set of Sigma-Genosys during the final stage of spinal neural tube 
closure at ED10.5. To this end, we interpreted genes to be expressed if the 
median fluorescence intensity obtained directly after Genepix analysis was higher 
than 1.4 times the local background. Expression of all inositol metabolism-related 
genes present on the microarray was detected in RNA obtained from both 
C57Bl/6 and BALB/c ED10.5 embryos (Fig. 1). High expression levels were 
observed for the genes glucosaminyl (N-acetyl) transferase 1 (Gcnt1; nr. 8), 
inositol phosphate 5'-phosphatase 2  (Inpp5H; nr. 17), myo-inositol 1-phosphate 
synthase A1 (IsynA1; nr. 5), phosphatidic acid phosphatase type 2c (Ppap2c; nr. 
11), phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (Pik3r2; nr. 
15), phospholipase C gamma-1 (Plcγ1; nr. 13) and diphosphoinositol 
polyphosphate phosphohydrolase (Dipp; nr. 1), intermediate to low expression 
was observed for all other inositol metabolism-related genes (indicated in the 
legends of Fig. 1). To investigate how these inositol metabolism-related genes are 
regulated in embryonic development around spinal neural tube closure we 
performed microarray analysis with RNA isolated from ED11.5 and ED12.5 
C57Bl/6 embryos and compared the expression profiles with those of ED10.5 
Chapter 3 
122  
embryos (groups II vs. III and II vs. IV). Multi-class and two-class response 
SAM analysis of the normalized microarray data sets showed no significant 
differences in the expression of these genes (as defined by q<5% and >2 fold 
difference in gene expression) between RNA obtained from ED10.5, ED11.5 and 
ED12.5 C57Bl/6 total embryos (data not shown). These results suggest that all 
inositol metabolism-related genes represented on the microarray are expressed at 
fairly constant levels during these stages of embryogenesis. 
 
 
 
 
Fig. 1 Inositol metabolism in the mouse. Enzymes for the reactions and transporters for 
inositol marked with a number were present on the microarray, EC identifiers are shown 
where available, 1: diphosphoinositol polyphosphate phosphohydrolase (Dipp) (EC 
3.6.1.52); 2: multiple inositol polyphosphate histidine phosphatase 1 (Minpp1) (EC 
3.1.3.62); 3: phosphatidylinositol transfer protein-alpha (Pitpn), -membrane-associated 
(Pitpnm), -beta (Pitpnβ); 4: inositol polyphosphate-1-phosphatase (Inpp1), inositol 
polyphosphate-4-phosphatase, type I, 107kD (Inpp4A) (EC 3.1.3.57); 5: myo-inositol 1-
phosphate synthase A1 (IsynA1); 6: Inositol (myo)-1(or 4)-monophosphatase 1 (Impa1) 
(EC 3.1.3.25); 7: solute carrier family 5 (inositol transporters), member 3 (Slc5a3); 8: 
glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), glycosyl phosphatidylinositol 1-
homolog (Gpi-1) (EC 2.4.1.198); 9: phosphate cytidylyltransferase 1, choline, alpha 
isoform (Pcyt1a) (EC 2.7.7.15); 10: diacylglycerol kinase α/ε  (Dgkα/ε) (EC 2.7.1.107); 
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11: phosphatidic acid phosphatase 2a (Ppap2a) (EC 3.1.3.4), phosphatidic acid 
phosphatase type 2c (Ppap2c) (EC 3.1.3.4); 12: protein kinase C α/β/ε/λ/µ/ζ/δ/γ/η/φ 
(Pkc α/β/ε/λ/µ/ζ/δ/γ/η/φ) (EC 2.7.1.37); 13: phospholipase C (Plc 
β/β2/β3/β4/γ1/δ/ε/ε2) (EC 3.1.4.11); 14: phosphatase and tensin homolog (Pten) (EC 
3.1.3.67); 15: phosphatidylinositol 3-kinase, type I (EC 2.7.1.137) [phosphatidylinositol 
3-kinase, regulatory subunit, polypeptide 1 (Pik3r1), polypeptide 2 (Pik3r2), catalytic 
subunit, alpha polypeptide (Pik3ca), catalytic subunit, delta polypeptide (Pik3cd), 
regulatory subunit], phosphatidylinositol 3-kinase]; type II (EC 2.7.1.154) [C2 domain 
containing, gamma polypeptide (Pik3c2g), C2 domain containing, alpha polypeptide 
(Pik3c2a)]; 16: phosphatidylinositol-4-phosphate 5-kinase [type I (EC 2.7.1.68): type I 
alpha (Pip5k1a), type I beta (Pip5k1b), type I gamma (Pip5k1c)], [type II: (EC 
2.7.1.149): type II alpha (Pip5k2a)], [type III (Pipk5k3)]; 17: inositol polyphosphate 
phosphatase-like 1 (Inppl1), inositol phosphate 5'-phosphatase 2 (Inpp5H), inositol 
polyphosphate-5-phosphatase, 75 kDa (Inpp5b) (EC 3.1.3.56). 18: inositol hexaphosphate 
kinase 1 (Itpk6-pending) (EC 2.7.1.152). The following enzymes involved in inositol 
metabolism were not on our microarray: 19: phosphatidylinositol synthase (EC 2.7.8.11). 
20: phosphatidylinositol 4-kinase (EC 2.7.1.67). 21: inositol polyphosphate-4-
phosphatase. Abbreviations: CDP-DAG= cytidine diphosphate-diacylglycerol, 
PA=phosphatidate, DAG=diacylglycerol, PtdIns4,5P2=phosphatidylinositol-4,5-
biphosphate, PtdIns4P=phosphatidylinositol-4-phosphate, PtdIns=phosphatidylinositol, 
GlycosylPtdIns=glycosylphosphatidylinositol, PtdIns3P=phosphatidylinositol-3-
phosphate, PtdIns3,5P2=phosphatidylinositol-3,5-biphosphate, PtdIns3,4 
P2=phosphatidylinositol-3,4-biphosphate, PtdIns3,4,5 P3=phosphatidylinositol-3,4,5-
triphosphate, Ins=inositol,  InsP=inositol-phosphate, InsP2=inositol-bisphosphate, 
InsP3=inositol-trisphosphate, InsP4=inositol-tetrakisphosphate, InsP5=inositol-
pentakisphosphate, InsP6=inositol-hexakisphosphate, PPInsP5=diphosphoinositol-
pentakisphosphate, [PP]2InsP5=bisdiphosphoinositol-tetrakisphosphate. Atransporter of 
phosphatidylinositol. BType II phosphatidylinositol 3-kinase can not phosphorylate 
Phosphatidylinositol-4,5-biphosphate. 
 
Expression of non-inositol metabolism-related genes during normal 
embryogenesis 
Multi-class and two-class response SAM analysis showed that several genes not 
directly related to the inositol metabolism were significantly regulated during 
embryonic development between ED10.5 and ED12.5. Table 2 shows a summary  
of the differentially expressed genes (q<5%). Four clusters of genes with similar 
expression regulation could be distinguished (Table 2, A-D). The minimal 
requirement to put a gene in a given cluster was a two-fold difference in gene 
expression between two embryonic stages. The regulated genes are involved in a 
wide range of cellular processes, like cell adhesion and cell shape and size 
determination, signal transduction and transcription regulation, as well as 
transport processes. Expression patterns observed by microarray analysis were 
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validated for four of the genes using semi-quantitative RT-PCR (NfI-a, Prph1, 
Ship and Fxy; Fig. 2A). Higher NfI-a and Prph1 RNA expression levels were 
detected for C57Bl/6 embryos at ED10.5 compared to ED11.5 and ED12.5 by 
RT-PCR. The same results were obtained for the microarray (Table 2: Prph1, 
gene cluster A; NfI-A, gene cluster B). As for the gene NfI-a, the differences in 
gene expression levels between RNA of embryos at ED10.5 and ED11.5 or 
ED12.5 were also confirmed by Northern blot analysis (data not shown). For 
Ship and Fxy no differences in gene expression were observed, consistent with 
the results of the microarray analysis. 
 
Gene expression during spinal neural tube closure in recombinant BALB/c-ct 
embryos 
To determine which genes might be involved in delayed spinal closure of the 
neural tube in ct, we compared RNA expression profiles of pooled affected 
recombinant BALB/c-ct embryos (ED10.5; somites 28-34) with those from 
pooled BALB/c embryos (ED10.5; somites 28-36) (comparisons V–VI and VII-
VIII, as shown in Table 1). One-class response SAM analysis yielded just one  
 
Table 2  List of genes that were differentially expressed during (ED10.5) and beyond 
(ED11.5 and ED12.5) PNP closure in C57Bl/6 embryos subdivided into 4 expression 
clusters (A-D). Normalised gene expression values for ED10.5 embryos were set at a 
value of 0 and the expression values for ED11.5 and ED12.5 embryos were presented 
relative to this value. AGene ontologies, http://www.sigma-
genosys.com/oligonucleotide.asp  
 
CLASS A 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 
- 
ED10.5 
ED12.5      
-         
ED10.5 
AF217545 
Mus musculus Mit1/Lb9 mRNA, 
partial sequence 
biological_process 
unknown 
[0000004] 4,1 8,5 
M55181 
Mouse spermatogenic-specific 
proenkephalin mRNA, complete cds 
neuropeptide 
signaling pathway 
[0007218] 4,7 11,8 
NM_007730 
Mus musculus procollagen, type XII, 
alpha 1 (Col12a1), mRNA 
cell adhesion 
[0007155] 2,2 4,3 
NM_008520 
Mus musculus latent transforming 
growth factor beta binding protein 3 
(Ltbp3), mRNA 
cell adhesion 
[0007155] 3,8 6,1 
NM_010430 
Mus musculus hypermethylated in 
cancer 1 (Hic1), mRNA 
transcription 
regulation 
[0006355] 5,4 8,5 
NM_010728 
Mus musculus lysyl oxidase (Lox), 
mRNA 
cell adhesion 
[0007155] 2,5 6,3 
NM_010866 
Mus musculus myogenic differentiation 
1 (Myod1), mRNA 
muscle 
development 
[0007517] 2,5 4,9 
NM_011618 
Mus musculus troponin T1, skeletal, 
slow (Tnnt1), mRNA 
muscle contraction 
regulation 
[0006937] 3,1 5,3 
NM_019967 
Mus musculus deleted in bladder 
cancer chromosome region candidate 1 
(Dbccr1), mRNA 
isocitrate 
dehydrogenase 
(NAD+) 
[0005962] 3,1 5,2 
U20264 
Mus musculus clone 1.5B/C/D LB9 
mRNA, 3'UTR, partial sequence 
biological_process 
unknown 
[0000004] 3,3 9 
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CLASS B 
 
 
 
 
 
 
      
Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
K02782 
Mouse complement component C3 
mRNA, alpha and beta subunits, 
complete cds 
inflammatory 
response [0006954] 3,0 4,1 
NM_007504 
Mus musculus ATPase, Ca++ 
transporting, cardiac muscle, fast twitch 
1 (Atp2a1), mRNA 
cation transport 
[0006812] 2,7 3,4 
NM_007698 
Mus musculus cholinergic receptor, 
muscarinic 1, CNS (Chrm1), mRNA 
biological_process 
unknown [0000004] 2,1 2,7 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
NM_007698 
Mus musculus cholinergic receptor, 
muscarinic 1, CNS (Chrm1), mRNA 
biological_process 
unknown [0000004] 2,1 2,7 
NM_007802 
Mus musculus cathepsin K (Ctsk), 
mRNA 
proteolysis and 
peptidolysis 
[0006508] 2,1 2,4 
NM_007925 Mus musculus elastin (Eln), mRNA 
cell growth and/or 
maintenance 
[0008151] 2,3 2,8 
NM_008048 
Mus musculus insulin-like growth factor 
binding protein 7 (Igfbp7), mRNA 
negative control of 
cell proliferation 
[0008285] 2,9 2,2 
NM_008264 
Mus musculus homeo box A13 
(Hoxa13), mRNA 
biological_process 
unknown [0000004] 2,7 2,5 
NM_008275 
Mus musculus homeo box D13 
(Hoxd13), mRNA 
transcription 
regulation [0006355] 2,8 3,6 
NM_008655 
Mus musculus myeloid differentiation 
primary response gene 118 (Myd118), 
mRNA 
cell cycle arrest 
[0007050] 2,1 2,4 
NM_008675 
Mus musculus neuroblastoma, 
suppression of tumorigenicity 1 (Nbl1), 
mRNA 
DNA binding 
[0003677] 2,6 3,1 
NM_008923 
Mus musculus protein kinase, cAMP 
dependent regulatory, type I beta 
(Prkar1b), mRNA 
embryogenesis and 
morphogenesis 
[0007345] 2,4 3,4 
NM_009001 
Mus musculus RAB3A, member RAS 
oncogene family (Rab3a), mRNA 
intracellular protein 
traffic [0006886] 2,6 3,6 
NM_009819 
Mus musculus catenin alpha 2 (Catna2), 
mRNA 
cell adhesion 
[0007155] 2,2 2,6 
NM_009920 
Mus musculus cornichon (Drosophila)-
like (Cnil), mRNA 
developmental 
processes [0007275] 2,4 2,6 
NM_010025 
Mus musculus doublecortin (Dcx), 
mRNA 
central nervous 
system development 
[0007417] 2,1 3,0 
NM_010308 
Mus musculus guanine nucleotide 
binding protein, alpha o (Gnao), mRNA 
muscle contraction 
[0006936] 2,4 2,4 
NM_010607 
Mus musculus potassium channel, 
subfamily K, member 2 (Kcnk2), mRNA
potassium transport 
[0006813] 2,1 2,7 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
NM_011021 
Mus musculus orthopedia homolog, 
(Drosophila) (Otp), mRNA 
transcription 
regulation [0006355] 2,4 2,7 
NM_011043 
Mus musculus protocadherin 10 
(Pcdh10), mRNA 
cell adhesion 
[0007155] 2,4 3,6 
NM_011250 
Mus musculus retinoblastoma-like 2 
(Rbl2), mRNA 
DNA binding 
[0003677] 2,3 2,7 
NM_011335 
Mus musculus small inducible cytokine 
A21a (leucine) (Scya21a), mRNA 
chemotaxis 
[0006935] 2,6 4,3 
NM_012040 
Mus musculus calcium/calmodulin-
dependent protein kinase 1, beta 
(Camk1b), mRNA 
signal transduction 
[0007165] 2,2 2,5 
NM_013639 
Mus musculus peripherin (Prph1), 
mRNA 
cytoskeleton 
organization and 
biogenesis [0007010] 3,3 5,0 
NM_013643 
Mus musculus protein tyrosine 
phosphatase, non-receptor type 5 
(Ptpn5), mRNA 
protein 
dephosphorylation 
[0006470] 2,5 2,7 
NM_013892 
Mus musculus granin-like 
neuroendocrine peptide precursor (Saas-
pending), mRNA 
neuropeptide 
signaling pathway 
[0007218] 3,8 4,5 
NM_015731 
Mus musculus ATPase, class II, type 9A 
(Atp9a), mRNA 
hydrogen transport 
[0006818] 2,2 2,9 
NM_019390 Mus musculus lamin A (Lmna), mRNA 
cell shape and cell 
size control 
[0007148] 2,1 2,9 
NM_019568 
Mus musculus small inducible cytokine 
subfamily B (Cys-X-Cys), member 14 
(Scyb14), mRNA 
signal transduction 
[0007165] 4,0 5,5 
NM_021324 
Mus musculus tweety homolog 1 
(Drosophila) (Ttyh1), mRNA 
cytoskeleton 
organization and 
biogenesis [0007010] 3,0 3,7 
U57633 
Mus musculus DNA binding protein 
NFI-A (NfiA) mRNA, partial cds 
DNA replication 
[0006260] 2,4 4,2 
X51983 
Mouse c-erbA-alpha mRNA for thyroid 
hormone receptor 
transcription 
regulation [0006355] 2,1 3,6 
X83932 
M.musculus mRNA for ryanodine 
receptor type 1 
calcium ion transport 
[0006816] 2,3 3,1 
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CLASS C 
 
 
 
 
 
      
Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
AJ006803 
Mus musculus mRNA for neurexin II, 
partial 
cell adhesion 
[0007155] 1,9 3,5 
AJ010752 
Mus musculus mRNA for gastric mucin-
like protein, partial 
cell growth and/or 
maintenance 
[0008151] 1,7 3,1 
D49802 
Mus musculus mRNA for leucine-rich 
repeat protein, partial cds 
cell adhesion 
[0007155] 1,7 3,5 
L31397 
Mus musculus dynamin (BreDnm19) 
mRNA, complete cds 
endocytosis 
[0006897] 1,7 2,6 
NM_007496 
Mus musculus AT motif binding factor 1 
(Atbf1), mRNA 
transcription 
regulation [0006355] 1,6 2,8 
NM_007833 Mus musculus decorin (Dcn), mRNA 
cell adhesion 
[0007155] 1,7 2,7 
NM_008125 
Mus musculus gap junction membrane 
channel protein beta 2 (Gjb2), mRNA 
cell-cell signaling 
[0007267] 1,8 3,1 
NM_008210 
Mus musculus H3 histone, family 3A 
(H3f3a), mRNA 
nucleosome assembly 
[0006334] 1,7 2,7 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
NM_008478 
Mus musculus L1 cell adhesion 
molecule (L1cam), mRNA 
cell adhesion 
[0007155] 1,8 2,8 
NM_008687 
Mus musculus nuclear factor I/B (Nfib), 
mRNA 
DNA replication 
[0006260] 1,9 4,2 
NM_008688 
Mus musculus nuclear factor I/C (Nfic), 
mRNA 
DNA replication 
[0006260] 1,7 2,7 
NM_008791 
Mus musculus Purkinje cell protein 4 
(Pcp4), mRNA 
neurotransmitter 
transport [0006836] 1,8 2,8 
NM_009305 
Mus musculus synaptophysin (Syp), 
mRNA transport [0006810] 2,0 2,5 
NM_009323 
Mus musculus T-box 15 (Tbx15), 
mRNA 
transcription 
regulation [0006355] 1,5 3,1 
NM_009347 
Mus musculus tectorin alpha (Tecta), 
mRNA 
cell growth and/or 
maintenance 
[0008151] 1,9 2,5 
NM_009783 
Mus musculus calcium channel, voltage-
dependent, T type, alpha 1G subunit 
(Cacna1g), mRNA 
calcium ion transport 
[0006816] 1,9 2,5 
NM_009822 
Mus musculus CBFA2T1 identified gene 
homolog (human) (Cbfa2t1h), mRNA 
transcription 
regulation [0006355] 1,4 3,2 
NM_009871 
Mus musculus cyclin-dependent kinase 
5, regulatory subunit (p35) (Cdk5r), 
mRNA cell cycle [0007049] 1,9 2,8 
NM_009926 
Mus musculus procollagen, type XI, 
alpha 2 (Col11a2), mRNA 
cell adhesion 
[0007155] 1,7 2,8 
NM_009946 
Mus musculus complexin 2 (Cplx2), 
mRNA 
neurotransmitter 
release [0007269] 1,4 3,3 
NM_010128 
Mus musculus epithelial membrane 
protein 1 (Emp1), mRNA 
mechanosensory 
behavior [0007638] 1,5 3,0 
NM_010354 Mus musculus gelsolin (Gsn), mRNA 
actin filament 
organization 
[0007015] 1,8 3,7 
NM_010691 
Mus musculus lady bird-like homeobox 
1 homolog, (Drosophila) (Lbx1h), 
mRNA 
transcription 
regulation [0006355] 1,8 2,5 
NM_011789 
Mus musculus adenomatosis polyposis 
coli 2 (Apc2), mRNA 
biological_process 
unknown [0000004] 2,0 2,3 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
NM_015734 
Mus musculus procollagen, type V, 
alpha 1 (Col5a1), mRNA 
cell adhesion 
[0007155] 1,6 2,7 
NM_016749 
Mus musculus myosin-binding protein H 
(Mybph), mRNA 
cell adhesion 
[0007155] 1,7 3,8 
NM_016753 Mus musculus latexin (Lxn), mRNA 
negative control of 
cell proliferation 
[0008285] 1,7 2,7 
NM_019431 
Mus musculus calcium channel, voltage-
dependent, gamma subunit 4 (Cacng4), 
mRNA 
ion transport 
[0006811] 1,7 2,8 
NM_021286 
Mus musculus seizure related gene 6 
(Sez6), mRNA 
complement 
activation, classical 
pathway [0006958] 1,6 3,1 
U20263 
Mus musculus clone 1.3C LB9 mRNA, 
3'UTR, partial sequence 
biological_process 
unknown [0000004] 1,8 4,4 
U78179 
Mus musculus sodium channel 2 
(mBNaC2) mRNA, partial cds 
signal transduction 
[0007165] 1,8 2,9 
 
CLASS D 
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Fold difference in 
gene expression 
level  
NCBI Gene 
accession 
number Gene  Gene ontologyA 
ED11.5 - 
ED10.5 
ED12.5 - 
ED10.5 
M11739 
Mouse cholecystokinin (CCK) mRNA, 
3' end 
signal transduction 
[0007165] -2,3 -2,3 
M21836 
Mouse extra-embryonic endodermal 
cytokeratin type II (EndoA) mRNA, 
complete cds 
cytoskeleton 
organization and 
biogenesis [0007010] -2,3 -3,5 
NM_007811 
Mus musculus cytochrome P450, 26, 
retinoic acid (Cyp26), mRNA 
metabolism 
[0008152] -2,3 -3,0 
NM_010264 
Mus musculus nuclear receptor 
subfamily 6, group A, member 1 
(Nr6a1), mRNA 
embryogenesis and 
morphogenesis 
[0007345] -2,2 -2,6 
NM_013500 
Mus musculus cartilage link protein 1 
(Crtl1), mRNA 
cell motility 
[0006928] -2,4 -2,7 
NM_019552 
Mus musculus ATP-binding cassette, 
sub-family B (MDR/TAP), member 12 
(Abcb12-pending), mRNA transport [0006810] -2,7 -3,9 
 
 
gene, cortistatin (Cort), with differential expression (q<5% and  >2 fold 
difference for each comparison). This gene had a 2.5 fold lower mean gene 
expression level in affected recombinant BALB/c-ct embryos compared to 
BALB/c embryos. More differentially expressed genes (q<5% and >2 fold 
difference for each comparison) were identified when only the gene expression 
profiles above the 30 somite stage of recombinant BALB/c-ct embryos (33-36 
somites) and BALB/c embryos (32-34 somites) were taken into account. At this 
time the spinal neural tube is expected to be closed in BALB/c embryos but still 
open in most affected recombinant BALB/c-ct embryos [19]. Significance of 
differential gene expression levels was set at 2x SD of the gene expression levels 
of all genes on the microarray and at least 2 fold expression level difference 
between the two embryo pools. Results of this analysis are shown in Table 3. 
Most of the listed genes were upregulated in affected recombinant BALB/c-ct 
embryos. None of the genes included in Table 3 were directly involved in the 
inositol metabolism. The gene with the largest difference in expression between  
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Table 3 Results obtained by comparison of gene expression profiles of ED10.5 BALB/c 
embryos and affected recombinant BALB/c-ct embryos at ED10.5 (comparison of group 
VII-VIII, as shown in Table 1). Positive value = higher RNA expression in ED10.5 
affected recombinant BALB/c-ct embryos; negative value = higher RNA expression in 
ED10.5 BALB/c embryos. AGene ontologies, http://www.sigma-
genosys.com/oligonucleotide.asp BBoth oligonucleotides belong to the same gene.  
 
NCBI ID Gene Gene ontologyA 
Fold difference 
in gene 
expression 
level ( table1, 
group VII - 
VIII) 
AF026565 
Mus musculus ring finger protein 
(Fxy) mRNA, complete cdsB 
cell shape and cell size control 
[0007148] 13,1
NM_010797 
Mus musculus midline 1 (Mid1), 
mRNAB 
transcription regulation 
[0006355] 10,0
NM_007506 
Mus musculus ATP synthase, H+ 
transporting, mitochondrial F0 
complex, subunit c (subunit 9), 
isoform 1 (Atp5g1), mRNA hydrogen transport [0006818] 5,8
AB041658 
Mus musculus brain cDNA, clone 
MNCb-3154 apoptosis [0006915] 5,6
NM_007519 
Mus musculus bile acid-Coenzyme A 
dehydrogenase: amino acid n-
acyltransferase (Baat), mRNA bile acid metabolism [0008206] 4,6
NM_011169 
Mus musculus prolactin receptor 
(Prlr), mRNA 
hematopoeitin/interferon-class 
(D200-domain) cytokine receptor 
[0004896] 4,2
X06746 
Mouse mRNA for Krox-20 protein 
containing zinc fingers 
transcription regulation 
[0006355] 3,4
NM_021274 
Mus musculus small inducible 
cytokine B subfamily (Cys-X-Cys), 
member 10 (Scyb10), mRNA inflammatory response [0006954] 3,3
AF183184 
Mus musculus brain otoferlin (Otof) 
mRNA, complete cds 
RAS protein signal transduction 
[0007265] 3,1
NM_021464 
Mus musculus protein tyrosine 
phosphatase, receptor type, T 
(Ptprt), mRNA 
protein dephosphorylation 
[0006470] 3,1
NM_009763 
Mus musculus BP-3 alloantigen 
(Bp3), mRNA 
post-translational membrane 
targeting [0006620] 2,8
NM_008759 
Mus musculus OG9 homeobox gene 
(Og9x), mRNA 
transcription regulation 
[0006355] 2,7
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NCBI ID Gene Gene ontologyA 
Fold difference 
in gene 
expression 
level ( table1, 
group VII - 
VIII) 
Z78152 
M.musculus partial cochlear mRNA 
(clone 302E7) 
biological_process unknown 
[0000004] 2,6
L04961 
Mouse nuclear-localized inactive X-
specific transcript (Xist) mRNA vision [0007601] 2,5
U60881 
Mus musculus Yac-2 NAD:arginine 
ADP-ribosyltransferase mRNA, 
complete cds 
post-translational membrane 
targeting [0006620] 2,5
NM_015808 
Mus musculus keratin-associated 
protein 5-1 (Krtap5-1), mRNA 
biological_process unknown 
[0000004] 2,4
AF093697 
Mus musculus clone 2.27 type D 
endogenous retrovirus, partial 
sequence 
proteolysis and peptidolysis 
[0006508] 2,4
AJ279833 
Mus musculus partial mRNA for 
hypothetical protein, clone mv12x1 
biological_process unknown 
[0000004] 2,4
Z78147 
M.musculus partial cochlear mRNA 
(clone 32B12) citrate metabolism [0006101] 2,4
U75374 
Mus musculus glutamate transporter 
mRNA, alternate 3' UTR 
biological_process unknown 
[0000004] 2,3
NM_012038 
Mus musculus visinin-like 1 (Vsnl1), 
mRNA protein myristylation [0006499] 2,3
NM_019985 
Mus musculus C-type lectin-like 
receptor 2 (Clec2-pending), mRNA 
cell surface receptor linked signal 
transduction [0007166] 2,3
NM_011643 
Mus musculus transient receptor 
protein 1 (Trrp1), mRNA calcium ion transport [0006816] 2,3
NM_007968 
Mus musculus Ewing sarcoma 
homolog (Ewsh), mRNA 
transcription regulation 
[0006355] 2,3
NM_008877 
Mus musculus plasminogen (Plg), 
mRNA 
proteolysis and peptidolysis 
[0006508] 2,3
AF118273 
Mus musculus hitchhiker-2 mRNA, 
complete sequence DNA recombination [0006310] 2,3
U20263 
Mus musculus clone 1.3C LB9 
mRNA, 3'UTR, partial sequence 
biological_process unknown 
[0000004] 2,2
NM_019931 
Mus musculus potassium channel 
Kv4.3L (LOC56543), mRNA potassium transport [0006813] 2,2
AF108398 
Mus musculus sodium/calcium 
exchanger isoform NaCa7 (Ncx1) 
mRNA, partial cds calcium ion transport [0006816] 2,2
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NCBI ID Gene Gene ontologyA 
Fold difference 
in gene 
expression 
level ( table1, 
group VII - 
VIII) 
NM_015768 
Mus musculus Bv 8 homolog 
(Bombina variegata) (Bv8-pending), 
mRNA 
embryogenesis and 
morphogenesis [0007345] 2,1
NM_008378 
Mus musculus imprinted and ancient 
(Impact), mRNA 
proteolysis and peptidolysis 
[0006508] 2,1
AJ279843 
Mus musculus partial mRNA for 
hypothetical protein, clone 
mvx11090 
biological_process unknown 
[0000004] 2,1
NM_010086 
Mus musculus a disintegrin and 
metalloprotease domain 24 (testase 1) 
(Adam24), mRNA fertilization [0007338] 2,1
AB010352 
Mus musculus mRNA for mszf33, 
partial cds 
transcription regulation 
[0006355] 2,1
NM_011150 
Mus musculus peptidylprolyl 
isomerase C-associated protein 
(Ppicap), mRNA protein binding [0005515] 2,1
NM_011887 
Mus musculus sodium channel, 
voltage-gated, type XI, alpha 
polypeptide (Scn11a), mRNA ion channel [0005216] 2,1
NM_007628 
Mus musculus cyclin A1 (Ccna1), 
mRNA cell cycle control [0000074] 2,1
U81823 
Mus musculus p38delta MAP kinase 
mRNA, complete cds 
cell surface receptor linked signal 
transduction [0007166] -2,1
NM_013843 
Mus musculus Zinc finger protein 
118 (Zfp118), mRNA 
transcription regulation 
[0006355] -2,1
NM_008118 
Mus musculus gastric intrinsic factor 
(Gif), mRNA cobalt ion transport [0006824] -2,1
AB010369 
Mus musculus mRNA for mszf62, 
partial cds 
transcription regulation 
[0006355] -2,2
U93277 
Mus musculus 8S-lipoxygenase 
mRNA, complete cds 
leukotriene metabolism 
[0006691] -2,2
NM_016887 
Mus musculus claudin 7 (Cldn7), 
mRNA cell adhesion [0007155] -2,2
AF127244 
Mus musculus Smcy (Smcy) mRNA, 
complete cds 
transcription from Pol II 
promoter [0006366] -2,3
NM_020579 
Mus musculus beta-1,4-
galactosyltransferase III (B4galt3), 
mRNA 
developmental processes 
[0007275] -2,5
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NCBI ID Gene Gene ontologyA 
Fold difference 
in gene 
expression 
level ( table1, 
group VII - 
VIII) 
NM_008058 
Mus musculus frizzled homolog 8 
(Drosophila) (Fzd8), mRNA 
frizzled-2 receptor signaling 
pathway [0007223] -2,5
NM_010498 
Mus musculus iduronate 2-sulfatase 
(Ids), mRNA steroid metabolism [0008202] -2,6
NM_009484 
Mus musculus ubiquitously 
transcribed tetratricopeptide repeat 
gene, Y chromosome (Uty), mRNA defense response [0006952] -2,7
U79525 
Mus musculus orphan G-protein 
coupled receptor Dez mRNA, 
complete cds 
G-protein coupled receptor 
protein signaling pathway 
[0007186] -2,8
NM_007745 
Mus musculus cortistatin (Cort), 
mRNA 
neuropeptide signaling pathway 
[0007218] -3,1
NM_011284 
Mus musculus replication protein A2 
(Rpa2), mRNA DNA replication [0006260] -3,4
NM_021790 
Mus musculus SoxLZ/Sox6 leucine 
zipper binding protein in testis 
(Solzt-pending), mRNA signal transduction [0007165] -3,4
NM_009997 
Mus musculus cytochrome P450, 2a4 
(Cyp2a4), mRNA electron transport [0006118] -3,4
NM_010476 
Mus musculus hydroxysteroid 17-
beta dehydrogenase 7 (Hsd17b7), 
mRNA steroid biosynthesis [0006694] -3,6
NM_020616 
Mus musculus C11orf17 (C11orf17), 
mRNA 
biological_process unknown 
[0000004] -3,7
NM_019950 
Mus musculus intestine N-
acetylglucosamine 6-O-
sulfotransferase (I-GlcNAc-6-ST), 
mRNA methionine metabolism [0006555] -4,7
 
recombinant BALB/c-ct embryos and BALB/c embryos was Fxy, which encodes 
the protein Midin. Two different oligonucleotides representing the 5’ and 3’ end 
of the gene Fxy were present on the microarray. The two spots indicated a 10 and 
13 fold higher gene expression level in affected recombinant BALB/c-ct embryos 
compared to BALB/c embryos during the 32-36 somite stage (Table 3). The 
upregulation of Fxy RNA in recombinant BALB/c-ct compared to BALB/c 
embryos was confirmed by semi-quantitative RT-PCR (Fig. 2B). To find out if 
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the differential expression of Fxy in recombinant BALB/c-ct versus BALB/c 
embryos was due to the slight difference in embryonic stages present in the two 
embryo pools (33-36 versus 32-34) we studied Fxy expression on microarray 
(data not shown) and by semi-quantitative RT-PCR (Fig. 2A) in C57Bl/6 
embryos at different embryonic stages (ED10.5-12.5). As mentioned above, no 
differential Fxy RNA expression was observed in these experiments. Other genes 
showing differential expression in BALB/c and recombinant BALB/c-ct included 
genes involved in a wide range of processes, such as signal transduction (like 
Solzt-pending and Cop9), transcription regulation (like Krox20 and Og9x), 
transport processes (like Mcx1 and Trrp1) and proteolysis (like Plg and Impact).  
 
A                                               B 
   
 
Fig. 2 Validation of microarray results with semi-quantitative RT-PCR analysis. A. 
Expression levels of Ship (housekeeping gene), Fxy, NfI-a and Prph1 in total RNA 
obtained from ED10.5-12.5 C57Bl/6 embryos. B. Expression levels of Fxy in RNA 
obtained from affected recombinant BALB/c-ct embryos (group VIII, as shown in Table 
1) and BALB/c embryos at ED10.5 (group VII, as shown in Table 1).  
 
PNP closure in ct is influenced by combinations of the effects of the ct genetic 
defect, modifier genes and environmental factors, like inositol. To find out if 
gene expression could distinguish affected (category 5) from unaffected (category 
1) ct embryos at ED10.5, we compared the expression profiles of affected and 
unaffected recombinant BALB/c-ct embryos with 26-37 somites using one-class 
response SAM analysis (comparisons IX–X, XI–XII and XIII–XIV, as shown in 
Table 1). This analysis yielded no significant differences in gene expression 
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profiles (q<5% and  >2 fold difference for each comparison) between the two 
(data not shown). 
 
Discussion 
To our knowledge, this is the first study using microarray-based gene expression 
analysis to identify molecular pathways involved in neural tube closure. We 
performed expression profiling on a oligonucleotide microarray representing 
7.500 murine genes to study affected and unaffected recombinant BALB/c-ct 
embryos, as well as C57Bl/6 embryos during the final stage of closure of the 
spinal neural tube (ED10.5). Our special interest were the inositol metabolism-
related genes, since the protective effect of myo-inositol in spinal neural tube 
closure in the NTD mouse model ct is mediated through the inositol/lipid cycle, 
stimulating PKC activity [7]. All inositol metabolism-related genes present on the 
microarray were expressed during spinal neural tube closure in BALB/c as well 
as in C57Bl/6 embryos, indicating the importance of inositol-related signaling 
pathways in early embryonic development. No perturbations in the expression of 
inositol metabolism-related genes were detected at the 28-36 somite stages in 
either the comparison of affected and unaffected recombinant BALB/c-ct embryos 
or the comparison of affected recombinant BALB/c-ct embryos with wild type 
BALB/c embryos. These results suggest that defective transcriptional regulation 
of the inositol metabolism-related genes on the microarray is not a causative 
factor for NTD in ct. However, we have to keep in mind that not all inositol 
metabolism-related genes were present on the microarray used in this study. 
Unlike genes directly involved in inositol metabolism, other genes on the 
microarray showed differential expression between affected recombinant 
BALB/c-ct embryos and BALB/c embryos. Proteins encoded by these genes have 
diverse biological functions, such as signal transduction, cytoskeletal 
organization, transport processes and proteolysis. Most of these genes were 
upregulated in the recombinant BALB/c-ct embryos. The most prominent 
upregulation was observed for the gene Fxy, which encodes the protein Midin 
involved in midline development during mouse embryogenesis [20]. The protein 
Midin is an E3 ubiquitin ligase that forms part of the proteosome complex in 
eukaryotic cells. Its substrate is protein phosphatase 2A (PP2A), which becomes 
ubiquinated and degraded, consecutively [21]. Mutations in the human ortholog 
of Fxy have been described in patients with Opitz syndrome, who show 
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malformations of the ventral midline, like cleft palate, agenesis of the corpus 
callosum, hypospadias, heart defects, imperforate anus, holoprosencephaly and 
mental retardation [21]. Mutation of FXY disrupts the ubiquitin degradation 
pathway of PP2A in these patients and leads to microtubule association of PP2A, 
which results in microtubule dissociation and disturbed cytokinesis. The murine 
gene Fxy is expressed at a higher level in proliferating cells than in non-
proliferating cells during embryogenesis [20]. Therefore, upregulated expression 
of Fxy in recombinant BALB/c-ct embryos at the 32-36 somite stage might reflect 
a secondary effect of the primary ct genetic defect, which is known to be 
associated with cell proliferation imbalances in ct embryos [13]. This 
upregulation of Fxy might be an attempt of the ct embryos to overcome the cell 
proliferation defect in the hindgut and notochord underlying the PNP closure at 
the 27-29 somite stage. 
In addition to the upregulation of a number of genes in affected recombinant 
BALB/c-ct embryos also downregulation of genes was observed in these embryos 
compared to BALB/c. One of the genes downregulated was Cort which encodes 
the neuropeptide cortistatin, an analog of the hormone somatostatin. 3H-inositol 
labeling studies in recombinant CCL39 cell lines have shown that the protein 
cortistatin can activate phospholipase C, leading to increased phosphoinositide 
turnover [22], which might provide a link with defective PNP closure in ct. 
Further studies are necessary to ascertain the importance of these genes in the 
delay of spinal neural tube closure in the ct. Some of the differences in 
expression levels detected with the microarray may be related to differences still 
present in genetic background between the affected recombinant BALB/c ct-
embryos and BALB/c embryos rather than being involved in defective spinal 
neural tube closure in ct. Furthermore, differential gene expression between male 
and female embryos at ED10.5 might account for some of the observed 
differences in gene expression, since we did not perform a sex-test prior to 
embryo pooling. The ct embryos that were used for expression profiling in our 
study may also have been too far developed to identify perturbations in inositol 
metabolism, since the cell proliferation defect occurs early in ct embryogenesis at 
the 22-29 somite stage and might be stage specific instead of permanent. 
Another approach to the analysis of the microarray results enabling the 
identification of genes that play a role in the etiology of NTD in ct can be the 
direct analysis of expression of genes located in the ct candidate region [23,24]. 
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However, in such an approach it would be better to analyse only those parts of 
the embryo that are directly affected (the spinal neural tube region) to increase 
specificity. Similarly, a drawback of our study is the fact that genes with 
disturbed expression levels only in local regions of the recombinant BALB/c-ct 
embryo have been missed with our whole embryo microarray approach. For 
instance, the genes RARβ, RARγ  and Wnt5a which were previously shown to be 
expressed abnormally spatially and temporally during defective spinal neural tube 
closure in ct [25-27] were not detected in our analysis. 
One of the approaches taken by us, which is the gene expression study at 
ED10.5, the time point of spinal neural tube closure in the mouse embryo, is 
suitable to identify new candidate genes for (human) NTDs: genes from Table 2 
might be good candidates for a role in the etiology of NTDs given expression in 
the relevant tissues. This has already been shown for some of the genes: knockout 
mice for Cyp26 show NTDs [28], and depletion of Nr6A1 RNA in Xenopus 
Laevis using morpholino antisense oligonucleotide technology resulted in 
defective secondary neurulation [29].  
The analysis of gene expression in C57Bl/6 embryos around the time point of 
spinal neural tube closure (ED10.5 to ED12.5) indicates active transcriptional 
regulation of many genes within the developmental stage just after spinal neural 
tube closure (e.g. Table 2, class B and C). This suggests major changes in the 
developmental program at this point of time and might support the idea of a fixed 
time frame for neural tube closure, after which the embryo is no longer sensitive 
to some of the stimuli promoting closure.  
In the future, the microarray procedure could be combined with other techniques 
to study the molecular mechanism involved in defective neural tube closure. For 
example, specific embryonic regions within a developing embryo that are 
involved in neural tube closure could be dissected with laser microdissection 
technology and RNA only from that specific region could be used for microarray 
analysis after linear amplification. Combination of these techniques could be used 
in a study to identify expression patterns of inositol-metabolism related genes that 
result from inositol suppletion to ct mice. In addition to microarray analysis 
another powerful technique, proteomics, is currently used to investigate the 
molecular mechanism behind neural tube closure [30]. Combined microarray and 
proteomics analyses for different mouse models of NTD, like ct, hopefully will 
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provide a more complete picture of the mechanisms underlying defective neural 
tube closure.   
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Genetic variants in ZIC1, ZIC2 and ZIC3 are no 
major risk factors for neural tube defects in humans 
 
 
R. Klootwijk, P. Groenen, M.M.V.A.P. Schijvenaars,  
F.A. Hol, B. Hamel, H. Straatman, R.P.M. Steegers-
Theunissen, E.C.M. Mariman & B. Franke 
 
 
ABSTRACT 
Neural tube defects (NTD) are congenital malformations arising from incomplete neural tube 
closure during early embryogenesis. Most NTD in humans show complex inheritance patterns, with 
both genetic and environmental factors involved in the etiology of this malformation. More than 
120 mouse models for human NTD exist. NTD have been observed in mice deficient for the Zic 
family genes, Zic1, Zic2 and Zic3. We performed mutation analysis in the human orthologs of these 
genes using DNA material from a large panel of NTD patients. In ZIC2 we identified a deletion of 
one codon that encodes an alanine residue located in the amino terminal alanine stretch of the 
protein. The deletion was present in one patient, but not in 364 controls. That may suggest a role - 
albeit small - of this variant in the etiology of NTD in humans. Transmission disequilibrium testing 
of a frequent polymorphism in the ZIC2 gene (1059C>T, H353H) in parent-spina bifida aperta 
child triads showed no association with NTD. One silent polymorphism (858G>A,V286V) of 
unknown significance was identified in ZIC3. Neither mutations nor polymorphisms were found in 
the coding region or flanking sequences of ZIC1. Our data indicate that ZIC1, ZIC2 and ZIC3 are 
no major risk factors for NTD in humans.  
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INTRODUCTION 
Neural tube defects (NTD) are congenital malformations which arise from 
incomplete closure of the neural tube during early embryogenesis. The most 
common types of NTD in humans are spina bifida and anencephaly, with a birth 
prevalence of 1 per 1,700 and 1 per 1,500 births in the Netherlands, respectively.  
About 70-80 % of all NTD in humans show complex or multifactorial inheritance 
patterns, indicating that both genetic and environmental factors play a role in the 
etiology of these malformations [Hall et al., 1988]. Periconceptional 
supplementation with the nutrient folic acid is known to reduce the occurence and 
recurrence of human NTD [Czeizel et al., 1994;MRC Vitamin Study Research 
Group, 1991]. Another environmental factor involved in the etiology of human 
NTD is zinc. Zinc is essential for proper functioning of many proteins in the cell, 
including enzymes and transcription factors. Dietary zinc deficiency in rats 
changes the activity of enzymes in different tissues [Yousef et al., 2002]. A 
relationship between zinc and NTD has been demonstrated in animal studies 
[Warkany et al., 1972] and has been shown in humans as well [Soltan et al., 
1982;Ghosh et al., 1985;Buamah et al., 1984;Cavdar et al., 1977;Cavdar et al., 
1988;Brenton et al., 1981]. Several zinc-dependent transcription factors are 
established risk factors for murine NTD,  like the Zic gene family members Zic1 
[Aruga et al., 1998], Zic2 [Nagai et al., 2000] and Zic3 [Klootwijk et al., 
2000;Carrel et al., 2000;Purandare et al., 2002]. The Zic gene family members 
in vertebrates, Zic1, Zic2, Zic3, Zic4 and Zic5, are the orthologs of the 
Drosophila pair-rule segmentation gene odd-paired, which is involved in 
parasegmental subdivision and visceral mesoderm development [Nagai et al., 
1997;Cimbora et al., 1995]. Zic genes are expressed in the dorsal neural tube and 
its derivatives, especially in the cerebellum [Nagai et al., 1997]. Their 
involvement in neural development has been investigated in humans, mice and 
frogs [Brown et al., 1998;Aruga et al., 1998;Nagai et al., 2000;Nakata et al., 
1998;Nakata et al., 2000].  
Zic1-deficient mice show cerebellar abnormalities and multiple malformations in 
the axial skeleton, including spina bifida occulta [Aruga et al., 1998].  
Zic2 knockdown mice exhibit a whole spectrum of NTD including spina bifida 
occulta, spina bifida aperta, exencephaly and anencephaly [Nagai et al., 2000]. 
Furthermore, these mice show holoprosencephaly. The latter also occurs in 
human patients with mutations in ZIC2 [Brown et al., 1998], sometimes in 
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combination with neural tube defects, which links ZIC2 to human NTD. 
Furthermore, holoprosencephaly in combination with exencephaly forms part of 
the phenotypic spectrum of the13q32 deletion syndrome.  In patients with this 
syndrome a region of approximately 1 Mb encompassing ZIC2 is deleted on the 
long arm of chromosome 13 [Brown et al., 1995]. Recently, suggestive evidence 
for a role of ZIC2 in human NTD was provided by transmission disequilibrium 
testing of a genetic variant of ZIC2 in hispanic NTD-patients [Brown et al., 2002] 
The Zic3 gene is involved in murine NTD as well. Zic3-deficient mice show 
exencephaly as well as tail defects and situs abnormalities [Purandare et al., 
2002]. The Zic3 gene is fully enclosed in a X-linked deletion in the spontaneous 
mouse mutant Bent tail. Spina bifida and exencephaly occur in these mice 
together with tail defects and situs abnormalities [Johnson, 1976;Klootwijk et al., 
2000;Carrel et al., 2000]. As for the human situation, mutations in the X-linked 
gene ZIC3 and a deletion of 0.6-1 Mb in size encompassing the ZIC3 gene have 
been reported in patients with situs abnormalities, in one case combined with a 
lumbosacral neural tube defect [Gebbia et al., 1997]. Furthermore, Goerss et al. 
[Goerss et al., 1993] reported a US family with a spina bifida aperta and a Xq26-
q27 duplication that fully contains the ZIC3 gene. These data might provide a link 
between ZIC3 and human NTD.  
Combined phenotypic and genotypic data of mouse models for Zic1, Zic2 and 
Zic3 deficiency, and limited clinical and genetic patient data make the zinc-
dependent genes, ZIC1, ZIC2 and ZIC3 good candidates for human NTD. We 
therefore performed mutation analysis in these genes in a large panel of NTD 
patients. 
 
MATERIAL AND METHODS 
 
PATIENTS AND DNA ISOLATION 
With approval of the local ethics committee patients with non-syndromic NTD 
have been collected from the Dutch population. 38 familial cases (selected 
according to criteria described by Mariman et al. [Mariman et al., 1992]) and 79 
isolated NTD cases [Mariman et al., 1992] were used for mutation analysis 
(group I). The types of NTD in the familial group were spina bifida aperta (37) 
and encephalocele (1). The isolated group consisted of patients with spina bifida 
aperta (75), anencephaly (2) and encephalocele (2). Additional isolated spina 
Chapter 4.1 
 150
bifida aperta patients came from a second collection (group II; P. Groenen, 
manuscript in preparation). 50 of those patients were added to the panel for ZIC1 
mutation screening. Spina bifida aperta patients of group I with their parents, and 
97 spina bifida aperta patients from group II with their parents were included in 
the TDT of a genetic variant in ZIC2. The control group used to test the 
relevance of the deletion in ZIC2 consisted of 364 unaffected and unrelated 
subjects randomly recruited from the Dutch population. For mutation screening in 
the X-linked ZIC3 gene, members of an Icelandic family with possible X-linked 
NTD [Jensson et al., 1988] and a patient from an American family with X-linked 
NTD [Hol et al., 2000] were added to the panel of patients from group I. 
Genomic DNA was extracted from whole blood according to standard procedures 
[Miller et al., 1988] or from buccal brushes according to a protocol by Richards 
and coworkers [Richards et al., 1993].  
 
SSCP AND SSLP ANALYSIS 
PCR amplification of ZIC1 fragments was performed in 25 µl reaction volume 
containing 50 ng genomic DNA, 125 ng of each primer, 10 mM Tris-HCl pH 
9.0, 50 mM KCl, 1.5 mM MgCl2, 0.01 % (w/v) gelatin, 0.35 mM dNTPs and 
0.5 U Taq DNA polymerase (Invitrogen, Breda, The Netherlands). Optionally 10 
% DMSO (v/v) was included in the reaction. Primer sequences, annealing 
temperatures and specifics of the PCR protocol are provided in table I. PCR 
amplification of ZIC2 and ZIC3 fragments was performed in 25 µl reaction 
volume containing 50 ng genomic DNA, 62.5 ng of each primer, 10 mM Tris-
HCl pH 9.0, 50 mM KCl, 1.5 mM MgCl2, 0.01 % (w/v) gelatin, 0.4 mM dATP, 
0.4 mM dTTP, 0.4 mM dGTP, 0.1 mM dCTP, 0.17 µl [α32P] dCTP (ICN 
Biomedicals, Zoetermeer, The Netherlands) and 0.5 U Taq DNA polymerase 
(Invitrogen). Optionally 10 % DMSO (v/v) was added to the reaction. For 
specific conditions of the PCR reactions see table I. Amplification-conditions 
were similar for all 3 genes: samples were denatured at 92°C for 5 minutes and 
then subjected to 35 cycles of amplification (92°C for 1 minute, annealing 
temperature for 1 minute and 72°C for 1 minute), followed by a final extension 
step of 72°C for 3 minutes. Amplifications were performed in a PTC-100 thermal 
cycler (ZIC2 and ZIC3) or in a PTC-200 thermal cycler (ZIC1) (MJ-Research Inc. 
via Biozym, Landgraaf, The Netherlands). 
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For SSCP analysis PCR products were mixed with 1 volume formamide dye 
buffer (95 % (w/v) formamide, 0.05 % (w/v) bromophenol blue, 0.05 % (w/v) 
xylenecyanol and 20 mM EDTA), denatured at 94°C for 5 minutes and placed on 
ice. 3.5 µl of each sample was loaded on a 5 % non-denaturing polyacrylamide 
gel with and without 10 % glycerol. Electrophoresis was performed at 4°C, at 40 
W for 3-6 hours. Earlier studies have shown that using this procedure 
approximately 80 % of all point mutations will be detected in our hands. 
However, large deletions that are only present on one allele will be missed, since 
the analysis is not a quantitative one.   
In the case of fragment ZIC2(1) containing a 3 bp deletion in one patient PCR 
was also performed for 364 control samples. Obtained products were analysed by 
simple sequence length polymorphism (SSLP) analysis on a 6.6 % denaturing 
polyacrylamide gel. ZIC1 bands from SSLP and SSCP analyses were visualized 
by a standard silver staining procedure [Budowle et al., 1991]. Gels with 
separated ZIC2 and ZIC3 bands were dried and exposed to Kodak X-omat S film 
overnight.  
 
SEQUENCE ANALYSIS 
PCR fragments producing aberrant SSCP banding patterns were analyzed on an 
ABI PRISM 3700 automated sequencer using the DyeDeoxyterminator cycle 
sequencing kit according to the protocol of the manufacturer (Applied 
Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). Sequences were 
determined using the forward and reverse amplification primers for SSCP 
analysis (table I). Positions of identified polymorphisms in ZIC1, ZIC2, and ZIC3 
were numbered starting with 1 at the first nucleotide of the ATG translation start 
codon. 
 
PYROSEQUENCE ANALYSIS 
PCR amplification of templates used for pyrosequencing was performed in 50 µl 
reaction volume containing 100 ng genomic DNA, 10 pmol of primer 
ZIC2(7)pyro1, 20 pmol of primer ZIC2(7)for (table I), 10 mM Tris-HCl pH 9.0, 
50 mM KCl, 1.5 mM MgCl2, 0.01% (w/v) gelatin, 0.35 mM dNTPs, 10 % 
DMSO (v/v)  and 1 U Taq DNA polymerase (Invitrogen, Breda, The 
Netherlands). Samples were denatured at 92°C for 5 minutes and then subjected  
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Primer name Primer sequence Region of the gene PCR product 
(bp) 
Annealing 
temperature (°C) 
DMSO 10% 
(v/v) 
ZIC1(1)for 5´-GGCTCGCCCCGAGCAGC-3´ Exon 1 196 62 + 
ZIC1(1)rev 5´-GCCGAAGCCAGCTCGTGC-3´        
ZIC1(2)for 5´-GCGCCTTCAAGCTCAACCC-3´ Exon 1 199 62 + 
ZIC1(2)rev 5´-CGCCGCGTCGCCAAAACC-3´        
ZIC1(3)for 5´-GCGGGACTTTCTGTTCCGC-3´ Exon 1 192 61 + 
ZIC1(3)rev 5´-CCCGTTGACCACGTTAGGC-3´        
ZIC1(4)for 5´-GCTTCACGAGCAGGCTGC-3´ Exon 1 183 61 - 
ZIC1(4)rev 5´-CGCCGGCGCCGTGATGC-3´        
ZIC1(5)for 5´-GCAGCTGCACGGCTACGG-3´ Exon 1 204 60 - 
ZIC1(5)rev 5´-GTGCTCCACGGTGACGTGC-3´        
ZIC1(6)for 5´-GGCCAACCCCAAAAAGTCG-3´ Exon 1 205 55 - 
ZIC1(6)rev 5´-GGGAAGGGGCAGGGAAAGG-3´        
ZIC1(7)for 5´-CCACATCCGCGTGCACACG-3´ Exon 1/Intron1 137 55 - 
ZIC1(7)rev 5´-GGTAGGGGTCCTACAGCTG-3´        
ZIC1(8)for 5´-CCCCTCTCATTCTACTTTGGC-3´ Intron1/Exon 2/Intron2 212 55 + 
ZIC1(8)rev 5´-GGCGACGAGAGTGCGGCG-3´        
ZIC1(9)for 5´-CGCACTGGCTCTTTATGTCC-3´ Intron2/Exon 3 282 55 - 
ZIC1(9)rev 5´-CTCTTAAATAGGGTTTTGTTCG-3´         
ZIC2(1)for 5´-CGCTGGCCATGCTCCTGG-3´ Exon 1 184 62 + 
ZIC2(1)rev 5´-GGCGGAGTCAACGAAGCCG-3´        
ZIC2(2)for 5´-GCGGCGGCGCAGAACGGC-3´ Exon 1 198 52 + 
ZIC2(2)rev 5´-GTAGGAGCCAACGTGCGC-3´        
ZIC2(3)for 5´-GCGGCCGCAGCGCTCGG-3´ Exon 1 200 55 + 
ZIC2(3)rev 5´-GAAGAGGAGGTGGCCCTGC-3´        
ZIC2(4)for 5´-CTGCACCACGCGCACTCG-3´ Exon 1 201 50 + 
ZIC2(4)rev 5´-GGTTGTGGAGTTGCGCCGC-3´        
ZIC2(5)for 5´-CGCGGACCGACCCCTAC-3´ Exon 1 203 58 - 
ZIC2(5)rev 5´-GGGATTGCTCAGTTGCTCGG-3´        
ZIC2(6)for 5´-CAGGAGCTAATCTGCAAGTGG-3´ Exon 1 225 60 - 
ZIC2(6)rev 5´-CTGTGTGCACGCGGATGTG-3´        
ZIC2(7)for 5´-GAGGGCAAGCCCTTCAAGG-3´ Exon 1 168 54 + 
ZIC2(7)rev 5´-CCTGTCCCAGCCCGCGG-3´        
ZIC2(7)pyro1 5´-biotin-GAGGGCAAGCCCTTCAAGG-3´ Exon 1/Intron1 168 54 + 
ZIC2(7)pyro2 5´-TCCGAGAACCTCAAGA-3´        
ZIC2(8)for 5´-GCGCCGATGTTTGCCGTCC-3´ Intron1/Exon 2/Intron2 243 63 + 
ZIC2(8)rev 5´-CCTCCTCCCGGCCGCCG-3´        
ZIC2(9)for 5´-GGGGAACATTTCTGGGGGTG-3´ Intron 2/ Exon 3 174 56 - 
ZIC2(9)rev 5´-GGGCGTGGACGACTCATAGC-3´         
ZIC3(5'UTR)for 5'-GAGTAACGAGCCTGCCTAC-3' 5'UTR 520 55 - 
ZIC3(5'UTR)rev 5'-CCGTCCAGGAGCATCGTCA-3'        
ZIC3(1)for 5´-CGGTACCCTCTCTCACCTCG-3´ Exon 1 157 55 - 
ZIC3(1)rev 5´-CATGCCTGCCGGCTCACGGTT-3´        
ZIC3(2)for 5´-GCTGAATCCCTTCGGGGACT-3´ Exon 1 203 59 + 
ZIC3(2)rev 5´-TAGCTGGGCACCCTGGCTGG-3´        
ZIC3(3)for 5´-CCACCATCACCATCATCACCC-3´ Exon 1 191 55 - 
ZIC3(3)rev 5-´GATGCCAGCTGGAGCAATGC-3´        
ZIC3(4)for 5´-ACGGGCTCTTCGGCGGCTC-3´ Exon 1 251 63 - 
ZIC3(4)rev 5´-GCTGTAGTTAGGAAACTGAGCG-3´        
ZIC3(5)for 5´-CCATACCGCCCAGTGGCCA-3´ Exon 1 189 55 - 
ZIC3(5)rev 5´-GCTGAGCCTCGTCGATCC-3´        
ZIC3(6)for 5´-CAAGCAGGAGCTGTCGTGC-3´ Exon 1 212 55 - 
ZIC3(6)rev 5´-GGTTGACCAGTTTGTACTTCG-3´        
ZIC3(7)for 5´-CTGCTACTGGGAGGAGTGC-3´ Exon 1/Intron1 218 55 - 
ZIC3(7)rev 5´-GGGTATCGCCAGTGGAACC-3´        
ZIC3(8)for 5´-GGCGCTGAACCGTATTTTACC-3´ Intron1/Exon 2/Intron2 249 55 - 
ZIC3(8)rev 5´-GTGTTTACCAAACCGCCGATCC-3´        
ZIC3(9)for 5´-AATTTTAATATTCAATTTAATTA     
ATAATATAATACA-3´ 
Intron2/Exon 3 256 54 + 
ZIC3(9)rev 5´-TTGGTCCAATTCTATAAATTAACAG-3´        
ZIC3(3'UTR)for1 5'-TGAGGACAAACACAAACCCTG-3' 3'UTR 807 55 - 
ZIC3(3'UTR)rev1 5'-CAAAACAAGAGAAAGGAGTCAG-3'         
ZIC3(3'UTR)for2 5'-GTGACGTTTAGTATACAGTTGC-3' 3'UTR 837 55 - 
ZIC3(3'UTR)rev2 5'-ACAAATCAGCCTTTGCCTTCC-3'         
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Table I. Primers and conditions for amplification of the coding region and flanking 
sequences of the human genes, ZIC1, ZIC2 and ZIC3. The genomic sequences of ZIC1, 
ZIC2 and ZIC3 were retrieved from Genbank (Accession no. NT_005775, NT_009952 
and NT_011719).  
 
to 40 cycles of amplification (92°C for 1 minute, 54°C for 1 minute and 72°C 
for 1 minute), followed by a final extension step of 72°C for 3 minutes. 
Amplifications were performed in a PTC-200 thermal cycler (MJ-Research Inc. 
via Biozym). Pyrosequencing [Ronaghi., 2001] was performed on a PSQTM96 
System with ZIC2(7)pyro2 primer (table I) according to the protocol of the 
manufacturer (Pyrosequencing AB, Uppsala, Sweden). 
 
STATISTICAL ANALYSIS 
Association between variant alleles of ZIC2 and susceptibility to spina bifida 
aperta was tested using Mc Nemar’s transmission disequilibrium testing (TDT) 
[Spielman et al., 1993]. In order to include missing parental genotypes in TDT-
testing a loglinear method described by Weinberg [Weinberg, 1999] was also 
used (data not shown). 
 
RESULTS 
SSCP analysis was performed on the coding region and flanking sequences of 
ZIC2 to screen for possible polymorphisms and mutations in 117 NTD patients. 
307 bp of the 3’ end of the coding region were left out of the analysis because the 
high GC-content of this sequence caused problems with the PCR amplification. 
The analysis resulted in the identification of two sequence variations in ZIC2. The 
first one was a single nucleotide polymorphism (SNP), a C→T transition located 
at position 1059 (H353H) of the coding region of the gene (exon 1). The allelic 
frequency of the 1059C>T polymorphism was 14 % (table II). Two groups of 
parent-affected child triads (only cases with spina bifida aperta were included) 
were genotyped for the SNP by pyrosequence analysis (table IIA). The genotype 
frequencies found in group I, II and in the combined group were consistent with 
the Hardy Weinberg equilibrium. Genotyping resulted in a total of 67 informative 
transmissions (table IIB). The genotyping data for the complete triads were 
analyzed by TDT for an association between the transmission of alleles and 
susceptibility to NTD. The analysis showed that carrying the 1059C allele does  
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Table II.  (A) Genotype distribution of parent-affected child triads (mother, father, child) 
for the 1059C>T polymorphism in the ZIC2 gene for two groups of spina bifida aperta 
patients (group I and II). Percentages are given for the combined groups (% I + II). 
Mother, father, child denote the number of copies of the 1059C allele carried by the 
mother, the father, and the spina bifida aperta child, respectively. (B) Contingency table 
of transmitted/nontransmitted allele distributions as observed for the complete triads of 
the combined group (I + II). 
 
A 
 
mother,father, child I (n=99) II (n=97) % (I + II)
0,2,1 3 0 1.5 
1,1,0 1 2 1.5 
1,1,1 1 3 2.0 
1,1,2 2 0 1.0 
1,2,1 7 7 7.1 
1,2,2 4 2 3.1 
2,0,1 1 0 0.5 
2,1,1 8 7 7.7 
2,1,2 9 5 7.1 
2,2,2 52 44 49 
Subtotal of complete triads 88 70   
       
?,1,? 1 0 0.5 
1,?,1 0 2 1.0 
1,?,? 0 1 0.5 
1,?,2 0 1 0.5 
1,2,? 0 2 1.0 
1,?,? 1 0 0.5 
?,?,2 0 5 2.6 
?,2,2 1 2 1.5 
?,2,? 2 5 3.6 
?,1,2 0 2 1.0 
?,?,0 0 1 0.5 
2,1,? 0 1 0.5 
2,?,? 6 4 5.1 
2,?,1 0 1 0.5 
Subtotal of incomplete triads 11 27   
 
“?” represents missing data due to failed genotyping or unavailability of family members. 
Abbreviations: I=group I, II=group II. 
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B 
 
Nontransmitted allele  I + II 
T C Total 
T 4 28 32 
Transmitted allele 
C 39 242 281 
 Total 43 270 313 
 
not confer an increased risk for NTD in our pedigrees, as the results showed no 
statistical significance (group I: χ 2= 1, p=1; group II: χ 2= 4, p=0.05, groups I  
+ II: χ 2=1.8, p=0.18; degree of freedom [df] = 1). The results obtained by 
TDT were confirmed by a log-linear modeling approach described by Weinberg 
et al. [Weinberg, 1999] in which incomplete triads could be included in the 
analysis, as well (data not shown).  
The second sequence variation identified in ZIC2 was a deletion of one codon 
(94-96delGCG) in exon 1 that resulted in the deletion of an alanine in the amino-
terminal stretch of 9 alanine residues in ZIC2. The so-called A8 variant was 
detected in one male isolated spina bifida aperta patient. The deletion was 
confirmed by SSLP analysis and by sequence analysis.  
The patient was found to be heterozygous for the A8 variant. Both the unaffected 
parents and grandparents of the patient were subsequently tested for the 
carriership of the A8 variant by SSLP analysis (fig 1). This showed that the 
mother and the grandmother of the patient were heterozygous for the A8 variant, 
whereas all other family members carried only the A9 variant. To test the 
possible relevance of the A8 variant in the etiology of  NTD a group of 364 non-
related controls were analysed. None of these individuals carried the A8 variant.  
To test the presence of other NTD risk factors in the patient with the A8 variant 
or his mother they were also genotyped for the 677C>T polymorphism in the 
MTHFR gene [van der Put et al., 1995], and for a haplotype in the promoter 
region of the PDGFRα gene [Joosten et al., 2001]. The patient proved to be 
heterozygous at position 677 of MTHFR, his mother was homozygous for the 
677C allele. For PDGFRα the patient was found to be homozygous for the H2α 
haplotype. 
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Fig 1. SSLP analysis of part of exon 1 of ZIC2. Pedigree in which the A8 variation of the 
ZIC2 gene is segregating. Arrows mark the observed shifted bands. 
 
ZIC3 was also screened for the presence of mutations or polymorphisms of the 
coding region and its flanking sequences by SSCP analysis in 120 NTD patients. 
A G→A transition at position 858 of the coding region (exon 1) that did not 
result in an amino acid change (V286V) was detected in one spina bifida aperta 
patient (fig 2). Except for the 858G>A polymorphism no other genetic variation 
in the coding region of ZIC3 was detected in the patients. In the search of 
polymorphisms that could be used for association studies the 5' -and 3' 
untranslated regions of ZIC3 were analysed by direct sequence analysis in 20 
arbitrary isolated spina bifida patients. No polymorphisms were detected in these 
sequences, either.  
The third ZIC gene family member that we analysed by SSCP analysis was ZIC1. 
Neither polymorphisms nor mutations were detected in the coding region and its 
flanking sequences in 167 NTD patients.  
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Fig 2. Allelic band patterns obtained through SSCP analysis of part of exon 1 of ZIC3. 
The first three lanes show the common SSCP pattern of controls (C), lane 4 shows the 
altered pattern of a spina bifida aperta patient (P). Arrows mark the shifted bands. 
 
DISCUSSION 
In the absence of large multigeneration pedigrees direct candidate gene analysis is 
the most suitable approach to identify risk factors for human NTD. In this paper 
we performed genetic variation analysis in 3 candidate genes that are risk factors 
for murine NTD. ZIC1 turned out to have perfectly identical coding regions and 
flanking sequences in all our patients. In ZIC3 we identified one silent variant in 
one single patient, indicating the conserved nature of the ZIC3 gene. This is 
consistent with data of Carrel et al. [Carrel et al., 2001] who did not detect any 
mutations or polymorphisms in coding and flanking sequences of human ZIC3 in 
three X-linked NTD families.  
Recently supporting evidence for an association of ZIC2 gene with human NTD 
has been published by Brown et al [Brown et al., 2002]. In a case control study 
approach a polyhistidine tract variant (10H allele) was found to be associated with 
isolated and non-syndromic human NTD. This association was confirmed by 
TDT, although with very few transmissions to analyse. The 10H allele was 
predominantly present in patients with a Hispanic genetic background. We did 
not observe this polymorphism in our Dutch patients. However, we identified a 
different novel frequent polymorphism in the coding region of ZIC2 (1059C>T, 
H353H). By TDT analysis we could not confirm the association between ZIC2 
and human NTD. However, rare genetic variations like the A8 variant identified 
in one of our male spina bifida patients might still play a role in the etiology of 
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this malformation. This deletion leading to a reduction of alanine residues from 9 
to 8 in the most proximal alanine stretch of the ZIC2 protein was also observed in 
the unaffected mother and grandmother of the proband, but not in 364 controls. 
Datamining showed that the length of the alanine stretch is conserved between 
humans and mouse. The ZIC2 protein contains 3 tracts consisting of 5 or more 
consecutive alanine residues. Polyalanine tracts have been proposed to repress 
transcription directly [Han et al., 1993], but might also act as flexible spacer 
elements between functional domains [Utsch et al., 2002]. Expansions of 
polyalanine tracts are already known to cause human disease [Brais et al., 
1998;Muragaki et al., 1996;Mundlos et al., 1997;Goodman et al., 2000] 
probably due to aggregation of the expanded protein [Fan et al., 2001]. This also 
holds true for the ZIC2 protein itself: a 10 residue expansion of the 15 residue 
polyalanine tract has been observed in several unrelated HPE patients with a 
profound developmental delay and microcephaly [Brown et al., 2001]. However, 
whether the deletion of residues from the alanine stretches and in particular the 
newly identified A8 variant of ZIC2 has an effect on the function of the protein 
remains to be elucidated by functional studies.  
Up to now many mouse model-based NTD candidate genes have been screened 
for their involvement in human NTD [Gelineau-van Waes et al., 2001]. Mostly 
only subtle changes, like infrequent missense mutations or silent polymorphisms, 
have been found in the coding regions of these genes. According to a threshold 
model of Mueller et al. [Mueller et al., 1995] combinations of negative influences 
caused by functional allelic variants might be needed to exceed a threshold which 
allows defects to occur in processes like the neural tube formation. We therefore 
screened the patient displaying the A8 variant of ZIC2 (and his mother where 
appropriate) for the presence of additional NTD risk factors, namely the 
677C>T polymorphism in MTHFR and the H1/H2 haplotype in the PDGFRα 
promoter. Homozygosity and (to a lesser extent) heterozygosity for the 677C>T 
polymorphism in MTHFR is known to be associated with decreased enzyme 
activity and elevated plasma homocysteine levels [van der Put et al., 
1995;Kluijtmans et al., 1996;Botto and Yang, 2000]. This increases the risk for 
NTD, especially if both mother and child posess the variant allele. Our patient 
proved heterozygous for the 677T allele, his mother was homozygous for the 
wildtype allele. This suggests that the NTD risk of the patient might be (further) 
increased somewhat by posession of an MTHFR variant. The patient was found to 
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be homozygous for the H2α haplotype in the promoter region of the PDGFRα 
gene, which is thought to be a neutral factor in the etiology of NTD [Joosten et 
al., 2001].    
Although it has been known for a long time that both genetic and environmental 
factors are involved in the etiology of human NTD, the task of identifying the 
specific risk factors involved has been very hard. Especially the genetic causes of 
this malformation are not well understood, yet. This is probably due to the fact 
that combinations of unfavorable genetic variants are more important than 
isolated mutations. Unraveling combinations of risk factors for NTD has been 
slowed down by the fact that until now all the genetic factors for human NTD 
have been identified with laborious methods like SSCP-analysis and sequencing. 
Better and faster techniques like mass spectrometry and SNP microarrays are now 
becoming available [Kristensen et al., 2001]. Apart from that, a better 
characterization of the neural tube defects of patients included in the studies, i.e. 
subdivision of NTD in encephalocele, anencephaly, spina bifida occulta, 
meningocele and myelomeningocele, could be of great importance for the 
homogeneity of the patient sample in association studies. Lastly, since there is a 
lot of evidence showing the large impact of environmental factors in the etiology 
of the anomaly, life style factors like diet, drug use, illness, biochemical 
characteristics and personal environment of the mothers of patients in the 
periconceptional period should be taken into account in association studies, as 
well. In conclusion, there might be a long way to go until we fully understand the 
role of genetic variation in the etiology of NTD. 
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NOTE ADDED 
During the review process of this paper additional polymorphisms in the ZIC 
genes were published in the online SNP database dbSNP 
(URL:http://www.ncbi.nlm.nih.gov/SNP). In ZIC1 a base pair deletion has been 
identified in intron 1 (+178delTG; rs3832180) in a sample of 24 unrelated 
Japanese individuals, and two SNPs were found in the flanking sequences of the 
coding region of the gene (rs3058068; rs1394042). None of them has been 
confirmed yet in another population. In ZIC2 several polymorphisms have now 
been described: the 1059C>T SNP in exon 1 is listed as rs1831992. An 
additional SNP has been identified in exon 3, a silent 1263C>T variant (G421G; 
rs1133911) we did not observe in our patients. In intron 1 and the 3’ UTR SNPs 
have been identified as well: rs1334586 is present in intron 1 and has been 
observed with a frequency of 45 % for the minor allele in a sample of 21 
Japanese individuals. The SNP in the 3’ UTR, a 456A>G variant (rs13542) has 
a frequency of 17 % in a sample of 94 unrelated CEPH individuals (Caucasian 
genetic background). In ZIC3 one SNP has been identified in the 3’ UTR 
(*648T>A; rs1053654). This SNP was not present in a sample of 20 of our 
patients analysed by sequence analysis. 
Using this information it would be possible to perform haplotype analysis at least 
for ZIC1 and ZIC2 and in this way extract more information about possible 
associations of the genes with disease. 
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Genetic variation analysis of MLP, TFAP2A and CSK 
in patients with neural tube defects 
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Key points 
• In this paper we present the results of an extensive mutation analysis in the genes coding for 
TFAP2A, MLP and CSK using a large panel of neural tube defect patients. 
 
• Using a TDT-based log-linear approach we found a relative risk of 5.3 for spina bifida aperta 
conferred by the 1257C allele in the TFAP2A gene (95 % CI 0.66 – 42.2). Sequence analysis of the 
entire coding region of MLP revealed no genetic variations. SSCP analysis of the coding region and 
part of the introns of the CSK gene followed by sequence analysis, identified three novel silent 
polymorphisms: 210C>T, 759C>T and 792C>T. These three polymorphisms were equally 
distributed in patients and controls. 
 
• In conclusion, by a TDT-based log-linear approach we were not able to demonstrate a significant 
role of the TFAP2A gene in the etiology of human neural tube defects. However, our results suggest 
the need for studies in larger patient samples that warrant a more powerful analysis. Furthermore, 
this study shows that CSK and MLP are no major risk factors for neural tube defects in humans. 
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Introduction 
 
Neural tube defects (NTD) are congenital malformations which arise from 
incomplete closure of the neural tube during early embryogenesis. The most 
common types of neural tube defects in man are spina bifida and anencephaly. 
Spina bifida and anencephaly can occur together in a single family and in some 
cases even in a single individual.1  
Approximately 70-80 % of all human NTD show complex or multifactorial 
inheritance patterns, indicating that both genetic and environmental factors play a 
role in the etiology of this malformation.2 Folic acid supplementation reduces the 
incidence of human and mouse NTD.3-7 Furthermore, supplementation of myo-
inositol reduces the incidence of NTD substantially in the NTD mouse model 
curly tail.8  
In curly tail embryos supplementary myo-inositol increases the flux through the 
inositol/lipid cycle, stimulating protein kinase C (Pkc) activity. Protein kinase C 
phosphorylates and thus activates several proteins that are directly involved in the 
formation of the neural tube, like Ap2-alpha and Mlp9 10  (fig 1). Ap2-alpha null, 
as well as heterozygous and chimeric knockout mice exhibit exencephaly.11 12 13 
Mlp knockout mice show exencephaly and spina bifida.14 15   
Apart from the genes involved in inositol-signaling NTD also occur in mice 
deficient for the Csk gene.16 This gene encodes a negative regulator of Src family 
tyrosine kinases and acts through phosphorylation of the Src family members at 
their C-terminal tyrosine residue17 (fig 1). Csk is involved in the organization of 
the cytoskeleton.18  
As outlined above, Ap2-alpha, Mlp and Csk are associated with NTD in the 
mouse. In man, Stegmann et al. have found no involvement of the human 
ortholog of Ap2-alpha, TFAP2A, in the etiology of human NTD using a case-
control study.19 Furthermore, no association was found between the human MLP 
gene and spina bifida using TDT analysis for a small set of simplex families.20 In 
this paper we present the results of an extensive mutation analysis in the genes 
coding for TFAP2A, MLP and CSK using DNA material from a large panel of 
NTD patients.  
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Figure 1  Signal transduction relationships between the proteins TFAP2A, MLP and 
CSK. Abbreviations: PTK=protein tyrosine kinase receptor, DAG=diacylglycerol, 
PLC=phospholipase C, PIP2=phosphatidylinositol 4,5-biphosphate, IP3=inositol 1,4,5-
triphosphate, PKC=protein kinase C, SRC=src-related protein tyrosine kinases 
 
 
Materials and methods 
 
Ascertainment of patients 
Patients with non-syndromic NTD described by Hol et al (1996) were used for 
mutation analysis in this study (group I).21 The collection includes samples from 
38 multiple case families, which were selected according to the criteria described 
previously.22 In brief, each family had at least two affected members having a 
close degree of relationship (≤ 3). DNA of one affected member of each of these 
families was included in the present study. The types of NTD in these familial 
cases were spina bifida aperta (SBA) (36), encephalocele (1) and 
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craniorachischisis (1). Furthermore, material from 79 sporadic NTD patients was 
included in the analysis, consisting of patients with SBA (75), anencephaly (2), 
and with encephalocele (2). For the TFAP2A association study a panel of 32 
patients (group II) was used in addition to the NTD collection of group I.  All of 
the affected children of group II had SBA and were ascertained in collaboration 
with the Dutch Spina Bifida Teams (Groenen P, submitted).  
 
RNA isolation and cDNA synthesis 
For the analysis of MLP total RNA was isolated from cultured lymphoblasts 
using the RNAzolTMB kit according to the protocol of the manufacturer (Tel-Test 
Inc. Texas, USA). First strand cDNA synthesis was performed in a 20 µl volume 
containing 250 ng total RNA, 100 ng random hexamer primers (Amersham 
Pharmacia, Freiburg, Germany), 10 mM Tris-HCl (pH 8.0), 50 mM KCl, 5 mM 
MgCl2 , 0.01 % (w/v) gelatin, 1 mM dNTPs (Life Technologies, Breda, The 
Netherlands), 50 U RNAsin (Amersham Pharmacia) and 1 U MMLV-reverse 
transcriptase (Life Technologies). Complementary DNA synthesis was completed 
by incubation at room temperature for 10 min followed by incubations at 37°C 
for 60 min and at 95°C for 6 min. 
 
SSCP analysis  
PCR-amplification of TFAP2A and CSK fragments was carried out in a total 
volume of 25 µl PCR buffer (50 mM KCl, 10 mM Tris-HCl  (pH 9.0), 0.01 %  
(w/v) gelatin, 0.1 % (w/v) Triton X-100, 1.5-6 mM MgCl2) containing 50 ng of 
genomic DNA, 0.45 mM of both forward and reverse primer, 0.1 mM dCTP, 
0.4 mM dTTP, 0.4 mM dATP, 0.4 mM dGTP (Amersham Pharmacia), 2.5 U 
Taq DNA polymerase (Life Technologies) and 0.1 µl [α32P]dCTP (200 µM; ICN 
Biomedicals B.V., Zoetermeer, The Netherlands). Samples were denatured at 
92°C for 5 min and then subjected to 35 cycles of amplification (92°C for 1 min, 
55°C for 50 seconds, 72°C for 1 min) in a PTC-100 thermal cycler (MJ-
Research via Biozym, Landgraaf, The Netherlands). Primers used in these PCR 
reactions are summarized in table 1. 
Aliquots of the amplified TFAP2A and CSK fragments were mixed with one 
volume of formamide dye buffer (95 % (w/v) formamide, 0.05 % (w/v) 
bromophenol blue, 0.05 % (w/v) xylenecyanol and 20 mM EDTA), denatured at 
95°C for 5 min, and placed on ice; 4 µl samples were loaded on a 5 %  non-
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denaturing polyacrylamide gel with and without 10 % glycerol. Electrophoresis 
was performed for 3 to 7 hours at 30 W and 5°C. The gels were dried and 
exposed to Kodak X-omat S film overnight.  
 
Sequence analysis 
Genetic variations in TFAP2A and CSK causing altered SSCP band patterns were 
identified by standard sequence analysis of PCR products. Sequences were 
determined in two directions using the forward and reverse primers used for 
SSCP analysis. Positions of identified polymorphisms in TFAP2A, CSK, and MLP 
were numbered starting with 1 at the first nucleotide of the ATG translation 
initiation codon. Sequencing was carried out on an ABI Prism 377 automated 
sequencer using the DyeDeoxyterminator cycle sequencing kit of the 
manufacturer (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). 
The complete coding region of MLP was PCR-amplified from cDNA in a total 
volume of 50 µl containing PCR buffer (5.0 mM Tris-HCl (pH 9.0), 0.15 mM 
MgCl2 and 0.01 % Triton X-100), 200-500 ng cDNA, 0.58 µM primer MLP1 
and 0.67 µM primer MLP2 (table 1), 0.13 mM of each type of dNTP (dATP, 
dCTP, dGTP and dTTP; Life Technologies) and 1 U of Taq DNA polymerase 
(Promega, Leiden, The Netherlands). The PCR cycling conditions involved an 
initial step of denaturation at 94°C for 4 min followed by 30 cycles of 1 min at 
94°C, 1 min at 55°C, and 1 min at 72°C. The final step was a 10 min extension 
step at 72°C. PCR-amplification of MLP fragments was performed using a Cetus 
thermal cycling machine (Perkin Elmer, Norwalk, USA). For sequence analysis 
primers MLP1-5 were used (table 1). 
 
Pyrosequence analysis 
Templates used for pyrosequencing were produced by PCR-amplification from 
200 ng genomic DNA in a total volume of 35 µl containing 10 pmol primers 
AP1pyro and AP2pyro (table 1), 0.1 mM of each type of dNTP (dATP, dCTP, 
dGTP and dTTP; Life Technologies), 2.9 mM Tris-HCl (pH 8.0), 14.3 mM 
KCl, 0.002 % (w/v) gelatin, 0.72 mM MgCl2 and 0.14 U AmpliTaq Gold  
(Perkin Elmer). PCR conditions for pyrosequencing were as follows: 50 cycles of 
92°C for 1 min, 60°C for 1 min and 72°C for 1 min. Pyrosequencing was 
performed on a PSQTM96 System with the AP3pyro primer (table 1) 
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Primer name Primer sequence Region of the gene PCR product (bp) 
AP-2-90for 5'-cgcacacgggagctctttc-3' promoter 187 
AP2-90rev 5'-tggagctactctctgggtag-3'     
AP2-803for 5'-cacccaggaaaccttagcctg-3' promoter 313 
AP2-803rev 5'-agaccggcgaagtcactccag-3'     
AP-21for  5'-cgccggagccagcactttg-3' exon1 176 
AP-21rev  5'-ctagtaggcacgccagtgtc-3'     
AP-22Afor  5'-tgttctttacctttcctctccc-3' exon2 204 
AP-22Arev  5'-tgcaccctcattcctagaacg-3'     
AP-22Bfor  5'-caatgccgacttccagccc-3' exon 2 212 
AP-22Brev  5'-gggctgtcgaccactccg-3'     
AP-22Cfor  5'-cagaggcagagccaggagt-3' exon 2 199 
AP-22Crev  5'-cacaagggagccgaccaac-3'     
AP-23for  5'-atgatacacttacatccatgtg-3' exon 3 144 
AP-23rev  5'-tttatcgtgagacggacattc-3'     
AP-24Afor  5'-gcagagccacagaatttcag-3' exon 4 141 
AP-24Arev  5'-tgtccttgttaatagggatgg-3'     
AP-24Bfor  5'-tgatccacgacgcccaacac-3' exon 4 334 
AP-24Brev  5'-ggcgcttcgcgtcaccaag-3'     
AP-25Afor  5'-gttttctaaatccctttctcgc-3' exon 5 (AP-2A specific region)a 268 
AP-25Arev  5'-cgtttctagtttgacgggttg-3'     
AP-25Bfor  5'-gaacttccttcttggaaaatgg-3' exon 5 (AP-2B specific region)a 240 
AP-25Brev  5'-gtcaagaatttgaacacgcaac-3'     
AP-26for  5'-tcattctctcgcactggctc-3' exon 6 217 
AP-26rev  5'-ctgtgtctctggggtatctc-3'     
AP-27for  5'-ctctctctctgctccacttg-3' exon 7 337 
AP-27rev  5'-ccgccccgccctcctctc-3'     
AP1pyro 5'-biotin-ctgtctctctgctccacttg-3 exon 7 328 
AP2pyro 5'-gggaggagagcctcactt-3     
AP3pyro 5'-tgttgtccgtgtggct-3 seq n.a. 
CSK1for 5'-cctcagtcttcatgctcttc-3' exon 1 144 
CSK1rev 5'-aatgcttgcatgtcccagac-3'     
CSK2for 5'-ccacgtgtcacctgccttg-3' exon2 183 
CSK2rev 5'-agggaaggcccagcagtg-3'     
CSK3for 5'-gggcctgagagcatgtctg-3' exon 3 172 
CSK3rev 5'-caacccctcctcgtggtac-3'     
CSK4for 5'-acctccagccctgctgctc-3' exon 4 275 
CSK4rev 5'-tgggagcaaggctctgtac-3'     
CSK5for 5'-gctgtctctgagcaccctg-3' exon 5 166 
CSK5rev 5'-tgggtgggcaagaggtctg-3'     
CSK6for 5'-ccatgtccctagtggcctc-3' exon 6 161 
CSK6rev 5'-caagttcggagtccctcag-3'     
CSK7for 5'-gggaacaagaccacctctc-3' exon 7 170 
CSK7rev 5'-cctaacctaggccaacctc-3'     
CSK8for 5'-cctttctgaccactctcgtc-3' exon 8  162 
CSK8rev 5'-cagttggaaggcctgagtg-3'     
CSK9for 5'-gcctggtctgtccttcctg-3' exon 9 125 
CSK9rev 5'-ccatccaagaggctgcttc-3'     
CSK10for 5'-ggacatgtggctggcctac-3' exon 10 255 
CSK10rev 5'-cacctctgtaggccccag-3'     
CSK11for 5'-ctgcttcttccatccacatg-3' exon 11 140 
CSK11rev 5'-gccaccctgatcccagtac-3'     
CSK12for 5'-ctggactgactcctgcctc-3' exon 12 271 
CSK12rev 5'-ccaggttcagtccccacag-3'     
MLP1 5'-cgaccccgccgtactatc-3' CDS 735 
MLP2 5'-caccaggtccaggcagtg-3     
MLP3 5'-gaacggaacagatgaggc-3' seq n.a. 
MLP4 5'-tggcctcagcaccctggc-3' seq n.a. 
MLP5 5'-tgcagcttagagatcacc-3' seq n.a. 
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Table 1 Primers for amplification of the coding region and flanking sequences of the 
human genes, TFAP2A, MLP and CSK and part of the promoter region of TFAP2A. The 
genomic sequence of TFAP2A and CSK, and the protein coding sequence of MLP were 
retrieved from Genbank (accession no. X77343, X74765 and NM_023009, respectively). 
Abbreviations: seq=primers used for (pyro)sequencing, CDS=complete coding 
sequence. aTwo splice variants exist for TFAP2A: AP2-A and AP-2B.30 
 
according to the protocol of the manufacturer (Pyrosequencing AB, Uppsala, 
Sweden).23 
 
Statistical analysis 
The genotype frequencies of the 1257C allele of the TFAP2A gene in group I, II 
and the combined group were tested for Hardy Weinberg equilibrium using the 
standard goodness-of-fit test. 
Association between variant alleles of TFAP2A and susceptibility to SBA was 
tested using the TDT (Transmission Disequilibrium Test)-based log-linear 
approach of Weinberg24 with an extension allowing for missing parents in case-
parent triads25. Unlike the commonly used McNemar’s TDT the log-linear 
approach allows the detection of and discrimination between effects of an 
inherited genotype and effects of the maternal genotype, which presumably would 
be mediated by prenatal factors.24 25 The program modeled the expected count for 
each of the 15 triad types shown in table 2A by fitting a Poisson regression. A 
maternal effect was included in the model by two yes/no covariables for mothers 
with homozygosity or heterozygosity for the 1257C allele of the TFAP2A gene 
(genotypes CC or CT). Also an effect of the inherited genotype was included by 
two yes/no covariates for children with 1 or 2 1257C alleles. Testing of maternal 
and inherited genotype was done using the likelihood ratio test (LRT). We fitted 
the log-linear model using the GENMOD procedure of the general statistics 
package SAS, release 6.12.  Relative risks (RR) and 95 % confidence intervals 
(95 % CIs) were calculated directly from the model. In addition to the TDT-
based log linear approach also Mc Nemar’s TDT test was performed as described 
by Spielman et al.26. 
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Results  
 
The TFAP2A gene was analyzed for its involvement in human NTD. The entire 
coding region, its flanking sequences and part of the promoter region of the gene 
were analyzed by single strand conformation polymorphism (SSCP) analysis in 
117 patients. Two polymorphisms were identified. The first one concerned 773-
53delG, recently also described by Stegmann et al.19, the second one was –
803G>T, which had been observed earlier by Kawanishi and coworkers27.  
 
Table 2.  (A) Genotype distribution of parent-affected child triads for the 1257C>T 
polymorphism in the TFAP2A gene. amother,father,child denote the number of copies of 
the 1257C allele carried by the mother, the father, and the SBA child, respectively. “?” 
represents missing data due to failed genotyping or unavailability of family members. (B) 
Relative Risk (RR) versus reference group predicted from log-linear analysis. Model 1 
assumes covariables for mother and child. Model 2 includes two covariables for the child. 
Model 3 includes one covariable for the child. Abbreviations: I=Group I, II=Group II, 
RR=relative risk.  
A 
mother,father,childa  I (n=100) II (n=32) % (I + II)  
0,1,1  1 1 1.5 
0,2,1  2 0 1.5 
1,0,1  1 0 0.8 
1,1,0  1 0 0.8 
1,1,1  2 1 2.3 
1,1,2  3 1 3.0 
1,2,1  9 4 9.8 
1,2,2  12 5 12.9 
2,0,1  1 1 1.5 
2,1,1  10 3 9.8 
2,1,2  11 4 11.4 
2,2,2  37 10 35.6 
subtotal of complete triads 90 30   
        
1,?,1  1 0 0.8 
2,?,1  1 0 0.8 
2,?,2  4 1 3.8 
?,1,1  1 0 0.8 
?,2,2  2 1 2.3 
?,?,2  1 0 0.8 
subtotal of incomplete triads 10 2   
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B 
RR versus Model Covariables in 
model reference 
95% CI p-value likelihood ratio test 
(LRT) 
Mother         
CT 0.78 0.18-3.47     
CC 0.78 0.17-3.49     
Ref: TT         
      0.95 LRT of model 2 
versus model 1 
Child         
CT 5.06 0.63-40.7     
CC 6.51 0.79-54.0     
1 
Ref: TT          
Child       
CT 5.06 0.63-40.7 0.090 
CC 6.52 0.79-54.0   
2 
Ref: TT       
LRT of model 2 
versus model with no 
covariables  
Child       
CT or CC 5.3 0.66-42.2 0.054 
3 
Ref: TT       
LRT of model 3 
versus model with no 
covariables 
 
The two polymorphisms, 773-53delG and –803G>T, had allelic frequencies of 
1.6 % and 4.2 %, respectively, in our sample of patients. The frequencies of the 
aberrant alleles were considered too low to test for an association with NTD 
using a TDT-based strategy. A novel frequent single nucleotide polymorphism 
(SNP), a 1257C>T transition of the TFAP2A gene, that had not been detected by 
SSCP analysis, was identified by sequence analysis in non-related spina bifida 
patient samples. The T-allele had an allelic frequency of 15.5 % in our patient 
panel. This polymorphism does not change the primary structure of the TFAP2A 
protein (N419N). For association testing two groups of parent-affected child 
triads were genotyped for this SNP by pyrosequence analysis (table 2A). In this 
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analysis only cases with spina bifida aperta were included. The genotype 
frequencies in group I, II and in the combined group fitted the Hardy Weinberg 
proportions (I: χ2=1.15 p-value=0.28; II: χ2=1.14 p-value=0.29; I + II: 
χ2=2.0 p-value=0.15). The genotyping data were analyzed by TDT 
(Transmission Disequilibrium Testing) for an association between the 
transmission of alleles and susceptibility to NTD (data not shown). To be able to 
use the full information content of our data, we then carried out a log-linear test 
as described by Weinberg et al.25. This test has several advantages for this type of 
association analysis as compared to the commonly used TDT. Firstly, it allows 
the inclusion of incomplete triads. Secondly, it is able to distinguish between 
effects caused by the maternal genotype and those caused by the genotype of the 
patient. Thirdly, codominant and recessive or dominant effects of a risk allele can 
be analyzed separately. Lastly, the log-linear approach provides an estimate for 
the relative risk conferred by the genotypes containing the risk allele. Using this 
approach for the analysis of the 1257C>T SNP in the TFAP2A gene we found 
that none of the maternal genotypes contributed significantly to the SBA risk of 
their children (p-value of LRT model 2 versus 1=0.95; table 2B). Simplifying 
the log-linear model by excluding a maternal contribution (model 2) showed the 
impact of the inherited CT and CC genotypes on the etiology of human SBA 
(CTchild, RR=5.06, 95 % CI 0.63 – 40.7; CCchild, RR=6.52, 95 % CI 0.79 – 
54.0, p-value of LRT model 2 versus model with no covariables=0.09; table 
2B). The fact that the relative risk of heterozygotes was already strongly 
increased indicated a dominant effect of the 1257C risk allele. Therefore, the 
separate contributions of the CT and CC genotypes to the log-linear model were 
combined in one yes/no covariable for CT/CC versus TT children in the final 
model (table 2B, model 3). This final model, which approached statistical 
significance ( p-value of LRT model 3 versus model with no covariables=0.054; 
table 2B), showed that the relative risk of having SBA conferred by the 1257C 
allele of the TFAP2A gene is 5.3. The 95 % confidence intervals were still very 
large (0.66 – 42.2) due to small numbers (only one TT child and 7 TT parents in 
the study).  
The second candidate gene we analyzed for its involvement in human NTD was 
MLP. This was done by sequence analysis of the entire coding region of MLP. 
However, no mutations or polymorphisms were found.  
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The third gene that we analyzed was CSK. SSCP analysis of the coding region 
and part of the introns of the CSK gene followed by sequence analysis of aberrant 
SSCP patterns, revealed three novel silent polymorphisms: 210C>T (Gly70Gly) 
in exon 3, and 759C>T (Gly253Gly) and 792C>T (Ile264Ile) in exon 8. All 
three SNPs were detected in both NTD patients and controls with similar 
frequencies (table 3). Frequencies were too low to perform TDT-based 
association studies in our parent-SBA child triads.  
 
 
  Alleles n (%) 
  210C>T 759C>T 792C>T 
  C T (%) C T (%) C T (%) 
Familial patients (36) 71 1 (1.4) 69 3 (4.2) 71 1 (1.4) 
Sporadic patients (731) 141 3 (2.1) 141 5 (3.4) 143 3 (2.1) 
Total (1091) 212 4 (1.9) 210 8 (3.7) 214 4 (1.8) 
          
Controls (522) 102 2 (1.9) 99 5 (4.8) 102 2 (1.9) 
 
 
Table 3. Distribution of CSK alleles in familial and sporadic spina bifida aperta patients 
(group I), and controls. 1 Except for  the 210C>T polymorphism for which 72 sporadic 
patients were included resulting in a total of 108 spina bifida aperta patients for this 
specific analysis. 2Unaffected and unrelated subjects were randomly chosen from the 
Dutch population and used as a control group. 
 
Discussion 
 
Genetic variation analysis of MLP and CSK exclude these genes as major risk 
factors for human NTD, despite the fact that Mlp and Csk deficiency cause NTD 
in mice. Our findings regarding MLP are in agreement with a study carried out 
by Stumpo and coworkers in a Caucasian population20. They found no evidence 
for linkage disequilibrium between a nearby microsatellite marker and spina 
bifida in a small sample of 43 patients using TDT. 
Our results obtained by mutation analysis and association testing indicate that 
TFAP2A is not a major risk factor for human NTD. However, the results of the 
association study approach significance even though our patient sample is 
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relatively small. Our results are comparable with results obtained from a case-
control study performed by Stegmann and coworkers, who did not find significant 
association between NTD and the intronic genetic variants in TFAP2A (773-
53delG and 892+284insCT) in 190 patients and 222 controls19. As for the 773-
53delG the number of sequence variants in both their patient and control panels 
was very small, 6 and 8 variants, respectively. Furthermore, the NTD cohort 
tested included approximately 90 % SBA patients, whereas the rest of the cohort 
consisted of anencephalic and encephalic patients. Since it is not yet clear if SBA 
and the other types of NTD are caused by exactly the same genetic factors 
association studies using a mix of  NTD types might not reveal the importance of 
a specific genetic factor.  
In conclusion, we showed by log-linear analysis that the TFAP2A gene is not a 
major risk factor involved in the etiology of human NTD. However, our results 
show the need for more association studies with larger patient samples to exclude 
a role of the gene in NTD entirely. Furthermore, this study shows that MLP is 
not a major risk for human NTD which is in line with a previous report20. This is 
the first study that provides information on the distribution of genetic variants in 
the CSK gene of spina bifida patients and non-related controls but it also shows 
that we can exclude the gene as a major risk factor for human NTD. 
Possible limitations of our association study are a certain heterogeneity and lack 
of categorization in our patient panel, i.e., SBA might further be subdivided into 
the phenotypes meningocele and myelomeningocele. Furthermore, we cannot rule 
out the possibility that some mutations or polymorphisms might have been 
overlooked in the mutation analysis, since the sensitivity of SSCP analysis is not 
100 %28. Also variation attributing to NTD-risk might be present in the promoter 
region of the investigated genes, as was recently shown for the PDGFR gene29. 
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Abstract 
Background. The nutritional factors myo-inositol, glucose and zinc and related genetic factors are 
suggested to be implicated in the etiology of spina bifida. Therefore, we  investigated the 
biochemical concentrations of myo-inositol, glucose and zinc, and polymorphisms in the myo-
inositol transporter gene KST1, myo-inositol synthase gene ISYNA1, and the zinc transporter 
SLC39A4 in association with spina bifida risk.  
Methods. Seventy-six spina bifida nuclear families were ascertained. In mothers, fathers and spina 
bifida children polymorphisms determined were KST1 (445C>T), ISYNA1 (1029A>G) and 
SLC39A4 (1069C>T). Serum myo-inositol and glucose and red blood cell zinc concentrations were 
determined in mothers and children with spina bifida. Transmission disequilibrium tests (TDT) 
were used to determine associations between the polymorphisms and spina bifida. The association 
between biochemistry and genotypes was studied by one-way analysis of variance (ANOVA), and 
interactions were analyzed using conditional logistic regression models. 
Results. The TDT-tests revealed no allelic association between KST1, ISYNA1 and SLC39A4 and 
spina bifida, χ2KST1=0.016, p=0.90; χ2ISYNA1=1.52, p=0.22, χ2SLC39A4=0.016, p=0.90; degrees of 
freedom [df] = 1. Mean maternal glucose concentrations were comparable for the three KST1 
genotypes. However, significantly lower myo-inositol concentrations were observed in spina bifida 
mothers with KST1 wildtype (CC), mean (SD) 14.2 (2.6) µmol/L compared to mothers with KST1 
TT-genotype, 17.0 (3.4) µmol/L, p<0.05. No significant associations between ISYNA1 and myo-
inositol and glucose, and between SLC39A4 and zinc were observed. A significant interaction was 
demonstrated between a maternal glucose concentration of less than 4.5 mmol/L and ISYNA1 
1029A>G polymorphism on spina bifida risk. 
Conclusion. These data may suggest that a borderline maternal glucose concentration together with 
1029A>G polymorphism in ISYNA1 protects against spina bifida in the offspring. Moreover, 
maternal KST1 445C>T polymorphism contributes to the serum myo-inositol concentration. The 
significance of these findings has to be confirmed in larger studies.  
 
Conditionally accepted for publication in Molecular Genetics 
and Metabolism.
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Introduction 
Neural tube defects (NTDs) are congenital malformations arising from incomplete 
closure of the neural tube during the first weeks of embryogenesis. The most 
common types of NTDs in humans are spina bifida and anencephaly, with a birth 
prevalence of 0.7 per 1,000 and 0.4 per 1,000 births, respectively, in the 
Netherlands. About 70-80% of all human spina bifida cases are considered to be 
caused by a combination of genetic, lifestyle and environmental factors [1]. 
Nutrition, in particular the B-vitamin folate, is an important lifestyle factor 
involved in the pathogenesis of spina bifida. Periconceptional folic acid 
supplementation reduces the occurrence and recurrence risk of spina bifida in 
human [2;3]. Other nutrients associated with spina bifida are the glucose 
derivative myo-inositol (MI) [4-6] and the trace element zinc [7-10]. Obesity [11-
13] and alcohol consumption [14] are both lifestyle determinants which have been 
associated with NTDs as well. 
The six-carbon sugar alcohol derivative MI is the most predominant stereoisomer 
of inositol in living cells. Greene and Copp (1997) [4] showed a reduction of 
spina bifida offspring in the genetically predisposed for spina bifida curly tail (ct) 
mouse, after MI supplementation. The same protective effect was observed in 
diabetic Sprague-Dawley rats having an increased risk of NTD offspring [15]. 
This finding is of particular interest because diabetic mothers have an increased 
risk of spina bifida offspring [16]. Moreover, type II diabetes is often observed in 
obese women who also have a higher risk of spina bifida offspring that could be 
related to hyperinsulinism [13]. Our observation in man that low maternal MI and 
mildly elevated glucose concentrations are risk factors for spina bifida offspring 
is herewith in line [6]. 
Although in ct mice MI increases the flux through the inositol-lipid cycle 
stimulating protein kinase C activity, the underlying molecular mechanism for the 
association between low MI and spina bifida risk is unknown. Myo-inositol 
supplementation may overcome a diminished uptake in the mother and/or transfer 
to the embryo. Several studies have shown that MI is taken up by H+/Na+- and 
energy dependent cotransporters located in the membranes of several adult 
murine tissues, including kidney, spleen, lung, liver, placenta and brain, as well 
as in embryonic tissues [17;18]. In humans the three genes known to transport MI 
are HMIT, a H+/MI cotransporter, and SMIT1 and KST1/SMIT2, the latter two 
being Na+/MI cotransporters, Figure 1, [19-21].  
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Schematic representation of myo-inositol (MI) and zinc (Zn2+) uptake, transport, synthesis 
and function of candidate genes, KST1, ISYNA1 and SLC39A4. ‘?’ represents an unknown 
MI-transporter in the small intestine. 
 
Figure 1. Zinc and myo-inositol uptake in humans. 
 
Apart from possible defects in the transport of MI, the synthesis of this nutrient 
can also be affected in MI related spina bifida. In the adult mouse, most tissues 
are able to synthesize myo-inositol-1-phosphate from D-glucose-6-phosphate by 
1L-myo-inositol-1-phosphate synthase (ISYNA1; EC 5.5.1.4) [22]. As the analysis 
of the EST database at the NCBI (http://www.ncbi.nlm.nih.gov/dbEST/) shows, 
ISYNA1 is expressed in embryos and extra-embryonic tissue. Genetic defects in 
this enzyme may result in low maternal and/or low embryonic intracellular MI 
concentrations and might ultimately disrupt signal transduction, cellular function 
and differentiation leading to spina bifida.  
The trace element zinc has also been associated with spina bifida and 
anencephaly. A study in rats was the first to show an increased incidence of 
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NTDs and other congenital malformations due to zinc deficiency [7]. The 
association between zinc deficiency and NTDs has been shown in humans as well 
[8-10]. A severe zinc deficiency together with an increased spina bifida risk is 
also observed in women suffering from Acrodermatitis Enteropathica, which is a 
rare autosomal recessively inherited disease. These patients show defective 
intestinal absorption of zinc, which can be overcome by zinc supplementation 
[23;24]. Recently, the SLC39A4 gene has been described as a cause in 
Acrodermatitis Enteropathica patients [23;24]. It encodes a zinc transporter that is 
involved in zinc uptake from the intestinal lumen that is expressed in the visceral 
mesoderm that surrounds the developing embryo and is regulated by zinc [25]. 
SLC39A4 therefore seems a good candidate gene for spina bifida, especially in 
cases where low zinc concentrations are observed. 
In this study we investigated polymorphisms in three candidate genes, KST1 
(445C>T), ISYNA1 (1029A>G) and SLC39A4 (1069C>T) for their 
involvement in the etiology of human spina bifida by using the Transmission 
Disequilibrium Test. We also studied these genetic data in combination with MI, 
glucose and zinc concentrations in blood of spina bifida patients and their 
mothers, periconceptional body mass index (BMI) and alcohol intake.  
 
Materials & Methods 
Subjects 
From the case-control triad study on spina bifida, previously described by 
Groenen et al. [6], we selected 76 parents and their children with nonsyndromic 
meningo(myelo)cele further referred to as spina bifida. Briefly, eligible for this 
study were children with spina bifida between one and three years of age and 
both their parents of Dutch Caucasian origin. Exclusion criteria were (i) 
pregnancy or breastfeeding at the moment of blood sampling, (ii) consanguinity, 
(iii) maternal diabetes mellitus, and (iv) blood transfusion within three months 
prior to blood sampling. The study protocol was approved by the Institutional 
Review Board of the University Medical Center Nijmegen, The Netherlands. 
 
Blood sampling and DNA isolation 
Parents and their children visited the outpatient clinic of the University Medical 
Center Nijmegen. Mothers fasted from 10 p.m. the day prior to blood sampling 
and were asked to refrain from adding sugar to their children’s breakfast. 
                                    Gene-environment interaction study 
187   
Mothers filled out at home a questionnaire regarding periconceptional use of 
alcohol defined as any alcohol use during the period 3 months prior to conception 
until 3 months after conception. During the hospital visit these questionnaires 
were checked and body weight and length were measured to calculate the body 
mass index (kg/m2). Two mL of maternal venous blood and 1 mL venous blood 
of the child was drawn into a potassium oxalate and sodium fluoride containing 
vacutainer tube for MI and glucose measurements. In addition, 4 mL and 0.75 
mL of venous blood from the mother and the child respectively, were drawn into 
an EDTA containing vacutainer tube for the measurement of zinc. Ten mL of 
venous blood from both parents was drawn into EDTA containing vacutainers for 
DNA isolation. Children’s DNA was isolated from the blood left over from the 
MI measurement. If the latter was not possible, DNA was isolated from buccal 
swabs. Genomic DNA was extracted from whole blood according to standard 
procedures [26] or from buccal swabs according to the protocol by Richards and 
coworkers [27]. 
 
Measurement of MI and glucose 
Myo-inositol and glucose concentrations were determined by trimethylsilylation 
and gas chromatography according to a modification of the procedure by Jansen 
et al. [28;29]. The detection limit of both MI and glucose were 0.5 µmol/L. The 
intra-assay coefficient of variation (CV) for MI and glucose was 10.4% and 
4.3%, respectively.                                                                                                       
 
Measurement of zinc 
Red blood cell zinc concentrations were determined by flame atomic absorption 
spectrophotometry (AAS) (Perkin Elmer 4100; Norwalk, Connecticut, USA). To 
1 mL of venous blood 9 mL of a physiological salt solution was added and the 
sample was centrifuged for 10 minutes at 400x g at 4°C. The supernatant was 
removed and the cell pellet resuspended in 10 mL of physiological salt solution 
after which centrifugation was repeated. After removal of the supernatant, the red 
blood cells were lysed by adding 2 mL of MilliQ. The lysed red blood cell 
samples were stored at –20°C until assayed. The intra- and inter-assay CV for 
zinc were 3.4% and 3.5% respectively, at a concentration of 12 µmol/L zinc. 
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KST1, ISYNA1 and SLC39A4  
For the KST1 gene we studied the common genetic variant, 445C>T present in 
exon 7 of the gene in transmembrane domain 5 of the encoded protein where it 
changes an amino acid, V182A. Protein structure prediction programs (TMPred: 
http://www.ch.embnet.org/software/TMPRED_form.html; Predictprotein: 
http://www1.embl-heidelberg.de/Services/sander/predictprotein/) did not reveal 
any changes of secondary structure for this variant. However, the amino acid 
valine at position 182 is conserved between species (e.g. in mouse and rabbit). 
Therefore, this amino acid position might be important for protein function. The 
ISYNA1 gene contains a common SNP in the coding region that was identified by 
Haga et al. [30]. This genetic variant, 1029G>A, does not result in an amino 
acid change (L343L) in the encoded protein and is therefore not considered to be 
a functional polymorphism itself. In our study it served as a marker SNP for 
unknown functional variants in linkage disequilibrium. A common SNP, 
1069C>T, located in exon 7 was analyzed for the SLC39A4 gene [30]. This 
genetic variant results in an amino acid change, A357T. Protein structure 
prediction programs revealed that the variant disrupts an α-helix structure in the 
protein. Therefore this polymorphism might have a functional impact on the gene 
product.  
 
PCR amplification 
PCR amplification of KST1 and SLC39A4 fragments was performed in a 50 µL 
reaction volume containing 100 ng genomic DNA, 250 ng of each primer (Table 
1), 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 0.01% (w/v) 
gelatin, 0.1% Triton X-100 (w/v), 0.35 mM dNTPs and 2 U Taq DNA 
polymerase (Invitrogen, Breda, The Netherlands). Amplification of ISYNA1 
fragments was performed in a 50 µL reaction volume containing 100 ng genomic 
DNA, 250 ng of each primer (Table 1), 60 mM Tris-HCl (pH 8.5), 15 mM 
(NH4)2SO4, 1.5 mM MgCl2, 10% DMSO (v/v), 0.35 mM dNTPs and 2 U Taq 
DNA polymerase (Invitrogen). 
Samples were denatured at 92°C for 5 minutes and then subjected to 35 (38 for 
SLC39A4) cycles of amplification (92°C for 1 minute, annealing temperature 
(Table 1) for 1 minute and 72°C for 1 minute), followed by a final extension step 
of 72°C for 3 minutes. Amplifications were performed in a PTC-200 thermal 
cycler (MJ-Research Inc. via Biozym, Landgraaf, The Netherlands). 
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Primer name Primer sequence 5’-3’ PCR product (bp) Annealing 
temperature (°C) 
KST1 for  CCTCCTTTCTTCACAGGTAG 139 53 
KST1 rev CCTTTGTTCAGTCTTACCAGC   
ISYN for GACGGGACACCGCTGATCGTTTA 
GGCAACAACGATGGGGAGCAGCT 
109 56 
ISYN rev ACCATGTCGTCCACCACGTTGC   
SLC39A4 for GCTTTCACAGCCGCCTCAC 209 51 
SLC39A4 rev GGCACACCTTGGGCGTCAG   
 
Table 1. PCR amplification conditions. Sequences were obtained from GenBank 
(Accession no. NM052944, AF220530 and NM130849). Mismatch positions are 
underlined for primer ISYN for. 
 
RFLP analysis 
PCR products were purified before digestion with restriction enzymes. 
MultiScreen PCR MANU03050 plates (Millipore, Amsterdam, The Netherlands) 
were used for purification of the PCR fragments from KST1 and SLC39A4. 
ISYNA1 amplification products were purified using the Montage SEQ96 
Sequencing Reaction Cleanup Kit (Millipore) because of the small size of the 
fragment.  
Seventy-six nuclear triads were genotyped for frequent genetic variants, described 
in literature or databases, in each of the coding regions of the genes, KST1, 
ISYNA1 and SLC39A4. The genetic variants were 445C>T (V182A) in KST1 
[21], 1029A>G (L343L) in ISYNA1 (dbSNP ID: rs2303697; 
http://www.ncbi.nlm.nih.gov/SNP/) and 1069C>T (A357T) in SLC39A4 
(dbSNP ID: rs2272662) [30]. The C>T change at position 445 of KST1 
abolishes an AluI restriction site. Digestion of the KST1 PCR product with AluI 
resulted in a fragment of 56 bp and a fragment of 83 bp for the homozygous 
445C genotype. A PvuII restriction site was generated by PCR using a forward 
Chapter 5  
190  
primer with mismatches (Table 1) for the analysis of the frequent genetic variant 
1029G>A in ISYNA1. Digestion of the ISYNA1 PCR product with PvuII resulted 
in a fragment of 47 bp and a fragment of 62 bp for the homozygous 1029G 
genotype. The C>T change at position 1069 of SLC39A4 abolishes a BstEII 
restriction site. Digestion of the SLC39A4 PCR product with this enzyme resulted 
in two fragments of 91 and 118 nucleotides, respectively, for the homozygous 
1069C genotype.  
Restriction reactions were performed overnight in a 15 µL volume, containing 10 
µl of the purified PCR product, 5 U of restriction enzyme and the appropriate 
restriction buffer. KST1 was digested at 37°C with AluI (Invitrogen, Breda, The 
Netherlands), ISYNA1 at 37°C with PvuII (Invitrogen) and SLC39A4 at 60°C 
with BstEII (New England Biolabs, Frankfurt am Main, Germany). Detection of 
fragments was performed by electrophoresis on a 4% agarose gel. 
 
Statistical analysis 
The Transmission Disequillibrium Test (TDT) was performed to test for 
associations between transmission of alleles of the candidate genetic variants and 
spina bifida in the offspring. 
Means (SD) were calculated for MI, glucose and zinc blood concentrations and 
one-way analysis of variance (ANOVA) was applied to determine the contribution 
of the specific genotypes on the blood concentrations of MI, glucose and zinc. 
We employed a conditional logistic regression model to test for and calculate the 
magnitude of the interactions between the transmission of specific alleles and 
observable covariates i.e., dichotomized blood concentrations of MI, glucose and 
zinc, BMI (≤ 25 kg/m2 vs. > 25 kg/m2) and periconceptional use of alcohol (yes 
vs. no). The cut-off values were 13.2 µmol/L for MI, 4.5 mmol/L for glucose 
and 190 µmol/L for zinc as described previously [6]. ‘Risk’ alleles were coded 1 
and control alleles were code 0. Conditional Odds Ratios (OR) were calculated 
for the magnitude of the interaction effect. The Likelihood ratio test was 
performed to evaluate the significance of the interactions of the transmission of 
specific alleles and observable covariates. This procedure has been described by 
Beaty et al. [31]. P-values less than 0.05 were considered statistically significant. 
All statistical analyses were performed using the SAS System for Windows 
version 8 (SAS institute Inc, Cary, NC).  
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Results 
In this study we used frequent genetic variants in the coding regions of each of 
the genes, KST1, ISYNA1 and SLC39A4 to determine their contribution as well as 
that of related biochemical determinants, and BMI and alcohol use as effect-
modifiers, on spina bifida risk. 
The genotype frequencies in the spina bifida children for each of the variants 
were consistent with the Hardy Weinberg equilibrium. Genotyping resulted in 61, 
64 and 62 informative transmissions in KST1, ISYNA1 and SLC39A4, respectively 
(Table 2). The TDT tests showed no statistical significances (Table 2; χ2KST1= 
0.016, p=0.90; χ2 ISYNA1= 1.52, p=0.22, χ2SLC39A4=0.016, p=0.90; degrees of 
freedom [df] = 1). 
 
 KST1 (445C>T)  ISYNA1 
(1029A>G) 
SLC39A4 (1069C>T) 
  Non 
transmitted 
  Non 
transmitted 
 Non transmitted 
  T C   A G  T C 
T 44 30  A 47 38 T 22 30 
Transmitted 
C 29 19  G 28 15 C 31 41 
χ2KST1=0.016, P=0.90; χ2ISYNA1=1.52, P=0.22; χ2SLC39A4=0.016, P=0.90 
 
 
Table 2. Transmission disequilibrium testing of genetic variants in KST1, ISYNA1, 
SLC39A4 in complete spina bifida triads. 
 
Genotypes of the patients for the genetic variants of KST1 and ISYNA1 were 
evaluated together with the mean MI and glucose concentrations in serum of 
spina bifida patients and their mothers. The same was carried out for the 
SLC39A4 genotypes and zinc concentrations in red blood cells of patients and  
 
 
 
 
 
 
Chapter 5  
192  
 
 
 
    Mother   Overall P-
value** 
  Spina Bifida 
Child 
  Overall P-
value** 
KST1  
genotype 
CC CT TT   CC CT TT   
MI¶  14.2 (2.6)
* 15.6 (3.2) 17.0 (3.4) 25.5 (8.2) 23.1 (3.9) 24.5 (6.9) 
(µmol/L) n=10 n=29 n=20 
0.07 
n=12 n=27 n=26 
0.48 
Glucose  4431 (423) 4385 (523) 4356 (638) 3679 (405) 3925 (408) 3859 (506) 
(mmol/L) n=10 n=29 n=20 
0.94 
n=12 n=27 n=26 
0.30 
         
ISYNA1  
genotype 
AA AG GG  AA AG GG  
MI  14.9 (3.0) 16.5 (3.1) 16.3 (3.4) 24.0 (7.3) 24.5 (4.8) 24.4 (7.1) 
(µmol/L) n=29 n=21 n=9 
0.18 
n=29 n=31 n=7 
0.95 
Glucose 4372 (538) 4319 (574) 4499 (520) 3918 (552) 3949 (532) 3611 (387) 
 (mmol/L) n=29 n=21 n=9 
0.71 
n=29 n=31 n=7 
0.31 
         
SLC39A4  
genotype 
CC CT TT  CC CT TT  
Zinc  216 (37.0) 211 (30.2) 214 (29.2) 160 (21.0) 161 (43.3) 148 (54.2) 
(µmol/L) n=14 n=30 n=8 
0.88 
n=16 n=24 n=10 
0.68 
 
 
 
¶ MI: Myo-inositol 
** Overall P-value of one-way ANOVA 
* P<0.05  CC-genotype compared to TT-genotype  
 
 
Table 3. Interactions between KST1, ISYNA1 and SLC39A4 variants and mean (SD) 
concentrations of serum myo-inositol and glucose and red blood cell zinc in spina bifida 
children and their mothers. 
 
mothers (Table 3). Although one-way ANOVA demonstrated equal mean MI 
concentrations in both mothers and children, mothers with the CC genotype in 
KST1 had significantly lower MI concentrations than mothers with the TT 
genotype (Table 3; [CCmothers]MI: 14.2 µmol/L,  [TTmothers] MI: 17.0 µmol/L, 
p<0.05). The glucose concentrations did not vary significantly between the KST1 
genotypes. One-way ANOVA revealed no association between the genetic 
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variants in ISYNA1 or SLC39A4 and MI or glucose profiles in serum of spina 
bifida patients and their mothers and mean zinc concentration in red blood cells 
from patients and mothers, respectively (Table 3).  
Using conditional logistic modeling, we observed a significant interaction 
between low maternal glucose concentration, the transmission of the 1029G allele 
in the ISYNA1 gene and spina bifida risk (Table 4; ORGlucose≥4.5 mmol/L=1.27 and 
ORGlucose<4.5 mmol/L=0.35, χ2interaction= 4.361, P<0.05, [df]=1). No significant 
interactions were observed for the genes KST1 and SLC39A4, and the MI, 
glucose and zinc concentrations in blood, Table 4. In addition, allelic 
transmission in the genes KST1, ISYNA1 and SLC39A4, maternal BMI and 
periconceptional alcohol intake did not reveal significant interactions with spina 
bifida risk, Table 4. 
 
Discussion 
Most evidence of the role of nutritional factors in the etiology of spina bifida 
comes from the B-vitamin folate. Less is known on other causes of spina bifida in 
humans. Recently, we showed that a low maternal MI concentration is a risk 
factor for human spina bifida [6]. Therefore, in the current study the 455C>T 
polymorphism in the MI transporter gene KST1 was studied in the same study 
groups of mothers and their children with spina bifida. Mothers with the KST1 
445CC genotype had significantly lower MI serum levels. However, it revealed 
from the TDT and conditional logistic regression analysis that this gene is not 
expected to be an important risk factor for spina bifida. The KST1 gene has also 
been studied in association with other neurological disorders, like infantile 
convulsions, choreoathetosis, and benign familial infantile convulsions [21], and 
did not seem to play a major role either. Because KST1 is one of three MI 
transporters in humans, we also tried to identify and study genetic variants in 
SMIT1. Several genetic variants are described in the NCBI database (dbEST), 
including rs1782995, rs2105485, rs2409513, rs2409514, rs2105486, rs2409515, 
rs2105487 and rs2409516 that were located in intron 1 of the gene. However, 
these variants were not detected by sequence analysis in 10 unrelated patients 
with spina bifida of our panel. In murine, Berry et al. [32] showed that SMIT1 is 
the major MI transporter in the transfer from the mother to embryo from 
embryonic day 10.5 onwards. The knockout mice showed disturbances in  
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Table 4. Conditional logistic regression analyses testing for interaction between the 
transmission of KST1, ISYNA1 and SLC39A4 alleles and the covariates myo-inositol, 
glucose and zinc concentrations, body mass index, and periconceptional use of alcohol. 
 
Model Description Odds Ratio Likelihood ratio 
Statistic 
P 
KST1     
I. All trios (N=55) 1.12 0.170 0.68 
II. Inositol > 13.2 µmol/L 1.24 
 Inositol ≤ 13.2 µmol/L 0.88 0.319 
Model II vs. 
I, P>0.05 
III. Glucose ≥ 4.5 mmol/L 1.33 
 Glucose < 4.5 mmol/L 1.00 
0.260 
Model III vs. 
I, P>0.05 
IV. Alcohol Yes 1.87 
 Alcohol No 0.90 
1.487 
Model IV vs. 
I, P>0.05 
V. BMI > 25 kg/m2 1.37 
 BMI ≤ 25 kg/m2 0.83 0.809 
Model V vs. 
I, P>0.05 
     
ISYNA1     
I. All trios (N=55) 0.56 3.966 0.05 
II. Inositol > 13.2 µmol/L 0.49 
 Inositol ≤ 13.2 µmol/L 0.83 0.566 
Model II vs. 
I, P>0.05 
III. Glucose ≥ 4.5 mmol/L 1.27 
 Glucose < 4.5 mmol/L 0.35 
4.361 
Model III vs. 
I, P<0.05 
IV. Alcohol Yes 1.00 
 Alcohol No 0.43 
1.797 
Model IV vs. 
I, P>0.05 
V. BMI > 25 kg/m2 0.71 
 BMI ≤ 25 kg/m2 0.39 0.995 
Model V vs. 
I, P>0.05 
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SLC39A4     
I. All trios (N=48) 1.14 0.200 0.66 
II. Zinc > 190 µmol/L 1.13 
 Zinc ≤ 190 µmol/L 1.18 0.004 
Model II vs. 
I, P>0.05 
III. Alcohol Yes 0.85 
 Alcohol No 1.28 
0.372 
Model III vs. 
I, P>0.05 
IV. BMI > 25 kg/m2 1.07 
 BMI ≤ 25 kg/m2 1.26 0.067 
Model IV vs. 
I, P>0.05 
 
KST1 (445C>T): Allele C is coded as 0 and T is coded as 1 
ISYNA1 (1029A>G): Allele A is coded as 0 and G is coded as 1 
SLC39A4 (1096C>T): Allele C is coded as 0 and T is coded as 1 
 
rhytmic respiratory neuronal activity, however no spina bifida was observed in 
the offspring. It may well be that other MI transporters such as HMIT is involved 
in spina bifida, or that MI transport simply is not critical in the MI-supply of the 
embryo. Besides species differences, this may be an important explanation for 
our negative findings, since the embryo is able to synthesize MI from glucose.  
Therefore, we also investigated whether synthesis of MI induced by ISYNA1 
played a role in spina bifida. Transmission disequilibrium testing revealed no 
association between the 1029A>G allele and spina bifida. However, modeling of 
combined allelic transmission data and maternal glucose serum concentrations 
demonstrated a lower risk of spina bifida offspring in mothers with the 1029G-
allele and having borderline glucose concentrations. This may suggest that the 
1029G-allele is involved in pathways involved in neural tube development that 
can be modulated by glucose status. Experimental studies should be performed to 
prove the relevance of this finding. 
We and others showed before that a low zinc concentration is a risk factor for 
spina bifida [6;9;10]. Therefore, we studied the association between the zinc 
transporter SLC39A4 gene and spina bifida. No association was observed between 
the 1069C>T variant of the SLC39A4 and spina bifida, nor was this variant 
associated with altered zinc concentrations in mothers or their affected children. 
Apparently the SLC39A4 variant or those in linkage disequilibrium appear no 
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major risk factors for spina bifida. These results leave the possibility open that 
other variants in SLC39A4, or other means of zinc transfer to embryos are 
involved in zinc related spina bifida. Genes that are implicated in zinc transfer are 
the family members of SLC39A4, ZIP1-3, and genes from the ZnT family. Their 
precise roles in maternal and embryonic zinc transfer with regard to formation of 
the neural tube remains to be investigated.  
The absence of interactions between BMI, alcohol consumption and the 
biochemical and genetic determinants can be interpreted as that these factors 
work independently, or the groups were to small to show any of these 
interactions. 
The strengths of this study are the homogeneity of the well-defined and clinically 
diagnosed spina bifida patients, and the availability of biochemical and genetic 
information of the mother and her spina bifida child. Moreover, the case-triad 
design enabled us to analyze by TDT in the best manner the associations between 
the genetic variants and spina bifida. On the other hand in this study associations 
have been tested without proper adjusting the type I error chance threshold. As a 
result, the overall type I error will be larger than 0.05, and thus increases the 
number of false positive results. Therefore, the allelic impact on the biochemical 
blood parameters have to be interpreted with caution, and the association between 
KST1 CC genotype and maternal MI in particular. Nevertheless, this and the 
finding that the borderline maternal glucose concentration together with 
1029A>G polymorphism in ISYNA1 may contribute to the prevention of spina 
bifida, is very interesting and has to be confirmed in larger studies. Moreover, 
confirmation of our findings in a control population is worthwhile to pursue. 
 
Acknowledgements 
The authors are indebted to the Dutch Spina Bifida Teams of the University 
Medical Center Nijmegen (Dr R. Mullaart), University Medical Center 
Amsterdam (Dr S. Ploos van Amstel), Free University Medical Center (Mrs. C. 
McDonald), Erasmus University Medical Center Rotterdam (Dr J. van Meeteren), 
University Medical Center Utrecht (Dr R. Gooskens), University Medical Center 
Groningen (Dr A. Staal-Schreinemacher), University Medical Center Leiden (Dr 
W. Overweg-Plandsoen), St Elisabeth Hospital Tilburg (Dr J. Bruinenberg), and 
Sophia Hospital Zwolle (Dr J. Collenburg). Sincere thanks go to the parents and 
their children who participated in this study.  
                                    Gene-environment interaction study 
197   
We are grateful to Dr C. van Oostrom and Mrs. M. van der Doelen of the 
Department of Pediatrics of the University Medical Center Nijmegen for practical 
assistance, Mr. W. Lemmens of the Department of Epidemiology and Biostatistics 
of the University Medical Center Nijmegen for data management and statistical 
support, R. Wevers, PhD, and Mrs. F. Janssen of the Laboratory of Pediatrics 
and Neurology, and Mrs. D. Swinkels, MD, PhD and Mr. S. Klaver of the 
Department of Clinical Chemistry of the University Medical Center Nijmegen for 
their laboratory technical contributions. This study was supported by a grant of 
the Dutch Organization for Scientific Research NWO (Grant No. 925-01-006 KV-
GO). 
 
References 
 
 [1] R. P. M. Steegers-Theunissen, R. W. Smithells, T. K. A. B. Eskes, Update of 
new risk factors and prevention of neural-tube defects, Obstet. Gynecol. Surv. 48 
(1993) 287-293. 
 [2] MRC Vitamin Study Research Group, Prevention of neural tube defects: results of 
the Medical Research Council Vitamin Study., Lancet 338 (1991) 131-137. 
 [3] A. E. Czeizel and I. Dudás, Prevention of the first occurrence of neural-tube 
defects by periconceptional vitamin supplementation, N. Engl. J. Med. 327 (1992) 
1832-1835. 
 [4] N. D. Greene and A. J. Copp, Inositol prevents folate-resistant neural tube defects 
in the mouse, Nat. Med. 3 (1997) 60-66. 
 [5] P. Cavalli and A. J. Copp, Inositol and folate resistant neural tube defects, J. Med. 
Genet. 39 (2002) E5. 
 [6] P. M. W. Groenen, P. G. M. Peer, R. A. Wevers, D. W. Swinkels, B. Franke, E. 
C. M. Mariman, R. P. M. Steegers-Theunissen, Maternal myo-inositol, glucose 
and zinc status is associated with the risk of offspring with spina bifida, Am. J. 
Obstet. Gynecol. 189 (2003) in press. 
 [7] J. Warkany and H. G. Petering, Congenital malformations of the central nervous 
system in rats produced by maternal zinc deficiency, Teratology 5 (1972) 319-334. 
 [8] D. P. Brenton, M. J. Jackson, A. Young, Two pregnancies in a patient with 
acrodermatitis enteropathica treated with zinc sulphate, Lancet 2 (1981) 500-502. 
 [9] P. K. Buamah, M. Russell, G. Bates, A. M. Ward, A. W. Skillen, Maternal zinc 
status: a determination of central nervous system malformation, Br. J. Obstet. 
Gynaecol. 91 (1984) 788-790. 
 [10] A. O. Cavdar, M. Bahceci, N. Akar, J. Erten, G. Bahceci, E. Babacan, A. 
Arcasoy, H. Yavuz, Zinc status in pregnancy and the occurrence of anencephaly in 
Turkey, J. Trace. Elem. Electrolytes Health Dis. 2 (1988) 9-14. 
 [11] G. M. Shaw, E. M. Velie, D. Schaffer, Risk of neural tube defect-affected 
pregnancies among obese women, JAMA 275 (1996) 1093-1096. 
Chapter 5  
198  
 [12] K. Kallen, Maternal smoking, body mass index, and neural tube defects, Am. J. 
Epidemiol. 147 (1998) 1103-1111. 
 [13] K. A. Hendricks, O. M. Nuno, L. Suarez, R. Larsen, Effects of hyperinsulinemia 
and obesity on risk of neural tube defects among Mexican Americans, 
Epidemiology 12 (2001) 630-635. 
 [14] S. M. Smith, Alcohol-induced cell death in the embryo, Alcohol Health & 
Research World 21 (1997) 287-295. 
 [15] E. A. Reece, M. Khandelwal, Y. K. Wu, M. Borenstein, Dietary intake of myo-
inositol and neural tube defects in offspring of diabetic rats, Am. J. Obstet. 
Gynecol. 176 (1997) 536-539. 
 [16] N. C. Myrianthopoulos and M. Melnick, Studies in neural tube defects. I. 
Epidemiologic and etiologic aspects, Am. J. Med. Genet. 26 (1987) 783-796. 
 [17] V. Scalera, D. Natuzzi, G. Prezioso, Myo-inositol transport in rat intestinal brush 
border membrane vesicles, and its inhibition by D-glucose, Biochim. Biophys. 
Acta 1062 (1991) 187-192. 
 [18] E. M. Wright, D. D. Loo, M. Panayotova-Heiermann, B. A. Hirayama, E. Turk, 
S. Eskandari, J. T. Lam, Structure and function of the Na+/glucose cotransporter, 
Acta Physiol. Scand. Suppl 643 (1998) 257-264. 
 [19] M. Uldry, M. Ibberson, J. D. Horisberger, J. Y. Chatton, B. M. Riederer, B. 
Thorens, Identification of a mammalian H(+)-myo-inositol symporter expressed 
predominantly in the brain, EMBO J. 20 (2001) 4467-4477. 
 [20] M. J. Coady, B. Wallendorff, D. G. Gagnon, J. Y. Lapointe, Identification of a 
novel Na+/myo-inositol cotransporter, J. Biol. Chem. 277 (2002) 35219-35224. 
 [21] P. Roll, A. Massacrier, S. Pereira, A. Robaglia-Schlupp, P. Cau, P. Szepetowski, 
New human sodium/glucose cotransporter gene (KST1): identification, 
characterization, and mutation analysis in ICCA (infantile convulsions and 
choreoathetosis) and BFIC (benign familial infantile convulsions) families, Gene 
285 (2002) 141-148. 
 [22] A. L. Majumder, M. D. Johnson, S. A. Henry, 1L-myo-inositol-1-phosphate 
synthase, Biochim. Biophys. Acta 1348 (1997) 245-256. 
 [23] K. Wang, B. Zhou, Y. M. Kuo, J. Zemansky, J. Gitschier, A novel member of a 
zinc transporter family is defective in acrodermatitis enteropathica, Am. J. Hum. 
Genet. 71 (2002) 66-73. 
 [24] S. Kury, B. Dreno, S. Bezieau, S. Giraudet, M. Kharfi, R. Kamoun, J. P. 
Moisan, Identification of SLC39A4, a gene involved in acrodermatitis 
enteropathica, Nat. Genet. 31 (2002) 239-240. 
 [25] D. K. Lee, J. Geiser, J. Dufner-Beattie, G. K. Andrews, Pancreatic 
metallothionein-I may play a role in zinc homeostasis during maternal dietary zinc 
deficiency in mice, J. Nutr. 133 (2003) 45-50. 
 [26] S. A. Miller, D. D. Dykes, H. F. Polesky, A simple salting out procedure for 
extracting DNA from human nucleated cells, Nucleic Acids Res. 16 (1988) 1215. 
 [27] B. Richards, J. Skoletsky, A. P. Shuber, R. Balfour, R. C. Stern, H. L. Dorkin, 
R. B. Parad, D. Witt, K. W. Klinger, Multiplex PCR amplification from the 
CFTR gene using DNA prepared from buccal brushes/swabs, Hum. Mol. Genet. 2 
(1993) 159-163. 
 [28] G. Jansen, F. A. Muskiet, H. Schierbeek, R. Berger, van der Slik W., Capillary 
gas chromatographic profiling of urinary, plasma and erythrocyte sugars and 
                                    Gene-environment interaction study 
199   
polyols as their trimethylsilyl derivatives, preceded by a simple and rapid 
prepurification method, Clin. Chim. Acta 157 (1986) 277-293. 
 [29] P. M. W. Groenen, H. M. W. M. Merkus, F. C. Sweep, R. A. Wevers, F. S. M. 
Janssen, R. P. M. Steegers-Theunissen, Kinetics of myo-inositol loading in women 
of reproductive age, Ann. Clin. Biochem. 40 (2003) 79-85. 
 [30] H. Haga, R. Yamada, Y. Ohnishi, Y. Nakamura, T. Tanaka, Gene-based SNP 
discovery as part of the Japanese Millennium Genome Project: identification of 
190,562 genetic variations in the human genome. Single-nucleotide polymorphism, 
J. Hum. Genet. 47 (2002) 605-610. 
 [31] T. H. Beaty, J. B. Hetmanski, J. S. Zeiger, Y. T. Fan, K. Y. Liang, C. A. 
VanderKolk, I. McIntosh, Testing candidate genes for non-syndromic oral clefts 
using a case-parent trio design, Genet. Epidemiol. 22 (2002) 1-11. 
 [32] G. T. Berry, S. Wu, R. Buccafusca, J. Ren, L. W. Gonzales, P. L. Ballard, J. A. 
Golden, M. J. Stevens, J. J. Greer, Loss of murine Na+/myo-inositol 
cotransporter leads to brain myo-inositol depletion and central apnea, J. Biol. 
Chem. 278 (2003) 18297-18302. 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
CHAPTER 6 
 
General discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                       General discussion   
203   
6.1 Zinc related neural tube defects 
Several research groups have shown that zinc status is involved in human neural 
tube defects (NTDs) (Soltan and Jenkins 1982; Breskin et al. 1983; Buamah et al. 
1984; Cavdar et al. 1988). For most of these studies zinc levels were measured in 
blood. Recently, in a parallel PhD project Groenen et al. (in press) also showed a 
lower zinc concentration in red blood cells of mothers with a spina bifida child 
compared to control mothers, but no real zinc deficiency was observed. It was 
concluded that these observations might be due to disturbances in transport of 
zinc in mothers or to a deranged zinc metabolism. Groenen and coworkers also 
showed that zinc concentrations did not differ between spina bifida children and 
controls. However, since zinc concentrations were measured approximately 1.5 
years after birth of the index-child, it can not be excluded that (local) 
disturbances in zinc metabolism and/or deranged transport of zinc might be 
present in certain human embryos at the time the neural tube closes, leading to 
neural tube defects. Until now, not much is known about the molecular 
mechanism behind zinc related neural tube defects even from animal studies. 
Studies by Warkany and Petering (1972) and Harding et al. (1988) show that zinc 
deficiency causes NTDs in rats. To learn more about zinc related NTDs we 
studied a model for X-linked NTDs, the Bent tail (Bn) mouse, for which we had 
previously identified the genetic defect as a submicroscopic deletion of 
approximately 300 kb, which completely encompasses the Zic3 gene coding for a 
zinc finger transcription factor (chapter 2.1). This deletion also encompasses a 
pseudogene (Ensembl Gene ID: ENSMUSG00000048861), two ESTs (Expressed 
Sequence Tags) (EST 2424689 and EST 111725) and one EST cluster (UniGene 
cluster Mm.172891)(chapter 2.2). Recently, a Zic3 knockout mouse was 
generated, which had a similar phenotype as the Bn mouse, including NTDs and 
tail deformities, showing that Zic3 is the major gene involved in the Bn phenotype 
(Purandare et al. 2002). However, it can not be excluded that the ESTs present in 
the genetic defect might have a minor impact on the phenotype of Bn since all 
ESTs are expressed during embryogenesis. Future experiments will reveal the 
genomic structure of the genes and, additionally, knockouts for these murine 
genes will reveal what their contribution in the Bn phenotype is. In addition to 
neural tube defects other abnormalities were present in the Bn mice, including 
omphalocele, orofacial schisis, kinked neural tube, tight amnion, delay in axial 
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turning, malrotation and situs abnormalities (chapter 2.1 and 2.3)(Purandare et al. 
2002; Klootwijk et al. 2000; Franke et al. 2003).  
Most of the research on the gene Zic3 has been focused on its role in left-right 
axis development, however less information is available on its role in neural tube 
development, such as the position of Zic3 in the neural network of its genetic 
interactors. Most of the information relies on murine and frog studies. Xenopus 
Zic3 expression is induced by a blockade of the BMP4 signal (Nakata et al. 
1997). BMP4 has an inhibitory effect on ectoderm differentiation into 
neuroectoderm (Wilson and Hemmati-Brivanlou 1995) indicating that the 
blockade of the signal triggers the neuroectoderm formation (Sasai et al. 1995; 
Xu et al. 1995; Hawley et al. 1995). In Xenopus the neuroectoderm is induced on 
the dorsal side of the embryo by signals such as noggin, chordin, follistatin, and 
Xnr3 emanating from the Spemann organizer during early gastrulation  (Smith 
and Harland 1992; Sasai et al. 1995; Hemmati-Brivanlou et al. 1994; Hansen et 
al. 1997; Smith et al. 1995). These signals may act as endogenous blockers of 
BMP4 by direct binding (Zimmerman et al. 1996; Piccolo et al. 1996; Fainsod et 
al. 1997).  Xenopus Zic3 induces proneural genes, like  Neurogenin, NeuroD, 
XASH-3, and XATH-3 (Lee et al. 1995; Ma et al. 1996; Turner and Weintraub 
1994; Chitnis and Kintner 1996; Takebayashi et al. 1997). Large scale expression 
profiling and proteomics analysis in Bn embryos might reveal the position of Zic3 
in the neural network more exactly and fit new proteins into this network. This 
analysis can also reveal new candidates for NTDs. 
We investigated the role of supplementation of zinc to Bn in NTDs using the tail 
abnormalities (tail length and number of tail kinks) as a marker for sensitivity of 
defective closure of the neural tube. This marker was used since Bn has a delayed 
timing of closure of the posterior neuropore (PNP) and subsequent might have a 
delayed outgrowth of the tailbud (chapter 2.4). This study showed no effect of 
zinc on the deformities in Bn. However, we can not exclude that in the Bn 
embryo a localized zinc deficiency occurs, which can not be overcome by zinc 
supplementation. The potential effect of zinc on PNP closure was not investigated 
in this study and should be investigated in the future. In addition, in our study we 
have not looked for an effect of zinc supplementation on the occurrence of 
exencephaly, due to its low incidence in Bn. This might be interesting to 
investigate in the future since severe zinc deprivation of cultured embryos results 
in the occurrence of exencephaly (Harding et al. 1988). In the future, 
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concentrations of the NTD related component zinc should be measured in 
maternal blood during neural tube closure to learn to what extent the biochemical 
mechanism of NTDs in Bn resembles the human situation (Groenen et al. in 
press).  
Apart from knockout mice for the Zic3 gene knockdown mice for its family 
member Zic2 show NTDs in their offspring (Nagai et al. 2000). Furthermore, the 
knockout mouse of the Zic1 gene shows cerebellar defects in addition to spina 
bifida occulta (Aruga et al. 1998). Therefore, we investigated the potential role of 
ZIC gene family members in human NTDs (chapter 4.1). Mutation analysis in a 
panel of NTD patients revealed that the ZIC genes, ZIC1 and ZIC3, seem to be no 
major factors involved in human NTDs. Our analysis revealed that the most 
upstream alanine chain in the protein encoded by ZIC2 might be important in 
neural tube formation. One of the probands in our patient panel as well as his 
apparently unaffected mother and grandmother had a heterozygous variant with 
eight subsequent alanines instead of nine. In light of the involvement of ZIC2 in 
brain development, it might be worthwhile reexamining the phenotype of the 
apparently unaffected mother and grandmother of the proband for subtle brain 
abnormalities in addition to NTDs.  
In addition to zinc related transcription factors, we also investigated the impact of 
the zinc transporter SLC39A4 in human NTDs, since patients with mutations in 
this gene suffer from acrodermatitis enteropathica with an increased risk for 
human NTDs (chapter 5)(Kury et al. 2002; Wang et al. 2002). This analysis 
revealed no major involvement of the gene SLC39A4 in human neural tube 
defects. In addition to SLC39A4 there are many other zinc transporters known 
that are embryonically expressed (reviewed by Andrews 2001, and Gaither and 
Eide 2001). However, not much is known about the impact of these zinc 
transporters on the closure of the neural tube. More insight in the involvement of 
these transporters in this process might reveal new candidates for zinc related 
NTDs in humans.   
At the moment, little information is available on the molecular mechanism behind 
zinc related defects in embryogenesis, like NTDs. Recent studies have indicated 
that maternal zinc deficiency leads to defects in primary germ layers and to early 
embryo loss (Hanna et al. 2003). These defects may be ascribed to cells 
undergoing apoptosis (Jankowski et al. 1995; Rogers et al. 1995; Harding et al. 
1988). Recently, Fernandez and coworkers performed a suppletion study which 
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suggested that the zinc and cadmium related NTDs might both be involved in the 
same apoptotic mechanism (Fernandez et al. 2003). This hypothesis is supported 
by results obtained from several other studies (Botton 2000; Thompson and 
Bannigan 2001; Marlow and Freeman 1989; Stewart et al. 2003). To get more 
insight in the pathogenic nature of zinc deprivation in diseases, Cousins and 
coworkers performed microarray-based expression analysis of zinc deprived 
human monocytic/macrophage THP-1 cells, which are derived from a leukemic 
cell line (Cousins et al. 2003). This analysis showed differences in expression of 
many genes, like zinc-finger transcription factors and zinc transporters. It would 
be interesting to use the same approach for unraveling the effect of marginal zinc 
deficiency during the formation of the neural tube. To this end, ectodermal 
derived cells, like teratocarcinoma could be used, which are better related to cells 
that form the neural tube rather than THP-1 cells.   
 
6.2 Inositol related neural tube defects 
Curly tail (ct) was described as a mouse model for inositol related NTDs about 
50 years ago (Van Straaten and Copp 2001). We used expression profiling on 
microarrays to get an idea of the molecular mechanism underlying defective 
closure at the PNP in ct. In chapter 3 we provide evidence of no major 
disturbances in RNA expression at final PNP closure (somitic range of 28-37) for 
those genes involved in metabolizing inositol that were present on our 
microarray. However, since RNA from total embryos was used it can not be 
excluded that local disturbances in RNA expression are present for the genes 
involved in inositol metabolism at the time the cell proliferation defect underlying 
defective PNP closure in ct initially occurs. Furthermore, there are some genes 
involved in inositol metabolism that are not present on the microarray. To date, it 
is not known how and where inositol exerts its protective effect at the molecular 
level in ct embryos: is the protective effect of myo-inositol mediated via a specific 
signal transduction pathway influencing Pkc, Rar and Wnt signaling or does this 
nutrient exert its influence aspecifically through generally stimulating cell 
proliferation ? This is further complicated by the fact that the ct gene and its 
modifiers have not been identified yet. Recently, the gene Grainyheadlike 3 
(Grhl3) that codes for a transcription factor has been put forward as an excellent 
candidate for the ct gene by Ting and coworkers (2003). Although no Grhl3 
mutations have been found in ct yet, their hypothesis is based upon several 
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observations. First of all, the phenotype of murine Grhl3-/- knockouts resembles 
the ct phenotype, including spina bifida and a curled tail. Secondly, the authors 
claimed a cellular proliferation defect to be present in the tail bud region of 
Grhl3-/-  knockouts, which is the case for ct embryos at the 21 to 25 somite stage. 
Thirdly, the authors found expression of the Grhl3 gene in non-neural ectoderm 
of embryos at ED8.5, which is a tissue known to influence neurulation (Barth et 
al. 1999; Streit et al. 1999; Wilson et al. 1995; Wilson et al. 2001). Fourthly, the 
expression of the Grhl3 gene was reduced in ct/ct embryos compared to controls. 
Fiftly, the Grhl3 gene has been mapped to the minimal critical interval for the ct 
gene in the neighbourhood of D4Mit69 (Neumann et al. 1994; Beier et al. 1995). 
Finally, crossings of homozygous ct with Grhl3+/- mice did not result in spina 
bifida cases, which together with the mapping analysis provide the most 
convincing evidence for the Grhl3 gene being the ct gene. Unfortunately, Grhl3 
was not present on the microarray used in our analysis of ct (chapter 3). Ting and 
coworkers hypothesized that disturbances in RNA expression of the Grhl3 gene 
as a result of mutations in distal regulatory sequences might underlie the ct 
phenotype, since no mutations were found in the coding region and flanking 
sequences of this gene. Unlike for ct, inositol supplementation has no preventive 
effect on spina bifida in the offspring of Grhl3 mice. The authors explain this 
observation by a hypomorphic nature of the mutated Grhl3 gene in ct. Residual 
expression of this gene might be necessary for inositol to exerts its protective 
influence. The authors showed an intermediate expression of Grhl3 in one out of 
two Grhl3+/- embryos tested compared to Grhl3-/- and homozygous ct embryos 
with Northern analysis. This was confirmed by real time (RT-)PCR. In a single 
Grhl3+/- embryo expression was equal to that in homozygous ct embryos. This 
might be explained by the presence of modifier loci in ct. The neural phenotype 
of Grhl3-/- knockouts is more severe than the phenotype of homozygous ct 
embryos. In addition, heterozygous Grhl3 knockouts have no neural phenotype. 
The authors suggest that Grhl3 gene might be linked to inositol via 
phosphorylation by MAP kinases that are activated by PKC (Bondeva et al. 1998; 
Toker 2002). It is still also possible that Grhl3 is not the ct gene and that modifier 
genes might be necessary for the protective effect of inositol in ct.  
Recently, it has been shown by Cogram and coworkers that inositol exerts its 
influence on ct through stimulation of the conventional Pkc (cPkc) isomers βI and 
γ, leading to prevention of neural tube defects in ct (Cogram et al. 2003). The 
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preventive effect of inositol in ct is most probably not mediated through a 
shortage of particular Pkc isotypes (Cogram et al. 2003). Results obtained from 
our microarray analysis are in agreement with this hypothesis (chapter 3). In the 
study of Cogram et al. (2003) the normalising effect of inositol on PNP closure 
was partially blocked by inhibition of the atypical PKC (aPKC) isomer ζ or 
phosphoinositide 3-kinase. Phosphoinositide 3-kinase stimulation has been linked 
to upregulation of PKCζ (Chou et al. 1998; Le Good et al. 1998). The RNA 
expression for all genes coding for phosphoinositide 3-kinase subunits that were 
present on our microarray was not disturbed in BALB/c-ct recombinant embryos 
during PNP closure. Inositol might still mediate its protective effect in ct through 
phosphoinositide 3-kinase since not all the genes encoding phosphoinositide 3-
kinase subunits were present on our microarray. Transient co-transfection studies 
using teratocarcinoma cells have shown that one of the other two Pkc isomers 
linked to NTDs in ct, Pkcγ, can potentiate the effect of Rarγ upregulation (Kurie 
et al. 1993). The RNA expression of Rarβ is affected in the hindgut of ct 
embryos. Retinoic acid is also known to bind directly to Pkc, at least to the α 
isotype (Ochoa et al. 2003). Proteins that are stimulated by Pkc might regulate 
the expression of Rarβ2 through a RARE element in the Rarβ2 promoter region.  
Another question that remains is why the protective effect of myo-inositol is 
lower than of one of its stereoisomers D-chiro-inositol (Cogram et al. 2002). It 
might suggest that an epimerase that converts myo-inositol to D-chiro-inositol is 
disturbed in ct, leading to less availability of D-chiro inositol in ct. However, no 
such epimerase has been identified in mice yet although epimerase activities have 
been observed in type 2 diabetic rats (Sun et al. 2002). Another possibility is that 
the activity of transporters of inositol stereoisomers is disturbed in the affected 
regions of ct during PNP closure; the transporters identified yet have a wide 
range of polyol substrates, e.g. Smit1 can transport myo-inositol, whereas Smit2 
also transports D-chiro-inositol (Coady et al. 2002). Greene and coworkers 
showed that inositides are not disturbed in ct (Greene and Copp 1997). However, 
since they used whole embryos during PNP closure for their analysis it can not be 
excluded that there is a disturbed distribution of different types of inositides in the 
embryo at the affected regions, which results in the local cell proliferation defect 
in ct. Future studies should give an answer to these questions.  
Results obtained from our microarray analysis showed no major defects in 
expression of the inositol metabolism related genes at the time of PNP closure in 
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ct (chapter 3). Severe changes in genes involved in the metabolism of inositol are 
known to cause diverse type phenotypes not related to that of ct, including acute 
myeloid leukemia, myotubular myopathies, cancer, Marie tooth syndrome, Lowe 
syndrome, diabetes mellitus type II and pathogenic bacterial invasion (reviewed 
by Pendaries et al. 2003). It might be that in ct more subtle (or localized) changes 
are present in the expression of inositol metabolism related genes, which can not 
be detected with our microarray procedure. A number of other genes, not directly 
related to this metabolism, like the genes Fxy, Cort, Krox-20 and Rpa2, showed 
significant differential expression in the comparison of affected BALB/c-curly tail 
recombinant embryos and the control strain BALB/c. At the moment, it is still 
difficult to place these genes in a molecular mechanism since our microarray 
represented only approximately one fifth of the complete genome (chapter 3). In 
the future, whole genome expression analysis could be performed. Also, affected 
tissues from ct, like tailbud and hindgut endoderm could be dissected from the 
embryos with a laser and RNA isolates could be amplified and subsequently used 
for whole genome expression analysis. Undoubtedly this approach will reveal 
other genes involved in the cell proliferation defect of ct and will give a better 
understanding of the mechanism involved in the ct phenotype. 
It is as yet unknown whether the inositol related ct model really reflects the 
human situation. However, inositol status seems to be involved in NTDs in 
humans as well (Greene and Copp 1997; Cogram et al. 2002; Groenen et al. in 
press). The work of Greene and coworkers showed that myo-inositol has a 
protective effect in spinal neural tube closure in ct which is mediated through the 
inositol/lipid cycle, stimulating Pkc activity (Greene and Copp 1997). In humans 
the major inositol/lipid to Pkc routing may be affected in embryos or mothers 
with lowered inositol status. To test this idea we have studied the involvement of 
two candidate genes in human NTDs which code for proteins that are substrate 
targets of PKC (chapter 4.2). These genes are TFAP2A, coding for a transcription 
factor, and MLP, coding for MARCKS like protein. Knockout mice for these 
genes show NTDs (Wu et al. 1996; Zhang et al. 1996). In chapter 4.2 we have 
presented evidence for no major involvement of the human genes TFAP2A and 
MLP in (spinal) NTDs. The latter protein is involved in actin filament formation. 
Ybot-Gonzalez and coworkers showed that the actin filament formation-disturbing 
agent cytochalasin does not interfere with spinal neurulation (Ybot-Gonzalez and 
Copp 1999). Therefore, proteins specifically involved in the process of actin 
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remodelling, like MLP and CSK, might not be good candidates for human spinal 
NTDs after all. Instead, these genes might be good candidates for cranial NTDs, 
such as anencephaly, since cytochalasin does disrupt cranial neurulation. In 
addition to genes encoding PKC substrates we also investigated the inositol 
cotransporter KST1 for its involvement in human NTDs (chapter 5). Our analysis 
showed no major involvement of this inositol transporter in human NTDs. To 
date, not much information is available on the spatio-temporal activity of different 
transporters in pregnant females during embryonic development. More 
information needs to be gathered on the impact of all inositol transporters in 
inositol clearance of maternal blood, intestinal absorption of inositol, or transfer 
between mother and embryo, to assess their relevance in NTDs. 
 
6.3 General overview: inositol, zinc and neural tube defects 
It is already known for quite some time that the nutrients folate and inositol have 
a distinct impact on the frequency of NTDs in mouse models for NTDs; there are 
several folate sensitive models and just one inositol sensitive model, the ct mouse 
(reviewed in Juriloff et al 2000). Groenen and coworkers showed that zinc and 
inositol levels in mothers and their children are associated with spina bifida 
(Groenen et al. in press). It remains to be investigated whether the molecular 
mechanisms involved in the human zinc and inositol related NTDs can be 
compared to the murine situation.  
Zinc status in embryos and mothers during proper closure of the neural tube 
reflects many processes, e.g. enzymatic conversions that depend on availablility 
of zinc, transport of zinc, global/local zinc regulation of gene expression through 
epigenetic processes (Graf and Oleinik 2000). The same can be said for inositol. 
At the moment, not much is known about how embryos and their mothers deal 
with these nutrients on a molecular level during neural tube closure, e.g. 
transport from mother to embryo or intra-embryonic transport. Furthermore, it is 
not known to what level the embryo depends on de novo synthesis of inositol for 
the formation of the neural tube. Better understanding of these processes 
underlying zinc and inositol homeostasis in murine embryos and their mothers 
will be helpful in selecting the proper candidate genes for human NTDs. Mouse 
studies have suggested that different molecular pathways are involved in NTDs at 
different positions along the neural axis (reviewed by Copp et al. 2003). For 
instance, the dorsal lateral hinge points (DHLP) are necessary for correct 
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formation of the cranial neural tube and this is not the case for the spinal neural 
tube. Genes implicated in the formation of the DLHP should therefore be good 
candidate genes for human cranial NTDs, but not for spinal NTDs. For the 
present studies, we have selected candidate genes for zinc and inositol related 
NTDs based on mouse models showing NTDs in their offspring. However, these 
models also show other embryonic abnormalities that form part of a syndrome. 
The syndromes in these models are usually caused by a severe genetic defect, 
e.g. gene knockout. We have tested only non-syndromal human NTD cases, 
which are generally believed to be caused by subtle genetic changes. It might 
therefore be interesting to also test syndromal human NTD cases, which probably 
have severe genetic defects underlying the syndromes. In the future, candidate 
gene analysis on selected panels of syndromic NTDs might reveal whether this is 
the case. 
To date, most of the genetic research on human zinc and inositol related NTDs 
was focused on spina bifida, due to the relative low availablility of DNA material 
from other types of NTDs, including anencephaly, encephalocele and 
(cranio)rachischisis. It might be interesting to investigate the influence of zinc and 
inositol related genes on the occurrence risk of these severe types of NTDs. To 
this end, a major effort should be undertaken to combine DNA material of 
patients from various clinical institutes. 
Apart from the genetic impact of zinc and inositol on NTDs not much is known 
about the dietary impact of inositol and zinc. Inositol and zinc intestinal 
absorption are influenced by the presence of several components in the diet 
(reviewed by Sandberg et al. 2002). For instance, the inositol related nutrient 
folate has been shown to influence zinc status in rats (Ghishan et al. 1986) and 
humans (Milne et al. 1984), although subsequent studies showed no such effect in 
rats (Keating et al. 1987) and humans (Butterworth, Jr. et al. 1988; Hansen et al. 
2001; Gibson et al. 2001; Green et al. 2003). It is also known that inositol 
inhibits intestinal absorption of zinc (reviewed by Sandberg et al. 2002). 
Nutritional studies in mothers with a NTD child should give a better idea of the 
impact of the dietary composition on the occurrence risk for NTDs. 
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Summary 
 
The formation of the neural tube is a complicated process in which many 
different type of genes and environmental factors are involved. Genes involved in 
neural tube defects (NTDs) can be placed in diverse functional groups, like 
cytoskeletal organization components, transcription factors, transporters, enzymes 
and signal transduction factors. Most of the information about genes involved in 
NTDs relies on mouse models. Over 80 mouse models for NTDs are already 
known. Most of these models are mice in which certain genes have been knocked 
out, only some of these models are spontaneous mutants. One such spontaneous 
mouse mutant is curly tail (ct), which has been studied in detail for its phenotype. 
Another spontaneous mutant is the Bent tail (Bn) mouse of which the neural 
phenotype had not been studied extensively at the start of this project. In addition 
to genes also environmental factors are involved in murine and human NTDs, 
including zinc, inositol and folate. Some of the mouse models for NTDs are 
folate responsive with regard to the frequency of NTDs in their offspring. There 
is just one mouse model, the ct mouse that shows a decrease in frequency of 
NTDs in its offspring after supplementation with the nutrient inositol during 
pregnancy.  
To learn more about the role of these nutrients and related genes in human NTDs 
we studied murine models for NTDs. We used Bn as a model for zinc related 
NTDs and ct as a model for inositol related NTDs. In addition to murine models 
we studied human patients and their mothers to learn more about the role of zinc 
and inositol and related genes in human NTDs. 
 
Bent tail 
About 50 years ago Grüneberg observed tail deformities in Bn with absence of 
some caudal vertebrae, malformed and small vertebrae. In this thesis we describe 
various other aberrations in Bn embryos including the cranial type of the NTD 
exencephaly, rotation defects and occasionally omphalocele, orofacial schisis and 
situs abnormalities (chapter 2.1 and 2.2). We were the first to identify the 
genetic defect of Bn as a submicroscopic deletion of approximately 300 kb fully 
encompassing the Zic3 gene (chapter 2.1 and 2.2). In addition to the gene Zic3 a 
pseudogene (Ensembl Gene ID: ENSMUSG00000048861), two Expressed 
Sequence Tags (ESTs) (EST 2424689 and EST 111725) and an EST cluster 
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(UniGene cluster Mm.172891) appeared to be deleted in Bn as well (chapter 
2.2). Recently, knockouts for the Zic3 gene were generated, which showed the 
same phenotypic characteristics as the Bn mouse, including exencephaly and tail 
deformities. Therefore, Zic3 seems to be the major gene involved in the Bn 
phenotype. We showed that also the ESTs in the deleted genomic area of Bn were 
expressed during embryogenesis in the wild type situation and might therefore be 
of (minor) importance for the Bn phenotype. In this thesis we used the Bn mouse 
as a model for zinc related human NTDs. 
We further examined the embryonic phenotype of the Bn mouse in detail to learn 
more about its neural development. In 11 - 16% of embryos from matings of 
heterozygous Bn females and hemizygous Bn males exencephaly was observed. 
This is a closure defect of part of the midbrain and hindbrain region of the 
anterior neural tube (chapter 2.1 and 2.3). A number of other defects were 
observed with electron microscopy in both wild type and Bn embryos including a 
kinked neural tube and a delay in axial rotation (chapter 2.3.). The severity of 
most defects, the delay in axial rotation excluded, was significantly higher in Bn 
embryos compared to wild type embryos. Other abnormalities were seen only in 
Bn embryos. These defects were related to anterior and posterior neural tube 
closure and resulted in exencephaly and a closure delay of the posterior 
neuropore, respectively. At a later stage of development (Embryonic Day (ED) 
14), the defective closure was followed by massive overgrowth of brain tissue 
both in the open parts of the neural tube and in the more rostral parts of the 
mesencephalon, causing disorganization of these brain structures as well as 
inducing some aspects of asymmetry.  
Since dietary zinc is involved in human NTDs and the zinc finger transcription 
factor Zic3 is not present in Bn we thought it would be worthwhile to study the 
effect of periconceptional zinc supplementation of the mothers’ diet in Bn. In 
addition to zinc also other NTD related components were studied accordingly on 
the Bn phenotype, including folinic acid and myo-inositol. To this end, the tail 
phenotype was used as a marker for NTDs since the posterior neuropore closure 
is delayed in Bn (chapter 2.3). This study revealed no significant effects of zinc, 
inositol and folinic acid on either the tail phenotype of the offspring or the size 
and genotypic composition of the litters (chapter 2.4). 
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Curly tail 
At the beginning of this study little was known about the molecular mechanism 
involved in inositol related NTDs in ct. The protective effect of inositol in ct is 
mediated via the phosphoinositide signaling pathway, leading to stimulation of 
Pkc. We used microarray-based expression profiling to get a better insight in 
these molecular processes. To this end, we focused our attention to the 
expression of inositol metabolism related genes. All inositol metabolism related 
genes represented on the microarray were expressed during (ED10.5) and beyond 
(ED11.5 and ED12.5) the embryonic stage of (wild type) spinal neural tube 
closure at a fairly constant level (chapter 3). Furthermore, two experiments were 
conducted on whole embryos during PNP closure: (1) a comparison between 
recombinant-BALB/c ct with affected PNP closure and BALB/c embryos, (2) a 
comparison between recombinant-BALB/c ct with affected and with unaffected 
PNP closure. Neither experiment showed significant differences in the expression 
of any of the inositol related genes (chapter 3). However, a number of other 
genes, not directly related to inositol metabolism, like the genes Fxy, Cort, Krox-
20 and Rpa2, showed significant differential expression in the comparison of 
affected recombinant-BALB/c ct embryos and the control strain. More studies in 
ct are necessary to place these genes in a molecular mechanism of inositol related 
NTDs. 
 
Candidate gene analysis 
Zinc related genetic factors in humans 
Zinc finger transcription factors depend on zinc for their binding to DNA. One 
family of genes that code for zinc finger transcription factors is the ZIC gene 
family, which comprises the members ZIC1-5. When Zic1 is knocked out in mice 
spina bifida occulta is observed in their offspring. Therefore, we performed 
mutation analysis on the coding region and flanking sequences of the human 
ortholog ZIC1 in a large panel of patients with NTDs. Neither mutations nor 
polymorphisms were found in the coding region or flanking sequences of ZIC1. 
Knockdown mice for Zic2 also show NTDs in their offspring. Therefore, we also 
analyzed the coding region and flanking sequences of the human ZIC2 gene. This 
analysis revealed a patient with a deletion of one codon that encodes an alanine 
residue located in the amino terminal alanine stretch of the protein (chapter 4.1). 
The deletion was present in one patient, but not in a large panel of controls. 
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Transmission Disequilibrium Testing (TDT) of a frequent (silent) polymorphism 
in the ZIC2 gene (1059C>T, H353H) in parent-spina bifida aperta child triads 
showed no association with NTDs (chapter 4.1). Since Zic3 knockout mice, as 
well as Bn mice, show X-linked NTDs we performed mutation analysis also on 
the coding region and flanking sequences of the human ortholog. One silent 
polymorphism (858G>A,V286V) of unknown significance was identified in 
ZIC3 in only one patient (chapter 4.1).  
Patients with zinc related NTDs might have a disturbed cellular uptake of zinc 
resulting in NTDs. One of the many zinc transporters, SLC39A4, is involved in 
the disease acrodermatitis enteropathica. Patients with this disease sometimes 
have NTDs in their offspring. Therefore we performed association testing of a 
frequent genetic variant in SLC39A4 (1069C>T, A357T) using a large panel of 
spina bifida patients and their parents. Transmission disequilibrium testing of this 
frequent polymorphism showed no association with NTDs (chapter 5). 
Furthermore, ANOVA revealed no association between the genetic variant 
1069C>T in SLC39A4 and mean zinc concentration in red blood cells from 
patients and their mothers (chapter 5). 
 
Inositol related genetic factors in humans 
Knockout mice for several targets of protein kinase C (PKC) show NTDs in their 
offspring. Examples are the MARCKS-like protein (MLP), which is involved in 
actin filament organization, and TFAP2A, which is involved in gene expression 
regulation. Since cleavage of phosphatidylinositol-(1,4)- biphosphate leads to 
PKC stimulation both PKC targets are related to inositol. The genes coding for 
these PKC targets, MLP and TFAP2A, were investigated for their involvement in 
human NTDs by candidate gene analysis using a large panel of patients.   
Using a TDT-based log-linear approach we found a relative risk of 5.3 (CI 0.66 – 
42.2) for spina bifida aperta conferred by the 1257C allele in the TFAP2A gene, 
encoding a transcription factor (chapter 4.2). This indicates that TFAP2A might 
be (a minor factor) involved in human NTDs. Sequence analysis of the entire 
coding region of MLP in a large panel of NTD patients revealed no genetic 
variations (chapter 4.2). Thus, variation in the coding region of MLP does not 
seem to be an important factor involved in human NTDs. Apart from the 
functionality of PKC targets also transport and/or synthesis of inositol might be 
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disturbed in patients with NTDs or their mothers. Transmission disequilibrium 
testing of a frequent polymorphism in the genes KST1 (544C>T, V182A), 
coding for an inositol transporter, and  ISYNA1 (1029A>G, L343L), coding for 
myo-inositol synthase, in parent-spina bifida aperta child triads showed no 
association with NTDs (chapter 5). However, ANOVA revealed a significant 
association between KST1 and mean maternal myo-inositol serum concentrations 
(chapter 5). Furthermore, conditional logistic regression modeling revealed a 
significant interaction between maternal glucose concentrations and the ISYNA1 
genetic variant on the risk of spina bifida (chapter 5). Apart form genes involved 
in inositol signaling we also investigated the gene CSK that is involved in a PKC 
regulated process, which is actin filament organization. The gene CSK encodes a 
negative regulator of Src family tyrosine kinases, like p59 and p60. Knockout 
mice for Csk show NTDs in their offspring. Therefore, we performed mutation 
analysis and association testing for the gene CSK in patients with NTDs. 
Mutation analysis of the coding region and part of the introns of the CSK gene 
identified three novel (infrequent) silent polymorphisms: 210C>T, 759C>T and 
792C>T (chapter 4.2). No differerence in occurrence was observed for these 
genetic variants between patients and controls. Thus, CSK also seems to be no 
major factor involved in human NTDs.   
 
Conclusion 
This is the first study that assesses the relevance of zinc and inositol related genes 
in murine and human NTDs. Microarray analysis in ct embryos and candidate 
gene analysis in human NTD patients seem to point to a direction of a normal 
inositol metabolism in non-syndromic NTDs. In addition to inositol related genes 
we have also analyzed  a number of zinc related genes for their involvement in 
human NTDs. The gene SLC39A4 codes for an important intestinal zinc 
transporter, but does not seem to be an essential factor in human NBDs. In 
addition to zinc transporters also zinc finger transcription factors depend for their 
activity on zinc. Many zinc finger transcription factors are involved in murine 
NTDs (e.g. Zic3 in Bn), but the relevance of the human orthologs in NTDs 
remains elusive; a question is whether the deletion of an alanine residue in the 
most proximal alanine stretch in ZIC2 of a single spina bifida aperta patient is of 
importance for correct formation of the human spinal neural tube, which requires 
a functional test. In the future, the impact and interaction of zinc and inositol 
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related genetic factors and dietary pattern (zinc and inositol status) on the 
formation of the neural tube need further investigation.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary & samanvatting 
227  
Samenvatting 
 
De vorming van de neurale buis is een gecompliceerd proces. Bij dit proces zijn 
veel typen genen betrokken. Deze genen behoren bij verschillende functionele 
groepen, zoals componenten van het cytoskelet, transcriptiefactoren, transporters, 
enzymen en signaaltransductie factoren. Veel onderzoek naar genen betrokken bij 
neurale buisdefecten (NBDs) is verricht in muizen. Voor NBDs zijn meer dan 80 
muizenmodellen bekend. Tot deze modellen behoren veelal muizen waarbij genen 
zijn verwijderd en een aantal van deze muizen zijn spontane mutanten. Curly tail 
(ct) is zo’n spontane mutant waarvoor het fenotype in detail is bestudeerd. Een 
ander spontane mutant is Bent tail (Bn). Voor start van dit project was het neurale 
fenotype van deze mutant echter nog niet intensief bestudeerd. Naast genen zijn 
ook omgevingsfactoren betrokken bij NBDs, zoals zink, inositol en foliumzuur. 
Bij een aantal muizenmodellen voor NBDs zorgt periconceptionele toediening van 
foliumzuur voor een afname van het aantal NBDs in de nakomelingen. De ct 
muizen mutant is het enige model waarbij inositol een zelfde effect te zien geeft.  
In deze studie hebben wij muizenmodellen gebruikt om meer te leren over de rol 
van deze nutriënten en gerelateerde genen in humane NBDs. De Bn muis is 
gebruikt als model voor zink gerelateerde NBDs en de ct muis als model voor 
inositol gerelateerde NBDs. Naast de situatie in muizen waren we ook 
geïnteresseerd in de humane situatie. Wij hebben patiënten en hun moeders 
bestudeerd om meer te weten te komen over de rol van zink- en inositol-
gerelateerde genen in humane NBDs.    
 
Bent tail 
Het fenotype van de Bn muis is zo’n 50 jaar geleden als eerste beschreven door 
Grüneberg: staartafwijkingen met afwezigheid van enkele vertebrae, en 
misvormde en kleine vertebrae. We beschrijven verscheidene andere embryonale 
afwijkingen van Bn in deze thesis, waaronder exencefalie, rotatiedefecten en 
omphalocele, orofaciale schisis en situsafwijkingen (hoofdstuk 2.1 en 2.2). Wij 
waren de eerste onderzoekers die het genetisch defect van Bn hebben 
geïdentificeerd als een  deletie van zo’n 300 kb, welke het volledige gen Zic3 
omvat. Verder maken ook een pseudogen (Ensemble Gen ID: 
ENSMUSG00000048861), twee Expressed Sequence Tags (ESTs) (EST 2424689 
en EST 111725) en een EST cluster (Unigene cluster Mm. 172891) deel uit van 
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de deletie in Bn (hoofdstuk 2.2). Recentelijk zijn Zic3 knockouts beschreven die 
een soortgelijk fenotype vertonen als Bn, waaronder exencefalie en 
staartafwijkingen. Hieruit kan worden geconcludeerd dat het Zic3 gen 
verantwoordelijk is voor het Bn fenotype. De ESTs die gelegen zijn in het 
gedeleteerde genomische gebied van Bn komen tot expressie tijdens de 
embryogenese en kunnen daarom een minder belangrijke rol vervullen in het Bn 
fenotype. In dit proefschrift is de Bn muis gebruikt als een model voor zink 
gerelateerde humane NBDs.  
Wij hebben het embryonale fenotype van de Bn muis nader bestudeerd om meer 
te leren van de neurale ontwikkeling in Bn. Kruisingen tussen heterozygote Bn 
vrouwtjes en hemizygote mannetjes resulteerde in 11-16% embryos met 
exencefalie. Dit is een sluitingdefect van de rostrale neurale buis van een deel van 
het mesencephalon en rhombencephalon (hoofdstuk 2.1 en 2.3). Een aantal 
andere afwijkingen zijn zowel in Bn als wild type embryos geobserveerd met 
electronen microscopie, waaronder kinks in de neurale buis en vertraging in 
axiale rotatie (hoofdstuk 2.3). De kinks in de neurale buis komen frequenter 
voor in Bn embryos dan wild type embryos. Dit is niet het geval voor axiale 
rotatie. Andere afwijkingen zoals exencefalie en een sluitingsdefect van de 
caudale neuropore komen alleen voor in Bn embryos. Defecte sluiting van de 
rostrale neuropore in Bn resulteert in overgroei van hersenweefsel zowel in de 
open delen van de neurale buis als in de meer rostrale delen van het 
mesencephalon op ED14. Dit veroorzaakt disorganisatie en asymmetrie van deze 
hersenstructuren.  
Om meer te weten te komen over de nutrienten status in Bn hebben wij het effect 
van periconceptionele zink suppletie onderzocht omdat zink betrokken is bij 
humane NBDs en het ontbreken van de zink vinger transcriptie factor Zic3 de 
oorzaak vormt van NBD bij Bn (hoofdstuk 2.4). Verder hebben wij onderzocht 
of de NBD-gerelateerde componenten foliumzuur en myo-inositol een rol spelen 
in het fenotype van de Bn muis. Voor deze studie is het fenotype van de staart 
gebruikt als merker voor NBDs omdat de sluiting van de caudale neuropore 
vertraagd plaatsvindt in Bn (hoofdstuk 2.3). In deze studie is geen significant 
effect gevonden van zink, inositol en foliumzuur op het staartfenotype en de 
genotypedistributie van de nakomelingen (hoofdstuk 2.4).  
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Curly tail  
Voor aanvang van deze studie was weinig bekend over het moleculair 
mechanisme van inositol gerelateerde NBD in ct. Het beschermend effect van 
inositol in ct ontstaat via phosphoinositide signalering en leidt tot stimulatie van 
Pkc. Wij hebben voor microarray-gebaseerde expressie profilering gekozen om 
een beter inzicht te krijgen in deze moleculaire processen. Hierbij hebben wij ons 
met name gericht op de expressie van genen betrokken bij het inositol 
metabolisme. Alle genen uit het inositol metabolisme die op de array aanwezig 
waren komen vrij constant tot expressie tijdens ED10,5 en gedurende ED11,5 en 
ED12,5, de embryonale stadia waarin de sluiting van de neurale buis plaatsvindt 
(hoofdstuk 3). Verder zijn twee andere experimenten uitgevoerd op hele embryos 
tijdens sluiting van de caudale neuropore: (1) een vergelijking tussen 
recombinant-BALB/c ct embryos met aangedane sluiting en BALB/c embryos, 
(2) een vergelijking tussen recombinant-BALB/c ct embryos met aangedane en 
normale caudale sluiting. Bij geen van deze experimenten zijn significante 
verschillen gevonden in de RNA-expressie van genen aan het inositol-
metabolisme (hoofdstuk 3). Een aantal genen die niet direct gerelateerd zijn aan 
het inositol-metabolisme vertonen echter wel  significante verschillen in expressie 
tussen aangedane recombinant-BALB/c ct embryos en de controle stam BALB/c 
(voorbeeld Fxy, Cort, Krox20 en Rpa2). Er zijn meer studies nodig in ct om deze 
genen in een moleculair mechanisme te plaatsen voor inositol gerelateerde NBDs.  
 
Kandidaat gen analyse  
Humane zink gerelateerde genetische factoren  
Zink vinger transcriptiefactoren zijn voor hun interactie met DNA afhankelijk van 
zink. De ZIC genen vormen een genfamilie van zink vinger transcriptie factoren; 
ZIC1-5. Zic1 knockout muizen vertonen spina bifida occulta in hun 
nakomelingenschap. Dit is de reden waarom wij mutatieanalyse hebben 
uitgevoerd voor de coderende en flankerende sequenties van de humane ortholoog 
ZIC1 in een groot panel van NBD patiënten. In de coderende en flankerende 
sequenties van ZIC1 zijn geen mutaties of andere genetische veranderingen 
aangetroffen. In muizen is deficiënte expressie van Zic2 geassocieerd met NBDs. 
Daarom hebben wij mutatie analyse uitgevoerd voor de coderende en flankerende 
sequenties van het humane gen ZIC2. Met deze analyse hebben wij een deletie 
gevonden van een codon dat codeert voor een alanine die gelegen is in de amino 
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terminale alanine stretch van het eiwit (hoofdstuk 4.1). De deletie is aanwezig in 
één patiënt, maar niet in een controlegroep. We hebben een Transmission 
Disequilibrium Test (TDT) uitgevoerd voor een frequent polymorfisme in het 
ZIC2 gen (1059C>T, H353H) van ouder-spina bifida aperta kind trio’s. Bij deze 
analyse is geen associatie gevonden met NBDs (hoofdstuk 4.1). Verder hebben 
we mutatieanalyse uitgevoerd voor de coderende en flankerende sequenties van 
het humane gen ZIC3 in een groot NBD patiënten panel, omdat Zic3 knockout 
muizen en Bn modellen zijn voor X-linked NBDs. Met deze analyse hebben wij 
een genetische verandering gevonden in het ZIC3 gen van een patiënt waarvan 
nog niet bekend is of het een effect heeft op de expressie van het gen (hoofdstuk 
4.1).  
Het is mogelijk dat patiënten met zink gerelateerde NBDs een verstoorde 
cellulaire opname hebben van zink. Er zijn veel zink transporters bekend en één 
daarvan is betrokken bij de ziekte acrodermatitis enteropathica. Dit is de zink 
transporter SLC39A4. Patiënten met acrodermatitis enteropathica hebben soms 
NBDs. Wij hebben daarom associatietesten uitgevoerd voor een frequente 
genetische variant van SLC39A4 (1069C>T, A357T) in een groot panel van 
spina bifida aperta patiënten en hun ouders. Wij hebben geen associatie gevonden 
met de TDT test tussen het frequente polymorfisme in SLC39A4 en de ziekte 
spina bifida aperta (hoofdstuk 5). Ook hebben wij geen associatie gevonden 
tussen de genetische variant 1069C>T in SLC39A4 en de gemiddelde zink 
concentratie in rode bloedcellen van patiënten en hun moeders (hoofdstuk 5).  
 
Humane inositol gerelateerde genetische factoren  
NBDs komen voor in de nakomelingenschap van knockoutmuizen van een aantal 
targets van PKC. Een voorbeeld van zo’n PKC substraat is MARCKS-like 
protein (MLP), welke betrokken is bij de organisatie van actine filamenten. Een 
ander voorbeeld is TFAP2A dat betrokken is bij gen regulatie. Beide substraten 
van PKC zijn gerelateerd aan inositol, omdat splitsing van phosphatidylinositol-
(1,4)-bifosfaat leidt tot stimulatie van PKC. Wij hebben de genen die coderen 
voor deze PKC substraten onderzocht op hun betrokkenheid bij humane NBDs 
met kandidaat gen analyse waarbij we gebruik gemaakt hebben van een groot 
panel van patiënten. Wij hebben een relatief risico van 5,3 (CI 0,66-42,2) 
gevonden voor spina bifida aperta dat veroorzaakt wordt door het 1257C allel van 
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TFAP2A met behulp van een op TDT gebaseerde log-lineare methode (hoofdstuk 
4.2). Deze resultaten geven aan dat het gen TFAP2A mogelijk een rol speelt in 
humane NBDs. Wij hebben geen genetische veranderingen gedetecteerd in de 
volledig coderende sequentie van MLP van een groot panel van NBD patiënten 
met behulp van sequentie analyse. Dus, de coderende sequentie van MLP lijkt 
niet als belangrijke factor betrokken te zijn bij humane NBDs. Naast de 
functionaliteit van PKC substraten kan ook transport van inositol en/of synthese 
van inositol verstoord zijn in NBD patiënten en hun moeders. Wij hebben een 
TDT test uitgevoerd voor een frequent polymorfisme in het gen KST1 (544C>T, 
V182A), dat codeert voor een inositol transporter. Hierbij is geen associatie 
gevonden met spina bifida aperta (hoofdstuk 5), ofschoon een significante 
associatie gevonden is tussen het gen KST1 en de gemiddelde maternale inositol 
concentratie in serum.  Hetzelfde resultaat is verkregen voor een TDT test 
waarvoor een genetische variant is gebruikt van het gen ISYNA1 (1029A>G, 
L343L) dat frequent voorkomt in een panel van ouder-spina bifida aperta trio’s 
(hoofdstuk 5). Naast genen uit het inositol-metabolisme hebben wij ook het gen 
CSK onderzocht op betrokkenheid bij humane NBDs. CSK is betrokken bij de 
organisatie van actine filamenten dat een PKC gereguleerd proces is. Het gen 
CSK codeert voor een eiwit dat de werking remt van Src tyrosine kinases, 
waaronder p59 en p60. Wij hebben mutatie analyse uitgevoerd voor het 
coderende deel en flankerende sequenties van het gen CSK in een groot panel van 
NBD patiënten. Dit resulteerde in de detectie van drie nieuwe genetische 
varianten die geen van allen resulteren in een aminozuurverandering: 210C>T, 
759C>T en 792C>T (hoofdstuk 4.2). Wij hebben geen verschillen gevonden in 
frequentie van deze genetische veranderingen tussen patiënten en controles. Dus 
CSK lijkt geen belangrijke factor te zijn voor humane NBDs.  
 
Conclusie  
Dit is de eerste studie waarin de relevantie van zink- en inositol-gerelateerde 
genen in NBDs van muis en mens onderzocht is. Onze microarray resultaten in ct 
embryos en kandidaat gen analyse in humane NBDs geven aan dat meestal een 
normaal inositol-metabolisme aanwezig lijkt te zijn in niet-syndromale NBDs. 
Naast inositol-gerelateerde genen hebben wij ook een select aantal zink-
gerelateerde genen geannalyseerd op hun betrokkenheid bij humane NBDs. 
Hierbij bleek het gen SLC39A4 dat codeert voor een belangrijke zink transporter 
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in darmen geen essentiële factor te zijn voor humane NBDs. Naast zink 
transporters zijn ook zink vinger transcriptiefactoren afhankelijk van zink voor 
hun functionaliteit. Vele zink vinger transcriptie factoren zijn betrokken bij 
muizen NBDs (voorbeeld Zic3 in Bn). Het is echter nog niet duidelijk wat de 
relevantie is van de humane orthologen in NBDs; een vraag is of de deletie van 
een alanine residu in de meest proximale alanine stretch van ZIC2 van een spina 
bifida aperta patiënt belangrijk is voor correcte formatie van de humane spinale 
neurale buis wat een functionele test behoeft. In de toekomst behoeft de impact en 
interactie van zink en inositol gerelateerde genetische factoren en het dieet 
patroon (zink en inositol status) op de formatie van de neurale buis verder 
onderzoek. 
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